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Name:   Lee Cameron 
Title: Evaluation of an orthotic intervention for the management of 
pregnancy related pelvic girdle pain (PGP) 
 
The overall aim of the thesis was to evaluate the effectiveness of a novel 
orthotic intervention, a customised Dynamic Elastomeric Fabric Orthosis (DEFO), in the 
management of both antenatal and post-partum pelvic girdle pain (PGP). In the first 
instance the fabric, from which the DEFO was constructed, underwent testing to 
determine if the different colour fabrics available possessed the same underlying fabric 
stiffness and elastic hysteresis to ensure that each orthotic was standardised. 
Laboratory testing identified significant differences in both fabric stiffness and elastic 
hysteresis, between colours. The findings of this study enabled standardisation of the 
intervention by using a single coloured customised DEFO (Black), ensuring rigor of the 
planned evaluation studies.   
A randomised controlled trial, with participants experiencing antenatal PGP, 
was then completed assessing the effectiveness of the novel customised DEFO in 
comparison to a standard issue pelvic belt (Serola Belt). It found that there was both a 
statistically (p<.05) and clinically significant (one point minimal clinically important 
difference (MCID)) change in favour of the DEFO in reducing both day and night pain as 




Following impromptu discussions with participants experiencing long-standing 
PGP, and a further review of the literature, it was evident that this was an under-
researched area.  A single case study series was therefore undertaken to explore the 
potential effectiveness of the customised DEFO in reducing pain and improving 
function and quality of life in women with chronic (> 3months) PGP. The single case 
study series also afforded an opportunity to identify potential outcome measures that 
could be used if a larger trial was considered in the future. This single case study series 
suggests that a customized DEFO could potentially reduce pain, increase health related 
quality of life, improve mood and increase activity levels for persons suffering from 
chronic post-partum PGP, thereby hopefully identifying a possible new treatment 
option for managing this condition. The results of this single case study series provides 
the basis for a larger clinical trial. 
Conclusion 
This thesis has provided an evaluation of orthotic intervention for pregnancy 
related PGP. The results have shown that orthotic intervention in antenatal PGP can 
provide an improvement in PGP related symptoms such as pain and function. This 
research has helped to fill a knowledge gap and provided current evidence to move 
towards improved clinical care. Furthermore, this thesis has provided a more in-depth 
awareness into chronic post-partum PGP and the magnitude of improvement that may 
be associated with the customized DEFO. The results of this single case study series 
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1.1 Introduction  
The purpose of this chapter is to provide a rationale for the work undertaken in 
this thesis. This chapter will introduce and critically appraise the current literature on 
pelvic girdle pain, discussing a range of issues pertaining to definitions, prevalence, 
aetiology, mechanical stresses, risk factors and orthotic strategies. More specifically, 
the aim of the literature review is to describe and critically appraise published research 
undertaken to investigate the effectiveness of pelvic orthotic interventions in women 
suffering from PGP. 
Pelvic Girdle Pain (PGP) is commonly experienced by women during pregnancy 
(Ho et al., 2009). It is, however, difficult to manage (Vleeming et al., 2008). It has a 
significant impact on the ability of individuals to undertake everyday activities such as 
turning in bed, prolonged walking, or carrying items; impacting negatively on quality of 
life and emotional status (Wang et al., 2004). In economic terms, societal costs are 
significant mainly as a consequence of work absenteeism (Vermani et al., 2010); with 
20% of women with PGP requiring an average of seven weeks sick leave (Bergstrom et 
al., 2015; Malmqvist et al., 2018; Norén et al., 1997). There are high direct health costs 
as well as increased health risks associated with care as women with PGP have a higher 
request for induction of labour and elective caesarean section to achieve symptomatic 
relief (Gholitabar et al., 2011; Norén et al., 1997; Vermani et al., 2010). The magnitude 
of this problem is substantial with 679,106 deliveries occurring throughout the United 
Kingdom (UK) in 2017/18, of which 5162 were in Cornwall and the Isles of Scilly 
(www.ons.org.uk), which is the geographical region in which the studies were 




1.2 Defining Pelvic Girdle Pain (PGP) 
PGP has been defined by the European Guidelines for the diagnosis and 
treatment of PGP as: “Pain experienced between the posterior iliac crest and the 
gluteal fold, particularly in the vicinity of the sacroiliac joints (SIJ). The pain may radiate 
in the posterior thigh and can also occur in conjunction with/or separately in the 
symphysis” (Vleeming et al., 2008). This now appears to be the most widely accepted 
terminology to describe PGP both within the clinical and research arena. This attempt 
by the European Guidelines (2008) to standardise terminology and to make a clear 
distinction between PGP and low back pain has, however, not always been recognised. 
For instance, in 2016 the World Health Organisation released information called 
‘Antenatal care for a positive pregnancy’ (WHO, 2016), which did not consider the 
classification of PGP as a separate condition to low back pain (LBP). It is perhaps 
unsurprising therefore, that PGP remains under classified, and that it has proven 
challenging to accurately understand the scale of this condition during pregnancy.    
 
1.3 Prevalence 
There is  a large disparity in the quoted prevalence of pregnancy related PGP, 
with ranges from 4% to 76.4% (Albert et al., 2001; Gutke et al., 2015; Ho et al., 2009; 
Kanakaris et al., 2011; Mogren et al., 2005; Ostgaard et al., 1991; Vleeming et al., 2008; 
Wang et al., 2004; Wu et al., 2004). Within this large variation, it is reported that of all 
women with pregnancy related PGP, 45% present with mild PGP symptoms, 30% 
moderate PGP symptoms and 25% with severe PGP symptoms (Ho et al., 2009). 
Symptoms can range from difficulties with activities such as walking or stair climbing, 
to use of walking aids, use of a wheelchair or confinement to bed (Wu et al., 2004).  
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The large disparity in prevalence of PGP is believed to be a result of the variable 
definitions used to encompass PGP, such as symphysis pubis dysfunction, sacroiliac 
joint dysfunction, and other non-pregnancy related pelvic pain (Kanakaris et al., 2011). 
PGP has historically also been classified under the umbrella term lumbopelvic pain 
(lumbar spine pain and pelvic pain). The interchangeable terminology and lack of 
uniformity has led to research being undertaken using these umbrella terms as 
opposed to PGP as a separate condition, with different classifications and diagnostic 
criteria although they are being considered as the same condition (Bertuit et al., 
2018a). This has led to challenges in accurately understanding the scale of pregnancy 
related PGP as a separate condition, in comparison to LBP. The European Guidelines 
(2008) emphasised that it was imperative to accurately classify PGP to aid future 
research and improve diagnosis, management and treatment (Vleeming et al., 2008).  
 
1.4 Anatomy and Physiology of PGP 
The pelvis is made up of the ilium and sacrum. It has three joints, the symphysis 
pubis (SP) at the anterior section of the pelvis where the ilium meets and bilateral 
sacroiliac joints (SIJ), which are located at the posterior section of the pelvis where the 
ilium meets the sacrum (Figure 1.1). Pain from a musculoskeletal origin is commonly 
experienced in either the symphysis pubis and/or sacroiliac joints. 
 The congruent state of the articular surface and cartilage of the SIJ increases 
friction through the joint, which in turn offers high friction coefficient that contributes 
to the stability of the SIJ. This is referred to as ‘form closure’ (Vleeming and Scheunke., 
2019). During load, daily activities or ambulation the pelvis is under vertical load that 
cause the sacrum to nutate (tip forward) and counter-nutate (tip backwards). This can 
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lead to a reduction of stiffness of the pelvic joints, and rely on lateral forces of the 
ligamentous, muscular and fascial structures to give adequate friction causing 
compression to the pelvic joints, leading to increase stability (Vleeming et al., 2008). 
This is referred to as ‘force closure’ (Vleeming and Scheunke., 2019). The implications 
of suboptimal form and force closure is described in more detail in section 1.6. In brief, 
it is postulated that pregnancy related PGP is musculoskeletal in its origin (Vleeming et 
al., 2008), arising as a result of pelvic instability, with a subsequent increase in shear 
forces through both the symphysis pubis and the sacroiliac joints. These shearing 
forces can apply excessive loading to tendons, ligament and the synovial membrane of 
the articular surface. It is suggested that this can lead to an inflammatory process 
leading to a nociceptive meditated response, which may be described as a stabbing, 







Figure 1.1 The pelvic anatomy, along with location of the symphysis pubis (Anterior red 







1.5 Potential causes of pregnancy related PGP 
The patho-physiological mechanisms which lead to PGP in pregnant women are 
still unclear (Vermani et al., 2010; Versraete et al., 2013; Vleeming et al., 2008). It was 
previously  thought that hormonal changes and metabolic changes can lead to 
musculoskeletal dysfunctions for women during pregnancy (Blackburn et al., 2007; 
Descherney et al., 2007). The hormone relaxin has historically been considered the 
potential cause of increased laxity in pelvic ligaments, leading to an increase in shear 
forces in both the anterior and posterior pelvis (Aldabe et al., 2012). More recently, 
however, this view has been questioned, with many highlighting the anomaly which 
exists with this argument given that PGP presents more frequently in the 2nd and third 
trimester, whereas relaxin is at its highest level in the first trimester (Aldabe et al., 
2012). Furthermore, studies demonstrate that an increase in relaxin does not 
significantly correlate with PGP during pregnancy (Bjorklund et al., 2000; Peterson et 
al., 1994). It is believed that pregnancy hormones can indirectly lead to pain and 
discomfort, but it has been postulated that this is due to their interaction with 
biomechanical stresses, which may be treatable with musculoskeletal physiotherapy 
(Aldabe et al., 2012).  
 
1.6 Mechanical Causes of Pregnancy related PGP 
Both Lee and Vleeming (1998) propose that the anatomical structures of the SIJ 
(form closure) are required to optimise stability through the pelvis. The anatomical 
position of the joint along with the ligamentous structures are said to increase the 
friction coefficient through the SIJ (Pel et al., 2008). The surrounding musculature and 
fascia (force closure) surrounding the joints increase friction and lead to an increase in 
tension across the joints. The two further components for creating optimal stability are 
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neuromuscular control, and emotional/awareness (Lee and Vleeming, 1998). There are 
variable factors which may lead to sub-optimal pelvic joint stability. 
It has been suggested that pelvic instability is the primary cause of PGP during 
pregnancy (Depledge et al., 2005). During pregnancy the related changes in posture 
and biomechanics can lead to altered pelvic stability (Branco et al., 2014; Foti et al., 
2000; Liddle and Pennick, 2015). Biomechanical changes occur in the lumbar spine and 
pelvis during pregnancy, due to the need to adapt to a change in the centre of gravity 
as a result of the increasing weight of the uterus, resulting from the growth of the 
foetus (Liddle and Pennick, 2015). The increase in maternal weight is believed to play a 
role in the requirement for changing lumbar biomechanics, with increased lordotic 
adjustment in the lumbar spine required to maintain the centre of gravity (Branco et 
al., 2014; Foti et al., 2000). The reduced ability to undertake the natural ‘self-locking’ 
mechanism of the SIJ can lead to abnormal forces through the pelvis (Arumugum et al., 
2012; Bertuit et al., 2018b). This reduced ability to transfer load through the pelvis 
(Mens et al., 2000) can lead to undue stress throughout the pelvic joints, leading to an 
increase in shear forces and subsequently pain (Damen et al., 2001). Research has 
shown that during pregnancy women can have altered symmetry in the SIJ (Damen et 
al., 2001). This could potentially prevent optimal joint stability leading to adverse 
stresses and load throughout the pelvis, due to reduced ‘form closure’. This leads to 
impaired motor control believed to be, in part, a result of pain inhibition (Mens et al., 
2017) or reduced ability to perform, due to posture and change in biomechanics 
(Aldabe et al., 2012; Mens et al., 2017). A study by Kalus (2008) identified a moderate 
correlation between poor muscle function at the beginning of pregnancy in women 
with severe PGP symptoms. Reduced force closure due to lack of transverse and 
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oblique activation has also been believed to lead to PGP (Hu et al., 2010), although 
studies undertaking training programmes specifically targeting these muscle groups 
did not find any significant improvement in symptoms (Mens et al., 2000). A study by 
Mens et al, (2017) went on to find that there is actually an excessive contraction in the 
transverse abdominus (TrA) of women suffering with PGP, when they undertook 
ultrasound imaging (using a RUSI, 2D mode) during an active straight leg raise (ASLR) 
test  in comparison to healthy controls. 
Many studies have observed the self-locking nature of the SIJs and the 
underlying joint surface ‘roughness’, which can aid an increase in friction alongside the 
self-locking ability (Pel et al., 2008; Soisson et al., 2015 ). It was believed that the 
release of reproductive and maternal hormones, in particular relaxin, could lead to 
connective tissue laxity but this hypothesis has now been rejected with recent 
research showing that there is a weak correlation between this hormone and the onset 
of PGP (Aldabe et al., 2012; Clinton et al., 2017).  
 
1.7 Risk factors 
A recent review concluded that there is moderate to strong evidence for a 
range of risk factors for pregnancy related PGP (Clinton et al., 2017). The risk factors 
identified were previous history of pregnancy (multiparity) alongside previous 
PGP/LBP, orthopaedic dysfunctions, increased body mass index (BMI), smoking, as well 
as work dissatisfaction and a lack of belief of improvement (Gutke et al., 2008; 
Kanakaris et al., 2013; Vermani et al., 2010;  Vleeming et al., 2008). Other risk factors 
for pregnancy related PGP have also been suggested in the literature, which include: a 
maternal age of ≥30 years (Gutke et al., 2017) and mode of delivery such as 
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instrumental or caesarean section (Albert et al., 2001; Gutke et al., 2017; Vleeming et 
al., 2008; Vollestad et al., 2009; Wuytack et al., 2018). 
 
1.8 Orthotic management  
Pregnancy support devices have been used throughout many cultures, and 
since the 12th century in Asia (Carr et al., 2003).  Within the context of this thesis, the 
term orthotics has been used to describe these “support devices”, however it is 
acknowledged that this terminology is not commonly used within the research 
associated with pregnancy related PGP. Instead such devices have been variously  
described as ‘maternity support binder’, ‘pelvic belt’, ‘pregnancy support’, ‘rigid or 
non-rigid belt’, ‘elastic or non-elastic support belt’ (Ho et al., 2008 ). As a consequence, 
it was challenging to ensure that all pregnancy orthotics were included within this 
literature review. Terminology is also broad because of the large variation in design 
such as belts, brief, cradle and torso support (Ho et al., 2008), which can be rigid, non-
rigid, elastic, non-elastic, and wide or narrow (Elden et al., 2005).  
Maternity orthotics capture a considerable proportion of this discipline as 
reflected by the large number of recorded patents of belt designs in this area (Ho et 
al., 2008). Notably, they have also been used to treat a host of conditions other than 
pregnancy related PGP, including LBP, athletic groin pain, pelvic instability and chronic 
pelvic pain. Despite their growing presence within the market, current international 
guidelines do not recommend their use due to the lack of high-level evidence to 
support their use (Vleeming et al., 2008). However, guidance by the World Health 
Organisation (WHO, 2016) recommends pelvic belts for use in pregnancy related PGP, 
although it is notable that this was made on the basis of the results of a single research 
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study and so should be considered with some caution. The research evidence on which 
these recommendations were drawn was by Kalus et al. (2008), who undertook a RCT 
(n=115) consisting of two groups, one wearing a BellyBra support and one wearing 
tubigrip support which was identified as being an underpowered study. Although both 
groups reported a decrease in pain and increase in function, and there was a greater 
improvement seen in the BellyBra group, the difference between the two groups was 
not statistically significant (Kalus et al., 2008). 
 
1.9 Critical Appraisal Tools  
In line with good practice, a critical appraisal tool was used to evaluate the 
retrieved articles. Katrak et al’s systematic review (2004), identified a wide range of 
critical appraisal tools that can be used to achieve this, with no single tool considered 
best able to inform allied health professionals. They recommended that, given the lack 
of such a ‘gold standard’, it was a requirement of the appraiser to choose the tool 
which they felt offered the best outcome for their review (Katrak et al., 2004). 
 
1.9.1 Physiotherapy Evidence Database (PEDro) Scale  
The Physiotherapy Evidence Database (PEDro) scale was developed in 1998 and 
was based on The Delphi List (Verhagen et al., 1998). It is an 11-item list to aid quick, 
critical appraisal of randomised control trials. To establish the generic core items of the 
PEDro scale, a group of experts in the field of quality assessment of RCTs participated 
in a Delphi study. Expert consensus was gained on nine of the 11 items listed.  
The PEDro scale was developed to aid the quick assessment of internal validity 
(questions 2-9) and assist in gaining sufficient statistical information to make results 
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interpretable (questions 10-11). Question one, which is aimed at evaluating the 
external validity of an RCT, does not count towards the total PEDro scale score, which 
has a total score range of 0-10 points. One point is scored, when the criteria is met, for 
each of the remaining 10 questions. Studies that score ≥6 points are considered 
“moderate” to “high” quality. This cut off score of six points has therefore been used in 
this literature review. The PEDro scale has demonstrated to be a valid measure for 
assessing methodological quality of RCTs (Morton, 2009). It has also been shown to 
possess acceptable reliability, based on consensus judgements, of RCTs (Maher et al., 
2003). The PEDro scale was also shown to be preferred over other critical appraisal 
tools for RCTs such as the Jarrad (Boghal et al., 2005).  
 
1.9.2 Critical Appraisal Skills Programme (CASP) Tool  
Studies which were not RCTs but were pertinent to include within this 
literature review were assessed using the Critical Appraisal Skills Programme checklist 
(CASP, (https://casp-uk.net/casp-tools-checklists/), thus allowing for studies such as 
cohort, case-control, and diagnostic studies to also be assessed in terms of their 
methodological quality. 
 
1.10 Database search strategy 
The literature review undertaken for this chapter employed a systematic 
approach to searching the following databases: CINHAHL (EBSCO), MEDLINE (OVID), 
Joanna Briggs Institute Library, PubMed, Web of Science, EMBASE (OVID), Cochrane 




The search was limited to articles from 1999- 2019, thereby covering a 20-year 
duration. This limit was made to ensure that the orthotic interventions evaluated were 
relevant to current practice as orthotic design has significantly evolved over the last 
15-20 years. It was considered that a 20-year search criteria would be wide enough to 
include all available relevant studies. The literature search was further refined to only 
include quantitative research designs and English language papers. 
To keep abreast of the most recent material available, a search of clinical trials 
registers via www.controlled-trials.com and http://clinicaltrials.gov was also 
undertaken to identify any current registered studies.  
Search terms: 
(“Pelvic pain” OR “pelvic girdle pain” OR “PGP” OR “lumbopelvic pain” OR “sacroiliac 
joint dysfunction” OR “symphysis pubis dysfunction” OR “anterior pelvic pain” OR 
“posterior pelvic pain”) AND (“pregnan*” OR “antenatal”) AND (“pelvic orth*” OR 
“pelvic support garment” OR “pelvic belt” OR “pelvic short*” OR “maternity support” 
OR “maternity belt” OR “Corset” OR pelvic corset” OR “lumbopelvic corset” 
OR  “Maternity corset” OR “Dynamic Elastomeric fabric Orth*” OR “DEFO” OR 
“Serola”). 
The results of the database searches are shown in Table 1.1, while the PRISMA 








DATABASE SEARCH RESULTS 
CINHAL VIA EBSCOHOST 27 
AMED 12 
MEDLINE VIA EBSCOHOST 33 
PUBMED 272 
MEDLINE VIA OVID 269 
COCHRANE LIBRARY 3 
TOTAL 616 
 







































Records screened by 
abstract n=272 
Records excluded 
following screening of 
abstract n=232 
Records screened by 
full text n=40 
Records excluded 
following screening of 
full text n=25 
Records excluded 
following screening of 
full text using CASP tool 
n=0, and PEDro Tool 
n=0 
Records assessed using 






Study Design Sample Sample Characteristics 
(All units of measurement 
figure use mean +/- SD) 
What did they do? Outcome 
Measures 
Findings 
Bertuit et al., 
(2018a) 
RCT n=46 
Divided into two groups A 
+ B (Group A was divided 
into subgroups of A1 and 
A2 depending on which 
belt was used. Group B 
was no belt). Both groups 
were pregnant women 
with PGP. 
Group A  
Age 30 (±5); Parity NR; 
Timing of intervention: 
Gestation 27 (±5);  
Baseline pain VAS 60 (±20). 
 
Group B 
Age 29 (±5); Parity NR; 
Timing of intervention: 
Gestation 27 (±6);  
Baseline VAS 50 (±30). 
Two different types 
of belt 
Wide and rigid, 





Pelvic belt reduced 
pain and increased 
function in both 
groups 
Bertuit et al.,  
(2018b) 
RCT n=127 
Divided into Three 
Groups: Pregnant women 
with PGP (n=46) (Group 
A), Healthy Pregnant 
women (n=58)(Group B) 
and non- pregnant 
women (n=23) control 
group (Group C) 
 
Group A was divided into 
A1 and A2: 
Group A1 (Belt 1) and 
group A2 (Belt 2) and 
Group B (No belt)  
Healthy pregnant women 
group B 
Non-pregnant women 
control group C 
 
 
Group A, Pregnant women with 
PGP group Age 30 (±5). 
 
Group B, Healthy pregnant 
women group Age 29 (±5). 
 
Group C, Non-pregnant women 
control group Age 27 (±5). 
 
For all groups: 
Parity NR; 
Timing of intervention: NR; 
Baseline pain not measured. 
 
Undertook gait 
trials at different 
velocities on a 
treadmill. 
Determining the 
effects of being 
pregnant or not; 
having pain or not; 
stage of pregnancy; 
and gait speed on 











PGP resulted in lower 
COP displacement and 
velocity. Wearing a 
belt during pregnancy 
decreased walking 
velocity and increased 
COP velocity. There 
were no differences 
between belts in 









Pregnant females with 
low back pain at 
minimum 20 weeks 
gestation.  
Group A no back support 
(n=10); Group B “Loving 
comfort” back support 
(n=30) 
Authors reported that groups 
did not differ from each other in 
ethnicity, age, and years of 
education or gestation;  
Parity NR; 
Baseline Pain: 
Group A 3.85 (±2.36), 
Group B 4.13 (±2.01); 
Intervention timing NR. 
Participants 






binder to wear 
while awake for 2 
weeks. At an 
appointment 2 
weeks later, a post-
test questionnaire 














effect on daily 
activities were 




Group B had a 
significant reduction in 
mean pain scores and 





Rigid support belt (n=28) 
Non-rigid support belt 
(n=29) 
Specific strengthening 
exercise programme and 
advice (n=30) 
 
Rigid support belt group 
Age 29.8 (±4.6);  
Parity 0.83 (±0.9);  
Timing of Intervention: 
Gestation 30.5 (±5.2); 
Baseline pain VAS 43.0 (±21.9). 
 
Non-rigid support group 
Age 28.7 (±6.3); Parity 0.83 
(±0.8);  








activities of daily 
living were given to 




Use of a rigid or non-
rigid belt did not add 
to the benefits of 




Gestation 31.1 (±5.4); 
Baseline pain VAS 50.5 (±18.5).  
 
Exercise only group 
Age 30.7 (±4);  
Parity 0.93 (±0.8);  
Timing of intervention: 
Gestation 32.2 (±5.2); 
Baseline pain VAS 47.8 (±14.2). 
2 of the groups 
were given either a 
rigid pelvic support 
belt or a 
Non-rigid pelvic 
support belt. 











Age 30.8 (±4.8);  
Parity NR; 
Timing of intervention: 
Gestation 24 (±3);  
Baseline pain VAS 23 (13-41). 
 
Acupuncture group 
Age 30.6 (±4);  
Parity NR; 
Timing of intervention: 
Gestation 24 (±3);  
Baseline pain VAS 23 (15-44). 
Stabilising exercise group 
Age 30.0 (±4);  
Parity NR; 
Timing of intervention: 
Gestation 24 (±3);  




consisted of a 




















superior to stabilising 
exercises for reducing 




included a pelvic belt. 
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Flexible Pelvic Belt n=10 
Rigid Pelvic Belt n=10 
Flexible pelvic belt group  
Age 28.6 (±5.6); Parity NR; 
Timing of intervention: 
Gestation 32.0 (±4.8);  
Baseline pain VAS 55.5 (±24.0). 
 
 
Rigid pelvic belt group 
Age 30.2 (±7.6);  
Parity NR; 
Timing of intervention: 
Gestation 29.6 (±5.5); 







effectiveness of a 






suggest the flexible 
pelvic support belt 
may be more effective 
in reducing pain and is 
potentially better 
tolerated than a rigid 
belt, although both 
groups showed good 
improvements in pain 
levels. Concluded that 
a larger trial is 
required. 
Haugaland et 




Control group (n=285) 
Intervention group 
Age 28.9 (±4.49); Parity NR; 
Timing of intervention: 
Gestation 24.0 (±4.79); 
Baseline pain VAS 6. 
Control group 
Age 28.9 (±4.41); Parity NR; 
Timing of intervention: 
Gestation 23.8 (±4.51); 
Baseline pain VAS 6. 
Looked at the 
difference in 
intervention group 






Control, were not 
offered any 
treatment but 
were free to seek 
advice and 
treatment 
VAS Identified no statistical 
difference between 
groups post-partum.  
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n=17 Age 28.7 (±2.8);  






on a treadmill and 
during an ASLR 






‘force closure’ theory, 
by identifying that the 
transverse and oblique 
abdominal muscles 
were less active in 
conditions with a 
pelvic belt, suggesting  
that the belt provides 
the forces required for 
‘force closure’. 
Kalus et al., 
(2008) 
RCT n=115 
BellyBra Group (n=55) 
Tubi Grip Group (n=60) 
The authors reported no 
significant differences between 
the study device and control 
groups in baseline data: age, 




Timing of intervention: 
Gestation 28.2; 
Baseline pain VAS 6.1 (±2.2).  
 
Tubi Grip group 
Timing of intervention: 
Gestation 29.2; 
Baseline pain VAS 6.0 (±2.0). 
Two groups one 
group trialled the 
“BellyBra” orthotic 
and group two 





Reduced pain in both 
groups and increased 
function was seen 
more in the “Belly 
Bra” group opposed to 
the Tubigrip group 
Kordi et al., 
(2013) 
RCT n= 105 
Exercise and belt group 
(n= 31) 
Information and belt 
group (n=31) 
Information alone (n=34) 
Lost to follow up (n=9) 
Exercise and belt group 
Age 26.45 (±5.37);  
Parity NR; 
Timing of intervention: 
Gestation 24.7 (±3.9);  
Baseline pain VAS 58.2 (±13.93). 
 
Information and belt group 
Trialled non-rigid 
pelvic belt plus 
information, belt 
plus stabilising 





Lumbopelvic belt plus 




information alone on 




Age 28.26 (±4.82); Parity NR; 
Timing of intervention: 
Gestation 26.5 (±3.7);  
Baseline pain VAS 64.4 (±13.96). 
 
Information alone group 
Age 25.45 (±5.59); Parity NR; 
Timing of intervention: 
Gestation 25.3 (±3.8);  
Baseline pain VAS 51.0 (±13.79). 
Mens et al., 
(2000) 
RCT N=44 
Group A control (n=14) 
Group B Placebo (n=14) 
Group C: Training of 
diagonal trunk muscle 
exercise (n=16) 
Age 31.7 (±3.2); 
No other data reported. 
Group A: refrain 
from exercises 
Group B: training of 
longitudinal trunk 
muscle exercises 
Group C: Training 






and how to use a 
pelvic belt given to 
all three groups 
VAS No significant 
difference in the mean 
change pain score 
(VAS) from baseline 
 
No significant 
difference in the mean 
change in global 
improvement and 
physical mobility 







Age 33.0 (±4.0);  
Parity 1.8 (±1.0); 
No other data reported. 
Influence of pelvic 
belt on SIJ laxity, 
during an ASLR. 
With pelvic belt 
and without.  
Two different 
locations ASIS (high 





Application of a pelvic 
belt significantly 
reduces SIJ laxity. 
Better reduction in SIJ 
mobility at level of 












Age 36.7 (±6.8); 
No other data reported. 
 
They assessed the 
pelvic belts’ effect 
during an ASLR and 




imaging of TrA 
thickness at rest 






contraction of TrA 
during ASLR with 
patients with 
longstanding posterior 
PGP, not supporting 
clinical understanding 








Non-elastic SIJ belt 
and advice (n=40) 
 
Home exercise group 




In clinic exercise group 




Age 28.4 (±3.9);  
Parity NR; 
Timing of intervention: 
Gestation 25 (±7);  
Baseline pain VAS 49 (8-77). 
 
Home exercise group 
Age 29.5 (±3.3);  
Parity NR; 
Timing of intervention: 
Gestation 22 (±7);  
Baseline pain VAS 46 (0-100). 
 
In clinic exercise group 
Age 29.7 (±5.4);  
Parity NR; 
Timing of intervention: 
Gestation 21 (±6);  
Baseline pain VAS 47 (5-95). 
 
Used 3 different 
groups to test the 
effect of non-
elastic SIJ belt and 
advice against all of 
the above plus 
home exercise 
programme and all 











the three groups 
In all groups pain 
decreased and activity 
ability increased 
between gestational 
week 38 and at 12 
months post-partum 
Wedenburg 






Age 28.4 (Range 21-39);  
Parity NR; 
Timing of intervention: 









pain and diminished 
disability in low back 




training programme and 
a trochanteric pelvic belt 
Baseline pain NR. 
 
Physiotherapy group 
Age 29.4 (Range 22-36);  
Parity NR; 
Timing of intervention: 
Gestation 24.2 (Range 20-29); 
Baseline pain NR. 
programme/trocha
nteric belt) for the 
management low 
back and pelvic 
pain in pregnancy 
physiotherapy group 





Table 1.2 Summarises the studies included in this literature review 
ASIS – Anterior Superior Iliac Spine  Preg – Pregnancy/pregnant   VAS – Visual analogue Scale    
ASLR – Active Straight Leg Raise   PSFS – Patient Specific Functional Scale  WHOQOL-BREF – World Health Organisation’s  
COP – Centre of Pressure    QBPDS – Quebec Back Pain Disability Scale Quality of Life Questionnaire   
DRI – Disability Rating Index    RCT – Randomised Control Trial 
EMG – Electromyography    RMQ – Roland Morris Questionnaire   
NR – Not Reported     SIJ – Sacroiliac Joint    
ODQ – Oswestry Disability Questionnaire  SWLS – Satisfaction with Life Scale      
PGP – Pelvic Girdle Pain    TrA – Transverse Abdominus     
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1.11 Study Design 
 
There were 11 RCTs and one controlled trial. Three observational trials 
assessed the effects of pelvic belts on either transversus abdominus (TrA) thickness or 
SIJ laxity (as measured via the transmission of ultrasound vibrations across the joint) in 
people with and without PGP (Table 1.2). The remaining observational study assessed 
healthy participants. It examined how abdominal muscle activation varied (as 
measured via surface and fine wire EMG) with and without a pelvic belt while walking.  
Most RCTs examined the long-term effects of an intervention against a control 
group although some (e.g. Bertuit et al., 2018b) examined the immediate effects of a 
belt on gait speed and measures of dynamic balance (centre of pressure). Only six of 
the RCTs were adequately powered; a further five did not report any power calculation 
nor state as being a pilot study. In the one pilot study, inferential statistical analysis 
was performed despite being inappropriate for a design of this nature.  
It is clear from figure 1.2 that many of the studies had methodological 
limitations with regards both allocation concealment and blinding of the subject, 
assessor and therapist, leading to potential risk of bias. 
 
1.12 Interventions 
Varied orthotics were used in the studies. These included pelvic belts, whose 
position could vary from high (ASIS level) to low (pubic symphysis level); Tubigrip and 
Bellybra. Orthotics could be used in combination with stabilising/ strengthening 
exercises or acupuncture. Exercises were used in isolation in one study. The length of 
the intervention period varied from short term (on the day measurement) and when 
worn over time from two to six weeks. 
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1.13 Outcome Measures 
Pain, function, activity levels, and health related quality of life were all 
outcomes that were assessed in the studies. There were many variations of outcome 
measures used making it difficult to compare and contrast results. The trials used 
recognised outcome measures whose psychometric properties (reliability and validity) 
have been defined in people with PGP. No disease specific questionnaires were used in 
the studies. It has been reported that commonly used outcome measures in PGP have 
good internal consistency along with test re-test reliability and construct validity 
(Grotle et al., 2012).  The observational studies used novel (e.g. assessment of 
vibration across the SIJ) or established methods (e.g. electromyography) but their 













Table 1.3 shows the CASP results 
49 
 
1.14 Study findings 
1.14.1 Studies investigating the effects of orthoses on pain and function 
In a three arm study (n=105), Kordi et al. (2013) evaluated the use of a non-
rigid belt plus standardised advice in comparison to an exercise group (specific 
stabilising exercises) and advice only group, reporting a significant decrease in pain 
intensity, along with decrease in disability in the orthotic group. It was a 6-week trial, 
with analysis of >85% of participants completing the study. A sample size calculation 
was not documented, and elements of methodology such as the allocation 
concealment procedure and lack of blinding of both the subject and assessor could 
have put the outcome at risk of bias. Nevertheless, it met the PEDro cut-off score, and 
was graded as moderate methodological quality.   
Along similar lines, Bertuit et al. (2018a) (n = 46) utilised two belts, one wide 
and rigid, and one narrow and flexible. They demonstrated that both pelvic belts 
reduced pain and increased function, although there was no statistically significant 
difference between groups (Bertuit et al., 2018a). Unfortunately, this study had poorly 
balanced groups with a significant drop out rate, particularly in the control group (n = 
12 dropouts), making it difficult to be confident of the results generated and to 
generalise the results to the pregnancy population.  
Depledge et al. (2005) also compared the effects of a rigid (n=28) and non-rigid 
belt (n=29), along with a control group who undertook a specific strengthening 
exercise programme (n=30). Participants, all of whom suffered from anterior pelvic 
girdle pain, were randomised into the groups. The addition of either a rigid or non-rigid 
belt did not show any significant difference to the specific strengthening exercise 
50 
 
programme group, although all groups did show an improvement in function with 
intervention. 
Nilson-Wilkmar et al. (2005) undertook a three-armed RCT (n=118) to 
investigate the difference between the use of: a non-elastic SIJ belt; a non-elastic SIJ 
belt plus home exercise programme; and a non-elastic SIJ belt and a clinic training 
programme. All groups had a reduction in pain levels and increase in activity levels but 
there were no significant differences between groups. Whilst it seems that the pelvic 
orthotic may have played an active role in reducing pain levels in this study, a lack of a 
control group means it is not possible  to ascertain the true benefit of the pelvic 
orthotic. It can be argued that it is unethical to recommend the use of a pelvic orthotic 
without considering standard treatment alongside as females may suffer the effect of 
increased pain, reduced function, and quality of life as a result; this poses challenges to 
researchers in this area. One way in which this conundrum can be managed is 
exemplified by a small study by Mens et al. (2000). In their study, participants were 
allocated to one of three groups. All participants were provided with “standard 
treatment” which comprised a pelvic belt, information and ergonomic advice. The 
groups were differentiated as follows: Group A refrained from exercises, Group B were 
given a placebo (training of longitudinal trunk muscles), and Group C were given 
diagonal trunk muscle exercises. No significant difference was demonstrated in the 
mean change for pain, global improvement, or physical mobility from baseline. It was 
disclosed that the study was powered for n=30 participants per group but ceased 
recruitment following 44 participants being enrolled into the study and did not disclose 
why. The conclusions drawn should be interpreted with caution as the study was 
significantly underpowered.  
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A similar study by Elden et al. (2005) also employed this methodology in a large 
three-armed RCT (n=386), wherein all groups engaged in standard treatment (which 
comprised of advice, exercises and pelvic belt), but with one group receiving 
acupuncture alongside standard treatment and another group engaging in specific 
stabilising exercises plus standard treatment. They concluded that both the 
acupuncture and stabilising exercises alongside standardised treatment had a more 
favourable outcome in the primary outcome, pain reduction. Their secondary outcome 
measure was an independent health professional assessment of improvement of the 
patients. Although they do not document how they went about this, it would be 
reasonable to assume that they repeated the pain provocation tests to identify if there 
was any improvement in these factors, although this cannot be confirmed. The results 
showed that patients had a reduction in pain as determined by the VAS. The 
independent examiners’ assessment also highlighted improvement in the groups that 
included an additional acupuncture or stabilising exercise modality (Elden et al., 2005). 
Flack et al. (2015) investigated the comparative effectiveness of two different 
pelvic orthotics, although this was in a small (n=20) randomised pilot study and so their 
results should be considered with some caution. Their study involved the comparison 
of a flexible (n=10) and rigid (n=10) pelvic orthotic, showing positive preliminary results 
for improved pain levels. In this study the flexible belt was evaluated as being 
marginally better at reducing pain levels than the rigid belt, and the flexible belt group 
also tolerated the orthoses better in terms of wearing comfort (Flack et al., 2015).  
Haugaland et al. (2006) also undertook an RCT with a large sample of 526 
pregnant women. They aimed to identify if there was any difference between standard 
interventions (an education programme that consisted of information, ergonomics, 
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exercises, pain management, advice for daily life movement, pelvic belt/crutches) and 
the control group (no formal treatment but the women were able to seek advice and 
treatment if required). Using the VAS as their primary outcome measure to evaluate 
pain, they introduced the intervention between the 18th and 32nd week of gestation 
and undertook two follow-up assessments at six and 12 months postpartum. This 
study found that there was no statistically significant difference between groups, with 
both groups demonstrating a gradual improvement in symptoms (Haugaland et al., 
2006). Within the control group, 60% of participants had sought intervention for their 
symptoms. As a result, it is difficult to clearly interpret and apply the results of this 
study to the pregnant population. The lack of standardisation of the control, meant 
that it was unclear what interventions were provided to the 60% of the control group 
who sought treatment for their symptoms. Furthermore, there was no follow-up prior 
to birth to ascertain whether there was any improvement pre-partum, which is a 
meaningful outcome for the antenatal PGP population. Finally, the post-partum effects 
are also difficult to attribute to the intervention as compliance was not monitored 
during this phase making it impossible to determine whether improvement was due to 
the intervention or to the natural course of pain postpartum. 
 
 1.14.2 Studies investigating potential mechanisms of effect 
When considering the effects a belt may have on the pelvis, Mens et al. (2017) 
looked at Doppler imaging of vibrations of the SIJ. They aimed to identify whether: (1) 
the application of a pelvic belt impacted on SIJ laxity; (2) there was a difference in 
relative effectiveness for different levels of belt application (high position, just caudal 
to the level of ASIS; or low position, at the level of the symphysis pubis). This small 
study sample (n=25), comprised of pregnant individuals suffering PGP. Results showed 
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that application of a pelvic belt significantly reduced SIJ laxity, and this was greater if 
the pelvic belt was applied to the high position. The application of a pelvic belt, either 
in a high or low position, also had a significant improvement in the ASLR (perceived 
effort scores) compared to without the pelvic belt (Mens et al., 2006). The limitation to 
this study was that although the Doppler was able to identify changes in perceived 
laxity, Doppler imaging has not been validated for this function.  
A potential symptom of pregnancy related PGP is a decreased activation of 
underlying musculature such as the transverse abdominal muscle (TrA). Treatments 
frequently aim at increasing the ability of this muscle to function in order to improve 
neuromuscular control of the pelvic girdle musculature via force closure (Gutke et al., 
2017; Vleeming et al., 2008). Ultrasound imaging is undertaken to identify changes in 
TrA muscular thickness (considered to reflect contraction of the muscle) during a 
functional activity such as an ASLR. Of interest, a study by Mens et al. (2017) this 
highlighted that, in people with PGP, TrA was activated more than controls. This 
finding challenges the current rationale for providing specific stabilising exercises to 
help reduce PGP. It suggests that stabilising muscles responsible for force closure are 
already active in people with PGP. This could reflect a compensatory strategy to aid 
stability and reduce pain or it could reflect pathological over activity that could 
contribute to the pain syndrome. The study included participants who suffered from 
PGP during their pregnancy but were now in their post-partum period, although were 
still suffering from persistent PGP, along with a group of a non-pregnant healthy 
women. As there were no pregnant women with PGP the results should be viewed 
with caution when generalising these findings to this patient group.   
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An investigation into whether the pelvic belt had any changes to the centre of plantar 
pressure motion while walking (a measure of dynamic balance) in pregnant women 
was undertaken by Bertuit et al. (2018b). They found that the pelvic belt increased the 
centre of plantar pressure velocity. This was hypothesised to reflect alterations in 
trunk/lower limb function as a result of wearing a pelvic orthotic.  However, there 
could be multiple causes of alterations in plantar pressure motion that may / may not 
reflect enhanced stability in the pelvic region (Bertuit et al., 2018b). 
 
1.15 Critical Appraisal Tools 
Two critical appraisal tools were used to assess the quality of studies within this 
literature review; the PEDro and CASP tools. This decision reflected the varying designs 
of the studies that were reviewed:  11 of which were RCTs (assessed using PEDro) and 
four studies (assessed using CASP – see Table 1.3). Figure 1.3 provides a schematic 
representation of the bias that studies present and highlights that blinding of either 
the subject, assessor or therapist was one common weakness with methodology in the 
studies, and along with this 36% of studies did not complete or document their 
allocation concealment procedure. 
 
1.16 Limitations 
This literature review highlighted methodological limitations in the design and 
conduct of studies undertaken to date, which included variability in the timing of 
intervention and selection of functional outcome measures across the studies. Sample 
sizes also varied considerably with many studies failing to report whether or not they 
had undertaken a sample size calculation. There was also a significant variation in the 
timing and duration of intervention. These are common methodological problems 
55 
 
faced in many RCTS evaluating health care interventions. More unique to the 
pregnancy PGP population is that the women experience the onset of symptoms at 
differing times within their gestation and that the gestation period varies with 
individuals. This means that some women may give birth prior to completion of the 
intervention; these factors add further challenges which need to be carefully 
considered when designing studies and interpreting the results. Variability in symptom 
onset also means that pregnant women’s gestational age varies across the three 
trimesters, which complicates the analysis and reporting of findings.  
Of note, the literature highlighted that there was a lack of consistency in the 
definition of PGP across studies; some included participants with lumbopelvic pain, 
and others included those with low back pain. A further potential limitation was the 
variety of treatments that were undertaken, often as a “package”, such as the 
provision of advice, exercises, pelvic belt, crutches, acupuncture, and specific 
stabilising exercises. This, in particular, makes it highly challenging to identify the true 
effect of pelvic orthotics in isolation as additional adjuncts / treatments were not 
matched between groups. One final limitation which was detected in all of the RCTs 
reviewed was that none  documented that they had conformed to the Consolidated 
Standards of Reporting Trials (CONSORT) statement. The CONSORT statement was 
developed to improve the reporting of RCTs, which shows transparency from the 
researcher but also assists readers in critiquing the validity and reliability of the studies 






1.17 Adverse Effects 
It has been identified that pelvic support belts can lead to increased pain in 
some patients, resulting in a discontinuation of their use (Mens et al., 1996). Assessing 
whether the orthotics are associated with any changes in maternal and foetal 
haemodynamics is a crucial safety aspect. Beaty et al. (1999) assessed this in 25 
pregnant women who were wearing pelvic support for a 20-minute time period (Beaty 
et al., 1999). No significant changes were detected in maternal blood pressure, cardiac 
outputs, or foetal heart rate (baseline and variability; Beaty et al., 1999), with the 
conclusion that these products were safe for both the mother and baby. A potential 
limitation was that common adherence patterns were not replicated and future 
studies could aim to provide further information. 
 
1.18 Discussion 
Pregnancy related PGP affects a significant proportion of women. Early 
identification of the condition, alongside consideration of risk factors aims to enhance 
its prevention (wherever possible) and early management, in order to minimise pain 
and maximise function throughout the pregnancy.  
In the case where pregnancy related PGP exists, with concomitant impaired 
function, the results of this literature review shows that  there is some evidence to 
support the use of a pelvic orthotic alongside standardised treatments in its 
management. However, there are many variations of pelvic orthoses that are 
commercially available, and no ‘gold standard’ orthotic appears to exist which 
complicates decision making in terms of the evidence-based selection of an orthosis 
for use in clinical practice. The varying designs, which include TubiGrip, BellyBra, 
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LovingComfort, Maternity Binders, all positively impact to some degree on pain and 
function although not always at a statistically significant level. Given this large range of 
products, their categorisation as either rigid, non-rigid, elastic, non-elastic, wide or 
narrow appears to be an appropriate way to classify pelvic orthotics when attempting 
to combine outcomes of the current literature. This approach may also allow for 
clearer guidance for clinicians on what type of orthotic to recommend.  
Although the European Guidelines (2008) have advocated an updated 
definition of pelvic girdle pain and made recommendations regarding diagnosis of the 
condition, there are a number of studies which have not appeared to adhere to this 
guidance, complicating both the interpretation and translation of results into clinical 
practice.  
 
1.19 Conclusion and recommendations 
The use of clear and standardised terminology, together with an agreed 
classification system for categorising pelvic orthoses would help to facilitate a more 
consistent approach to both the design and reporting of future research studies, and 
better identification of the potential benefits of different orthoses. Alongside this, 
further comparative trials would help to form a better understanding of their relative 
benefits for reducing pregnancy related PGP. New research should aim to conform to 
the European Guidelines (2018) for both the definition and diagnosis of PGP. Alongside 
this, where available, future studies should consider incorporating disease specific 















































This chapter describes an experiment undertaken to investigate the fabrics that 
are used to construct the customised Dynamic Elastomeric Fabric Orthoses (DEFO) 
which was the intervention evaluated in the studies undertaken for this dissertation. 
The customised DEFO, which is produced by DM Orthotic Ltd 
(https://www.dmorthotics.com), can be made in a range of nine colours. Following 
discussions with the DM Orthotic Ltd production team, it was felt that on ‘touch’ and 
‘feel’,  the different fabric colours appeared to have different properties with some 
having greater tension when stretched compared to others. This is an important 
consideration since the mechanism of effect of the orthoses is hypothesised to be, at 
least in part, due to increased stability of the pelvis as a direct consequence of the 
external pressure provided by the stiffness of the DEFO.  
The overall aim of the dissertation was to evaluate the effectiveness of the 
customised DEFO in the management of pregnancy related PGP; it was therefore 
essential to have a standardised intervention offering the same support to each 
participant. Therefore, the experiment described in this chapter aimed to objectively 
investigate the underlying properties of the fabrics used to make the customised DEFO 
to determine whether participants engaged in the interventional studies could be 
offered a choice in the colour of their orthoses, or not. 
 
2.2 Background 
The customised DEFO is constructed with two fabrics, Lycra and Powernet. 
Both fabrics are made of a combination of Nylon and Elastane.  Nylon and Elastane 
have shown to be the most popular choice of fabric in the construction of pressure 
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orthoses in the UK (Macintyre and Baird, 2005). The relative composition of Nylon and 
Elastane determines the fabric’s ability to maintain tension, also referred to as stiffness 
(Macintyre and Baird, 2006) and its’ elastic properties (Anbumani and Hayavadana, 
2011). From a clinical perspective this is essential because an orthosis is used to brace 
or support a weak or injured body part. Nylon and Elastane can be described as 
synthetic linear macromolecules. Nylon is a thermoplastic with strands made up of 
repeating units joined by amide links. Adjacent strands can align up and form hydrogen 
bonds creating a strong supermolecule structure. Elastane (also known as spandex) 
consists of a long chain of at least 85% segmented polyurethane bonds, which is 
broken into hard and soft segments. It is the soft segments of the chain that give the 
Elastane its exceptional elastic properties and its recoverable stretch ability, otherwise 
referred to as elastic hysteresis (Anbumani and Hayavadana, 2011). The fabric also 
possesses durable qualities, which the hard chain segments supply. The selection for 
the use of this fabric in the construction of a support orthosis is based upon the need 
for a combination of properties such as elasticity, its ability to support, durability and 
breathability whilst allowing the participant to maintain freedom of movement (Uttam 
et al., 2013). 
 
2.3 Research Question and Aims 
 
2.3.1 Research Question 
In this fabric testing study, we asked the question: “Are there underlying 
differences in fabric stiffness and elastic hysteresis in the Lycra and Powernet materials 
which are used to produce the customised DEFO?” 
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2.3.2 Research Aims 
 To investigate if there were any differences in stiffness between fabric colours 
in both the Lycra and Powernet fabrics, used as the basis for the customised 
DEFO. 
 To investigate if there was any difference in elastic hysteresis between fabric 





2.4.1 Study Design 
This study used a repeated measures design 
 
2.4.2 Measurement of Fabric Stiffness 
Fabric stiffness was measured by applying different weights and measuring the 
subsequent elongation of the fabric. Each fabric was tested by attaching the fabric to a 
constructed overhang using clamps, and then a bucket attached to the bottom of the 
fabric to which weights were added in a systematic manner (Figure 2.1). The weights 
used for the fabric testing ranged from 0.2kg to 1.2kg. The weights were added to the 
bucket in weight order as follows: 0.2kg (1.96 N), 0.4kg (3.92 N), 0.6kg (5.88 N), 0.8kg 






Figure 2.1 Apparatus laboratory set up for fabric stiffness testing 
 
The change in position when a weight was added was measured using a 
Codamotion system (Codamotion, Lancashire, UK). Codamotion is a 3D movement 
analysis and motion capturing device (Figure 2.2). The technology uses miniature infra-
red markers (each with a unique identity) to track the key position on any subject. 
Signals from the infra-red markers are beamed to ‘CODA’ sensor units. The ‘CODA’ 
sensor units, consisting of three masked linear arrays (MLAs) in each CODA unit, 
combine to measure X, Y and Z coordinates of each marker, providing an immediate 





Figure 2.2 Codamotion 3D movement analysis and motion capturing device (above left) 
and a sensor (above right) 
 
The Codamotion system measured the positional change that occurred to the 
fabric following the application of each weight change. Markers were placed at the 
highest and lowest point of the fabric (Figure 2.1).  After each weight was added and 
the system was stationary a 10 second recording was made. Signals were sampled at 
100 Hz. The mean position of the lower marker in the vertical (y) direction was 
determined. Data was subsequently exported into excel for analysis. 
 
2.4.3 Measurement of Fabric Elastic Hysteresis 
A Biodex computerised robotic dynamometer (System 3, UK) was used to test 
material stretch-recovery. Metal accessory bars were added to the Biodex and clamps 
were used to attach the fabrics to the Biodex machine in a standardised manner. The 
system was then set-up to repeatedly stretch the fabric by 15 degrees with a peak 
velocity of degrees (deg/s) for a duration of 120 seconds.   The analogue torque and 
position signals (Figure 2.3) were obtained via the EMG-analog interface. They were 
65 
 
sampled at 1Kz via an analog-digital converter (1401, CED Cambridge UK) and stored 








Figure 2.3 Biodex wave forms showing torque, velocity and position 
 
2.5 Analysis  
 
2.5.1 Analysis of Fabric Stiffness 
For each fabric a plot of the position of the lower marker (mm) versus applied 
weight (N) was made and a best-fit line was determined using a least squares error 
method in excel (Figure 2.4). The slope of the line gives a measure of the stiffness of 




Figure 2.4 Fabric stiffness testing (Lycra) 
 
2.5.2 Analysis of Fabric Elastic Hysteresis 
Text files were then exported to Matlab for secondary analysis using a program 
written in house. To eradicate high frequency noise a Butterworth low pass filter was 
applied. The Butterworth low pass filter has been designed to only allow certain 
frequencies to pass through the filter and to eliminate any undesired frequencies (high 
frequency noise) (Manal and Rose, 2007). The allowances and elimination of certain 
frequencies is dependent upon the limits set up within the filter. A Butterworth low 
pass filter set to 30Hz was applied to the wave form data, effectively ‘smoothing’ the 
wave form data. The onset / offset of each stretch cycle were determined by 
differentiating the position trace to detect the acceleration maxima and minima. The 
first five cycles were then aligned and a plot of torque versus position made (Figure 
2.5). An upslope identifies the change the fabric undergoes whilst it is being stretched, 
and the downslope identifies the change the fabric undergoes when the fabric is 
returning to the start position (Liang et al., 2019). The area between the curves 
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provides a measure of hysteresis. The higher the value the more viscous the material. 
Viscocity transforms kinetic energy into heat; thus the area between the curves is an 
indication of the energy lost (to heat) with repeated stretching. 
 
Figure 2.5 Elastic hysteresis curves for A black Lycra and b Beige Lycra (above right), 
with arrows identifying upslope or downslope. 
 
The area under the stretch and release curve (Nm/deg) was determined using a 
trapezium rule. This divides the area concerned into smaller trapezium shapes (h). A 
formula is then applied to the total area of each trapezium used (Figure 2.6). The 
difference gives the area between the curves (Xo – Xn). The area under the curve was 
measured over the same angular change for each fabric as indicated by the lines in 
figure 2.6. For each fabric the mean area +/- standard deviation for the five stretch-











Figure 2.6 Trapezium rule equation (top): y0,y1..yn  indicate the y (torque) values when 
the position (x)=xo,x1..xn. h indicates the sampling interval between  (x1-xo) and 




2.6.1 Fabric Stiffness Results 
Fabric stiffness and elastic hysteresis were analysed using a 95% confidence 
interval to identify statistical differences between fabrics. The change in position for 
each applied load is given in appendix 1. The mean stiffness (+/- 95% confidence 
interval) is indicated in Table 2.1 (Lycra and Powernet). The data demonstrate that 











Table 2.1 Stiffness (K) coefficients and 95% confidence intervals for each fabric colour/ type 
 
The beige Powernet had the highest recorded stiffness of 10.2 N/mm, a 
difference of 3.7 N/mm from the white Powernet, which recorded the lowest stiffness 
(6.5 N/mm) (Figure 2.7). This trend is also seen in the findings from the Lycra stiffness 
testing; with purple Lycra having the highest recorded stiffness at 6.1 N/mm, 
compared to red Lycra recording the lowest stiffness at 4.5 N/mm (Figure 2.7), a 
difference of 1.6 N/mm. There were larger differences in stiffness between the 
Powernet coloured fabrics compared to the Lycra coloured fabrics. 
 
Fabric Colour/Type Compliance (N/mm) 95% Lower CI 95% Upper CI 
Beige Powernet 10.2 9.7 10.7 
Blue Powernet 9.0 8.8 9.3 
Red Powernet 8.3 7.5 9.0 
Black Powernet 7.3 7.0 7.6 
Purple Powernet 6.8 6.6 7.0 
White Powernet 6.5 6.1 6.9 
Purple Lycra 6.1 5.6 6.5 
White Lycra 5.2 5.0 5.4 
Blue Lycra 5.1 5.0 5.3 
Beige Lycra 4.7 4.7 4.9 
Black Lycra 4.5 4.4 4.6 





















Figure 2.7 Fabric stiffness Mean and upper and lower 95% confidence intervals values 



























2.6.2 Fabric Elastic Hysteresis Results 
The area under the curve varied with the colour of the lycra and powernet 
(Table 2.2 and Figure 2.8). Higher values indicate that the fabric was more viscous; 
offering greater resistance to movement with faster stretches. For lycra the most 
viscous material was the black colour whilst for Powernet the most viscous material 
was the blue colour. 
 
Table 2.2 Hysteresis mean data and 95% confidence intervals (CI); Lycra (top) and 
Powernet (bottom) 
 
Fabric Colour/Type Mean (Nm/deg) 95% Lower CI 95% Upper CI 
Beige Powernet 0.98 0.91 1.04 
Black Powernet 1.17 1.06 1.27 
Blue Powernet 1.37 1.31 1.45 
Purple Powernet 1.20 1.08 1.31 
Red Powernet 1.25 1.09 1.38 
White Powernet 0.85 0.81 0.89 
Beige Lycra 0.63 0.57 0.70 
Black Lycra 1.00 0.91 1.09 
Blue Lycra 0.47 0.35 0.59 
Purple Lycra 0.42 0.39 0.46 
Red Lycra 0.53 0.31 0.75 







Figure 2.8 Fabric stretch-recovery hysteresis data, including mean and upper and lower 





There is little current guidance about standardised testing for pressure garment 
fabrics. The decision to use the current methods were based partly upon burn 
management and scar management literature which use similar fabrics (Macintyre and 
Baird, 2005; Macintyre and Baird, 2006; Macintyre, 2007). There are many factors that 
could potentially affect the findings. Factors such as fabric slippage, changes in tension 
around clamp sites, the edge effect (changes in tension around the lateral edges of the 
fabric) and a wide range of machinery developed to test very similar properties may all 
have a potential impact on the results( Anbumani and Hayavadana, 2011). 
The fabrics that have undergone investigation in this study were those that 
were available to be selected for use by DM Orthotics Ltd in the construction of the 
customised DEFO orthoses used for pregnancy related PGP. As described previously, 
this DEFO aims to add support, and thereby stability, to the participant’s pelvic girdle. 
To have more ecological validity this study would have tested the multi-directional 
nature of the fabrics since these are the forces that the customised DEFO supplies to 
the pelvic girdle. However limitations with the laboratory equipment available 
precluded the testing of such multi-directional, real-time performance. Therefore, a 
unidirectional test had to be applied to the fabric. Nevertheless, the results were able 
to provide an estimation of the fabrics’ capabilities and properties, and to highlight 
differences between fabric colours and types. It is not unreasonable to assume that 
these differences would remain, at least to some extent, with multi-directional testing.    
The construction of a pressure garment normally requires a reduction factor to 
be added, which is a reduction to the initial fabric measurements to allow the fabric to 
increase pressure to the area it needs to support. This reduction factor is normally 
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around 20% (Macintyre, 2007). Previous studies testing stretch-recovery have applied 
a reduction factor to the fabric and this was considered during this study. However, it 
was decided that the test would be adequate to identify any differences in the fabric 
properties, and that a reduction factor would be more appropriately required if the 
research aim was to test pressures supplied by the fabric. The differences in fabric 
stiffness and elastic hysteresis would have directly affected the level of reduction 
factor given to each of the participant’s pelvic orthoses and therefore we could not 
standardise our intervention.  In the interventional studies undertaken for this 
dissertation (described in future chapters) it was essential to have a standardised 
intervention offering the same support and therefore, based on the results of this 
fabric testing study, a decision was made  for the DEFO’s to be produced in the same 
colour for every participant.  
The hysteresis values clearly demonstrated the black Lycra material to have the 
greatest viscosity, with values that were in the mid-range for the Powernet compared 
to the other colours. Overall, therefore, the black materials offered greater resistance 
to movement.  In addition, informal discussions with women (who are the audience for 
wearing the orthosis), highlighted a strong preference for black over the other 
colours.  Black was therefore chosen based on the rationale that the aim of the DEFO is 
to increase pelvic girdle stability as a direct consequence of the external pressure 
provided by the stiffness of the DEFO, and that acceptability of the DEFO from an 
aesthetic perspective is important to enhance adherence to wear-time. 
There is a potential for each batch of fabric to potentially have slight 
differences in fabric specification, even within the same colour spectrum. To 
investigate this we could have repeatedly tested each colour before comparing to 
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other colours. It is acknowledged that this is a limitation of this study; however, the 
time constraints imposed by the PhD time schedule meant that this was not feasible to 
implement. It is proposed that future studies should test individual fabrics more 
extensively before testing as a group. A further limitation is that the elastic hysteresis 
was tested in a unilateral direction. To my knowledge there are currently no devices to 
test such multi-directional, real-time stresses. Should technological advances be made 
within this area then future studies should incorporate a multi-directional approach to 
enhance ecological validity.  
 
2.8 Conclusion 
The aims of this fabric testing study were to investigate if there were any 
differences in stiffness and elastic hysteresis between different fabric colours, in both 
Lycra and Powernet. The results showed a significant difference in fabric stiffness and 
elastic hysteresis between fabric colours in each type of fabric (Lycra and Powernet). 
They demonstrated that it would be inappropriate to offer the participants of the 
interventional pelvic-girdle pain studies a choice in coloured fabric for their customised 
DEFO orthosis. An evidence-based decision was therefore made to choose a single 
































Management of Antenatal Pelvic Girdle Pain study (MAPS): A Single 
Centred, Blinded, Randomised Comparative Trial Evaluating the 












This chapter will detail the RCT, which was undertaken to fill the knowledge gap 
identified within the literature (Chapter 1). It will include a description and critical 
appraisal of the research methods used to evaluate the effectiveness of two pelvic 
orthoses in the management of antenatal PGP. An explanation of the study research 
question, aims and objectives will be followed by a discussion of the approach used to 
address the research question. The format of this methods chapter is based around 
the framework provided by the CONSORT (Consolidation Standards of Reporting Trials) 
Guidelines for the Reporting of Randomised Controlled Trials (Schulz et al., 2010), the 
CONSORT Extension for Randomized Trials of Non-pharmacologic Treatment (Boutron 
et al., 2017), and TiDieR Guidance (Hoffman et al., 2014). 
3.2 Background 
The background context of this study was introduced in Chapter 1, Section 1.2. 
There is a need for clinical trials to undertake comparative evaluations to facilitate the 
knowledge gap that exists for this intervention (Vleeming et al., 2008).  This is the first 
randomised comparative trial undertaken to evaluate the use of a rigid pelvic belt 








3.2.1 Research Question and Aims 
3.2.1.1 Research Question 
This single-centre, blinded, randomised comparative trial asked the question 
“In women with pregnancy related PGP, what is the relative clinical and cost-
effectiveness of wearing a rigid pelvic orthotic (Serola belt) compared to a customised 
DEFO, in terms of pain, activity, and health related quality of life?”  
 
3.2.1.2 Primary Aim: 
To determine the relative effectiveness of a rigid pelvic belt (plus standardised 
advice) compared to a customised DEFO (plus standardised advice) in affecting the 
level of pain in pregnant women with PGP. 
 
3.2.1.3 Secondary Aims: 
 To determine the relative effectiveness of a rigid pelvic belt (plus standardised 
advice) compared to a customised DEFO (plus standardised advice) in affecting 
activity levels and health-related quality of life in pregnant women with PGP. 
 
 To determine the cost effectiveness of a rigid pelvic belt (plus standardised 
advice) compared to a customised DEFO (plus standardised advice) in pregnant 









3.3.1 Trial Design 
A single centred, double blinded, randomised comparative trial (RCT) was used 
to evaluate the effectiveness of two pelvic orthoses. RCT’s are considered the gold 
standard for evaluating interventions because of their ability to minimise or avoid bias 
(McPherson et al., 2012). CONSORT guidelines were adhered to in order to maintain a 
quality and transparent approach to this RCT (Schulz et al., 2010). Ethical approval was 
gained from the National Research Ethics Service, South West 3 Regional Ethics 
Committee (REC reference number: 12/SW/0014), and from the Faculty of Health 
Ethics Committee at The University of Plymouth. National Health Service (NHS) 
Research and Development approval was gained from the participating NHS centre. 
The trial was registered with ClinicalTrials.gov, registration number NCT01820013. 
3.3.2 Participants 
3.3.2.1 Inclusion Criteria 
Participants were required to have intermittent PGP (commenced or 
aggravated by pregnancy), which caused walking and/or stairs to be bothersome and 
were between 20 and 36 weeks pregnant. The participant also had to test positive on 






3.3.2.2 Exclusion Criteria 
Potential participants were excluded if they reported any history or signs and 
symptoms indicative of a serious cause of pain that might be inflammatory, infective, 
traumatic, neoplastic, degenerative or metabolic, i.e. trauma, unexplained weight loss, 
history of cancer, steroid use, drug abuse, HIV infection, immunosuppressed state, 
neurological symptoms such as bowel or bladder, sensory, motor, reflex involvement 
(cauda equina, lumbar disc lesion, spinal stenosis), fever, systemically unwell, obstetric 
complications, pain that did not improve with rest/severe disabling pain, history of 
chronic back or pelvic pain requiring surgery, focal inflammatory signs/tenderness of 
the spine (spondylolisthesis). Also excluded were any participants who had a known 
allergy to Lycra, or were <20 or > 36 weeks pregnant. The decision was taken to not 
enrol any participants before 20 weeks due to the potential for increased complication 
rates within the 1st Trimester. Along the same lines, they were not enrolled into the 
trial if they were > 36 weeks pregnant due to the time it would take to issue the 
participant with a customised pelvic orthosis; the participant would already be 37 
weeks pregnant and very close to their delivery date, which would effectively make the 
orthosis redundant. 
 
3.3.2.3 Recruitment Process, Setting and Location 
The trial, and associated recruitment processes were carried out within the 
Princess Alexandra Wing (maternity department) at The Royal Cornwall Hospital 
(Treliske, Truro, Cornwall, TR1 3LJ), between January 2013 and July 2014. The 
Consultant Obstetricians and Midwifery staff were the main recruiters for the study, 
due to their first contact with participants with pregnancy related musculoskeletal 
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problems. These staff members raised awareness about the study with their clients 
and, with the clients consent, subsequently informed the researcher (LC) of potential 
participants via a generic email account pelvicpainstudy@plymouth.ac.uk or contact 
telephone number. This ethically approved process had been successfully utilised by 
other studies previously undertaken within this Department at this Trust.  The 
researcher attempted to contact the participant by telephone within 24 hours to 
identify if they met the inclusion criteria and, with the verbal consent of the potential 
participant, booked an initial appointment to undergo further screening for the study. 
Individuals were invited consecutively until the target sample size had been achieved 
(see section 3.3.7, page 109).   
 
3.3.3 Screening  Procedure 
Screening (visit 1) was carried out at The Royal Cornwall Hospital (Treliske), 
Truro, Cornwall within the outpatient clinic rooms in the maternity department 
(Princess Alexandra Wing). A second person (female chaperone) was present at this 
session. Having verbally confirmed the participant wished to take part in the study, 
their written informed consent was obtained (Appendix 2) prior to enrolment.  
Following this, the screening procedure was commenced. Data gathered at the 
screening session occurred in a standardised order: 
 Demographic baseline information (age, gestation, parity and body mass index 
(BMI) (Appendix 3). This information was gathered by self-report, and 
confirmed by the lead researcher by cross checking details with the 
participant’s medical records.  
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 Identification of pain sites using a Pain Referral Map (Appendix 4) 
 Pain provocation test battery (section 3.3.5).  
If the participant met the inclusion criteria they were then enrolled in the study. 
3.3.4 Study  Procedures 
Following enrolment into the study, the participant was immediately measured 
for a pelvic orthosis (measurements detailed in section 3.3.9). They were then 
requested to return to the clinic for a pre-scheduled appointment with the researcher 
one week later.   
After the participant left the room, they were immediately randomly allocated 
by the method of minimisation (see section 3.3.8) to either group A or B. Depending on 
group allocation, the researcher then either conveyed these measurements to DM 
Orthotics Ltd to enable manufacturing of the customised DEFO, or to collect a correctly 
sized Serola Belt.  
The participant returned to the outpatient clinic rooms in the maternity 
department at The Royal Cornwall Hospital in seven days. At this appointment the 
female chaperone provided the participant with their first questionnaire to 
independently complete in the waiting room before contact with the researcher (to 
maintain researcher blinding). When they had completed their first baseline self-report 
questionnaire booklet (Appendix 5) the participant placed the questionnaire booklet 
into a sealed, opaque, freepost envelope and was asked by the chaperone to then post 
the envelope.  
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Following completion of the questionnaire booklet, the participant was seen by 
the researcher who fitted them with either a customised DEFO or Serola Belt, 
depending on their randomised group allocation. They were provided with a standard 
advice sheet regarding the washing of their orthosis (Appendix 6) and the standard 
advice booklet from the Association of Pelvic, Obstetric and Gynaecological 
Physiotherapy (see section 3.3.9.3). They were also given two folders containing their 
self-report, postal questionnaire booklets:- 
- Folder One: this pink folder (Appendix 7) contained the self-report, postal 
questionnaire booklets and freepost envelopes for the participant to complete 
during their pregnancy. This folder contained between three and 10 self-report 
questionnaire booklets depending upon their current gestation time.  
- Folder Two:  this blue folder (Appendix 7) contained the self-report, postal 
questionnaire booklets and freepost envelopes for them to complete during 
their first six weeks post-partum. This folder contained three self-report 
questionnaire booklets.   
The only time the participant was contacted was if they did not return a self-
report questionnaire booklet or if there was missing information on their returned self-
report questionnaires, as identified by the independent (blinded) assistant. 
The participants were requested to return their self-report postal questionnaire 
booklets every two weeks from the date they received their orthosis. The associated 
freepost envelopes were addressed to ‘PELVIC PAIN STUDY, Faculty of Health, 
Education & Society, Peninsula Allied Health Centre (Derriford Road), University of 
Plymouth, FREEPOST PHY271, Drake Circus, PL4 8ZZ’. Each envelope was uniquely 
identifiable by the independent blinded assistant by a unique code containing 
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‘Participant number, questionnaire number, and pre or post pregnancy e.g. P01-WK01-
PREPREG or P01-WK01-POSTPREG and once checked the questionnaire booklet was 
locked into a steel cabinet, within a locked office, which only the external assistant had 
access to.  
The independent blinded assistant was responsible for checking every 
questionnaire booklet that was received to ensure that every question within the 
questionnaire booklet was completed correctly (for example a number outside of the 
possible available range). If there was any missing or incorrect data or a questionnaire 
booklet had not been received, the independent assistant immediately issued the 
researcher with the participant ID and the item on the questionnaire that was missing 
or completed incorrectly. This ensured that the information was gained in a timely 
manner so that it was relevant to the same questionnaire week. The researcher then 
telephoned the participant, to obtain any missing data. This was the only time that the 
participant could have potentially been influenced, or the researcher could have 
biased the proceedings. To prevent this happening at the beginning of the telephone 
conversation the researcher informed the participant that they were being contacted 
as the questionnaire had some missing information and the researcher would like to 
gather this information. The researcher then read the question out, asked the 
participant for a response, and repeated that the researcher could only read the 
question and not explain or alter it. The use of a script allowed all telephone 
conversations with participants to be standardised. 
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3.3.5 Pain Provocation Tests 
A wide range of pain provocation tests are currently used for the diagnosis of 
pregnancy related PGP (Vleeming et al., 2008). They are divided between sacro-iliac 
joint (SIJ) and symphysis pubis (SP) pain provocation tests, to identify between 
posterior and anterior PGP respectively. Common tests which have been identified in 
the literature for SIJ symptoms are the Posterior Pelvic Pain Provocation (PPPP or P4), 
Long Dorsal Sacroiliac Ligament (LDL), Patrick’s/Flexion-Abduction-External Rotation 
(FABER), Compression, Separation, Distraction, Sacral Thrust, Gaenslen’s test and 
Menell’s Test (Albert et al., 2000; Arab et al., 2009; Gutke et al., 2010; Laslett et al., 
2005; Robinson et al., 2007; ). Tests identified for the SP symptoms are the Modified 
Trendelenburg test and Palpation of SP (Albert et al., 2000; Hansen et al., 1999; 
Kristiansson et al., 1996;). The following section will detail the reasoning behind why 
specific pain provocation tests were chosen for this study. These decisions were 
informed by the literature, which included the most recent European Guidelines 
(Vleeming et al., 2008) for the diagnosis and treatment of PGP. Key to selection of the 
screening measures were that they demonstrated good levels of sensitivity and 
specificity as diagnostic screening tests, and that they generated reliable results.  
 
3.3.5.1 Pain in the Sacroiliac Joint (SIJ) 
The European Guidelines (Vleeming et al., 2008) supported the use of four pain 
provocation tests from the above list for the diagnosis of posterior PGP, of which three 
were considered for this study; the posterior pelvic pain provocation test (P4/Thigh 
thrust), Patrick’s FABER test, and Gaenslan’s test. Within the literature there is a wide 
variability in results for the sensitivity, specificity and validity of these tests (Albert et 
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al., 2000; Arab et al., 2009; Gutke et al., 2010; Hansen et al., 1999; Laslett et al., 2005; 
Robinson et al., 2007; Vleeming et al., 2008;), which is thought to be due to differing 
sample sizes, different sample populations, experience of examiners and stages of 
pregnancy (antenatal or post-partum). Table 3.1 shows the inter-rater reliability (kappa 
coefficient level) of these tests and Table 3.2 shows the sensitivity and specificity for 
the chosen SIJ pain provocation tests. To optimise sensitivity and specificity it has been 
suggested that a cluster of techniques are performed for the diagnosis of SIJ 
symptoms, therefore the participant was considered positive for posterior PGP and 
eligible for the study if they were found to be positive in two out of five SIJ tests (Arab 
et al., 2009; Laslett et al., 2005; Robinson et al., 2007). 
 
3.3.5.1.1 Posterior Pelvic Pain Provocation Test (P4,PPPP test) 
To perform the P4 test the patient lies supine with the hip flexed to 90°. The 
examiner applies pressure on the flexed knee in the longitudinal axis of the femur 
while stabilizing the pelvis, with the other hand resting on the opposite anterior 
superior iliac spine. The test is considered positive if this maneuver produces a familiar 
pain in the gluteal region of the provoked side. It is recorded as either yes or no and 
both left and right sides are tested and scored separately, therefore this test can 
potentially be counted as two positive tests per participant. 
The P4 test has demonstrated a kappa coefficient level of 0.70 when tested within 
a pregnant population (Albert et al., 2000). This study by Albert et al. (2000) completed 
a battery of 15 pain provocation tests on a large sample of 535 pregnant women, who 
met inclusion criteria from a possible 2269 women. Other studies report variable 
reliability (0.50-0.80) within a non-pregnant population (Gutke et al., 2010); Robinson 
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et al., 2007). Even though this level of reliability is rated as good to moderate, it is 
unclear as to why there is such a wide spectrum of values. It is hypothesised that this is 
related to the limitations previously discussed within this section, namely the differing 
sample sizes, populations, experience of examiners and stages of pregnancy. 
 
Table 3.1 Inter-rater reliability scores for the sacro-iliac joint provocation tests, 
detailing kappa coefficient levels  
Test Kappa Coefficient Population Author 
P4 0.70 Women peri-
partum 
Albert et al. (2000) 
 0.50-0.80 Non pregnant Gutke et al. (2010) 
 0.74-0.76 Non pregnant Robinson et al. 
(2007) 
FABERS 0.54 Women peri-
partum 
Albert et al. (2000) 
 0.48-0.60 Non pregnant Robinson et al. 
(2007) 
 0.44-0.49 Non pregnant Arab et al. (2009) 
Gaenslan’s 0.41-0.50 Women peri-
partum 
Gutke et al. (2010) 
 0.72 Non pregnant Laslett et al. (2005) 




The P4 test has been specifically evaluated for use in antenatal women and has 
demonstrated to have a sensitivity and specificity of 0.69-0.93 and 0.80-0.98 
respectively (Albert et al., 2000; Kristiansson et al., 1996; Mens et al., 2001; Ostgaard 
et al., 1994). Studies by Dreyfuss et al., (1994, 1996) reported much lower sensitivity 
and specificity levels (0.36 and 0.50 respectively). However, systematic reviews have 
questioned the validity of the results of the studies by Dreyfuss (Van der Wurff et al., 
2000) because of their poor methodological quality as reflected by their lack of 
documentation about blinding, examiner experience, inclusion/exclusion criteria, and 
no standardization in the description of the performed pain provocation test.  
 
3.3.5.1.2 Patrick’s or FABER (Flexion, Abduction, External Rotation) Test 
To perform the FABER test the patient lies supine; the examiner flexes the hip, 
and abducts and externally rotates one leg to bring the ipsilateral heel to rest on the 
opposite knee. The patient is asked to relax the limb to allow the weight of the leg to 
draw the knee toward the floor. The test is considered positive if pain is felt in the 
ipsilateral SIJ or in the symphysis pubis. 
The FABER test has shown to have some of the highest reliability and specificity 
scores, and is one of the most commonly used tests along with the P4 test (Albert et 
al., 2000; Arab et al., 2009; Hansen et al., 1999; Van der Wurff and Meyne, 2000; 
Vleeming et al., 2008). Albert et al. (2000) reported it to have a moderate kappa 
coefficient level (kappa = 0.54), which  is consistent with other authors findings 
showing a kappa level of 0.48-0.62 amongst a post-partum PGP population (Robinson 
et al. 2007). The FABER test was deemed to have a superior sensitivity of 0.70 
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compared to the other 15 pain provocation tests that were studied, and was reported 
to have a very high specificity of 0.99.  
The sensitivity of the FABER test has been reported to be 0.41-0.70 (peri-
partum) and 0.57-0.77 (non-pregnant) and with a specificity of 0.99 (peri-partum) and 
0.49-1.00 (non-pregnant) (Albert et al., 2000; Arab et al., 2009; Hansen et al., 1999; 
Van der Wurff and Meyne, 2000; Vleeming et al., 2008), showing the test to have 
moderate (although variable) sensitivity but very high specificity.   
 
3.3.5.1.3 Gaenslan’s test 
To perform Gaenslan’s test, the patient lies supine near the edge of the table. 
One leg hangs over the edge of the table and the other hip and knee is flexed towards 
the patient’s chest. The examiner applies firm pressure to the knee being flexed to the 
patient’s chest and a counter pressure is applied to the knee of the hanging leg, 
towards the floor. The procedure is carried out on both sides (thus it can be counted as 
two tests). The test is positive if the patient experiences pain in the SIJ or gluteal area. 
Inter rater reliability has been evaluated for women peri-partum producing 
kappa levels of 0.41-0.50 (Gutke et al., 2010) and for non-pregnant populations kappa 
levels of 0.61-0.72 (Dreyfuss et al., 1994; Dreyfuss et al., 1996; Laslett et al., 2005). The 
sensitivity and specificity have shown to be moderate to good (0.50-0.63 and 0.71-0.79 
respectively) (Gutke et al., 2010; Laslett et al., 2005; Van der Wurff and Meyne, 2000).  
Studies by Dreyfuss et al., (1994, 1996) were excluded by Van der Wruff and Meyne 
(2000) when completing a systematic methodological review. The Dreyfuss studies 
presented a sensitivity of 0.71 but specificity of 0.26 that was unusual as it differed 
markedly from many other studies; it was excluded due to a low methodological score. 
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Test Sensitivity Specificity Population Author 
P4 0.81 0.80 Women Peri-
partum 
Ostgaard et al. 
(1994) 
0.84-0.93 0.98 Women peri-
partum 
Albert et al. 
(2000) 
0.69 0.90 Women peri-
partum 
Kristiansson et al. 
(1996) 
0.69  Women peri 
partum 
Mens et al. 
(2001) 
0.88 0.69 Non pregnant Laslett et al. 
(2005) 
0.80 1.00 No pregnant Van de Wurff et 
al. (2000) 
0.93 0.64 Non pregnant Van de Wurff et 
al. (2000) 
FABERS 0.70 0.99 Women Peri-
partum 
Albert et al. 
(2000) 
0.77 1.00 Non pregnant Van der Wruff et 
al. (2000) 
0.44 0.49 Non pregnant Arab et al. (2009) 
0.41-0.44 No data Women peri-
partum 












Table 3.2 Sensitivity and specificity scores for the sacroiliac joint provocation tests  
 
3.3.5.2 Pain in the Symphysis Pubis (SP) 
The European guidelines have supported both the Modified Trendelenburg test 
and the palpation of the SP and both tests have been used within a pregnancy related 
PGP population (Albert et al., 2000; Hansen et al., 1999; Kristiansson et al., 1996; 
Vleeming et al., 2008). Table 3.3 shows the inter-rater reliability (kappa coefficient 
level) for each for the tests and Table 3.4 shows the sensitivity and specificity for the 
chosen SP pain provocation tests. As previously stated, to optimise sensitivity and 
specificity, it has been suggested to perform a cluster of techniques for the diagnosis 
of PGP, therefore the participant was considered positive for posterior PGP and eligible 
for the study if they were found to be positive in one out of the two SP tests (Arab et 







0.50-0.53 0.71-0.77 Non pregnant 
population 
Laslett et al. 
(2005) 
0.63 0.79 Non pregnant 
population 
Van der Wruff et 
al. (2000) 
0.71 0.26 Non pregnant 
population 




3.3.5.2.1 Direct Palpation of the Symphysis Pubis 
To perform this test the examiner palpates the participants symphysis pubis 
and if the woman experiences symphyseal pain, then the test is considered positive 
(Vleeming et al., 2008). The palpation of the SP has shown to have acceptable 
reliability with kappa levels of 0.55-0.89 (Albert et al., 2000). Sensitivity and specificity 
has been reported as 0.60-0.87 and 0.85-0.99 respectively (Albert et al., 2000; Hansen 




Table 3.3 Inter-rater reliability scores for the symphysis pubis provocation tests, 







Palpation of the SP 0.89 Women peri-partum Albert et al. (2000) 




0.63 Women peri-partum Albert et al. (2000) 





Table 3.4 Sensitivity and specificity scores for the symphysis pubis provocation tests  
 
3.3.5.2.2 Modified Trendelenburg tests 
To perform the Modified Trendelenburg test the patient stands on one leg and 
flexes the ipsilateral hip and knee to 90 degrees. If pain is experienced in the 
symphyseal area then the test is considered positive (Vleeming et al., 2008). Reliability 
scores for the Modified Trendelenburg test show acceptable kappa levels of 0.52-0.63 
(Albert et al., 2000; Hansen et al., 1999). It has been shown to have reduced sensitivity 
compared to palpation of the SP (0.40-0.62) (Albert et al., 2000; Hansen et al., 1999; 
Kristiansson et al., 1996). The sensitivity and specificity of this test has been reported 
to be 0.40-0.62 and 0.99, respectively (Albert et al., 2000; Hansen et al., 1999; 
Kristiansson et al., 1996), which is considered acceptable. 
 
Test Sensitivity Specificity Population Author 
Palpation of the SP 0.60-0.81 0.99 Women Peri-
partum 
Albert et al. 
(2000) 




0.80 No Data Women peri-
partum 




0.60-0.62 0.99 Women Peri-
partum 
Albert et al. 
(2000) 
0.40 No Data Women Peri-
partum 





The feasibility of implementing a battery of outcome measures is an important 
consideration, for instance in minimizing patient burden, participant drop-out, and 
missing data. Therefore, in the design stage of the study, a discussion was undertaken 
with an experienced midwife regarding the feasibility of implementing the pain 
provocation tests in women suffering with severe PGP who would be participating in 
this study. There was concern that the tests would potentially exacerbate the 
participants’ symptoms, with subsequent impact on both the participants’ well-being, 
and methodological issues such as a reluctance for potential participants to engage in 
the study having completed the screening phase. The outcome of this clinically focused 
discussion was that a hierarchy of tests would be performed, aimed at limiting 
irritation of the women’s current symptoms whilst remaining sensitive to identifying 
the presence of PGP (figure 3.1). For the SIJ pain provocation tests the P4 test would 
be performed first (bilaterally), followed by FABERS test (bilaterally), followed by 
Gaenslan’s test. As soon as the participant had met the inclusion criteria for the study 
the testing would cease to avoid further potential exacerbation. If inclusion was not 
met then the screening tests would continue.  
The order of the tests was organized in the light of both clinical experience and 
the literature (previously discussed). It was felt that Gaenslan’s test would be more 
difficult to perform on someone with severe PGP and therefore would be the last 
provocation test implemented. A decision was also made to perform the Modified 
Trendelenburg test prior to the direct palpation of the SP, as if found to be positive it 
would prevent the participant from undergoing direct palpation. This was for two 
reasons;  the test can be very unpleasant when implemented, and there are delicate 
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issues associated with this area of palpation, particularly when the palpation is 
undertaken by a man, even though a female chaperone was going to be present at all 
times. 
 
3.3.5.4 Summary  
All pain provocation tests selected for the study were based on the best 
available evidence alongside the information provided from the European Guidelines 
(Vleeming et al., 2008). There are limitations with the pain provocation tests chosen, 
especially with regard to the validity of the SIJ pain provocation tests, however, given 
the lack of a ‘gold standard’ test for PGP, assessing the validity of these tests is 
challenging. Of importance, the pain provocation tests used in this study have been 
widely used with the pregnant PGP population, enabling familiarity for the relevant 
readership in terms of interpreting the results, and the ability to compare the results 










Figure 3.1 The pain provocation pathway required for inclusion or exclusion of participants to the study
98 
 
3.3.6 Outcome Measures 
This section describes the standardised outcome measures that were used to 
determine the effectiveness of the pelvic orthoses evaluated within this study. These 
measures were chosen on the basis of their proven psychometric abilities (reliability, 
validity, responsiveness) to measure the most common symptoms reported in 
pregnancy related PGP.   All outcome measures used within this study are self-report 
questionnaires. This was due to their feasibility and low cost of implementation; 
clinician rated measures would have required participants to attend a potential 15 
clinic appointments. This was considered prohibitive for a number of reasons. Most 
importantly it would have been overly burdensome to participants, many of whom 
would be experiencing considerable PGP when travelling. This inevitably would have 
impacted on both recruitment and drop-out rate, and hence the generalizability of 
study results. Furthermore, it would have incurred extensive researcher time, 
chaperone costs and expenses for all parties, which was cost-prohibitive within the 
scope of this PhD dissertation. 
The individual self-report questionnaires are described in turn below. For the 
purposes of this study they were all compiled into a single stapled booklet, to minimise 
the potential for loss of questionnaires and to optimise the likelihood of the 
questionnaires being completed by the participants in the same order. These 
questionnaire booklets were provided to the participants at the beginning of the study 
in two folders (see appendix 7). A total of between 79 and 88 questions could be 
answered within the booklet. Some answers required extra information if answered 
‘yes’ or ‘no’ and that could lead to an extra nine questions from the core  79.  
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The primary outcome measure used was the Numerical Pain Rating Scale 
(NPRS); to evaluate changes in pain levels. For the secondary outcome measures a 
disease specific questionnaire, the Pelvic Girdle Questionnaire (PGQ) was used to 
identify activity/disability levels. Non-disease specific questionnaires - the European 
quality of life - 5 Dimensions  (EQ5D – 5L) and the Short-Form 36 Item Health Survey 
version 2 (SF36-V2) - were used to identify changes in health related quality of life. All 
selected questionnaires were chosen for their proven psychometric properties. The 
intention of the following sections is to review the reliability, validity and 
responsiveness of each measure.  
 
3.3.6.1 Primary Outcome 
 
3.3.6.1.1 Numerical Pain Rating Scale (NPRS) 
The NPRS is widely used within healthcare and has been considered 
appropriate for research and clinical practice due to good validity and reliability and 
self-report being the gold standard for reporting pain (Ferreira-Valente et al., 2011; 
Jensen et al., 1999; Williamson and Hoggart et al., 2005). The NPRS aims to measure 
the participant’s perceived pain intensity using an 11-point self-report scale consisting 
of integers from 0 (no pain) to 10 (unbearable pain). The participant is required to 
select one number that best represents their pain intensity. In this study pain intensity 
was measured using the NPRS, by asking participants two questions: “Over the last 
week, how would you rate your average level of pelvic pain during the day?” and “Over 
the last week, how would you rate your average level of pelvic pain during the night 
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(after going to bed)?” Pain classifications were divided between mild pain, (0-4) 
moderate pain, (5-7) and severe pain (8-10).  
Many studies have shown the NPRS to have good validity in a wide range of 
disease populations (Childs et al., 2005; Farrar et al., 2008; Ferreira-Valente et al., 
2011; Jensen et al., 1999; Hjermstad et al., 2011). Acceptable to good levels of test re-
test reliability have also been demonstrated by a number of studies including that of 
Childs et al. (2005)(ICC 0.61) and Farrar et al (2008) (ICC = 0.83) (Farrar et al., 2008).  
When using an outcome measure it is important to consider the measure’s 
ability to detect change over time. The minimal detectable change (MDC) can be 
considered, as the smallest change, which is not likely to be due to measurement error 
(Wright et al., 2012). Childs et al. (2005) determined that the MDC of the NPRS 
required a two-point change to be statistically significant and thus avoid any change 
being attributable to random error (MDC= 1.99 points). It is important to consider that 
the MDC is calculated on a statistical threshold, meaning that the MDC alone does not 
provide information on clinical significance (Wright et al., 2012). Also important to 
consider is the score change that is meaningful to the patient. This is termed the 
minimal clinically important difference (MCID) (Ferreira et al., 2012). It is the smallest 
difference in score reported by patients that correlates with the patient stating they 
are ‘slightly better’ in comparison to early scores (Salaffi et al., 2004). As the MCID is 
based upon patient response-anchor method, it is more appropriate for assessing 
clinical significance (Wright et al., 2012).  
However, this can be complicated to interpret, since the importance of a 
change in pain intensity can differ depending upon issues such as where the score is on 
the pain scale, or the health condition (Dworkin et al., 2008). A number of studies have 
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attempted to define what score change reflects this clinically significant change for the 
NPRS in musculoskeletal conditions. The range of values across these studies, 
however, do differ. For example, Salaffi et al. (2004) reported that a 15.0% (1 point) 
change on the NPRS represented the MCID for the patient signifying a ‘slightly better’ 
change. Others have determined that a two-point change is required to be deemed 
clinically significant (Farrar et al., 2001; Jensen et al., 1999), with a 1.7 point change 
required for those with chronic musculoskeletal pain (Farrar et al., 2001). Whilst 
recognising these differences exist, recommendations have been made for interpreting 
the clinical importance of treatment outcomes in chronic pain clinical trials (The 
IMMPACT Recommendations, Dworkin et al., 2008). These recommendations suggest 
that, on the basis of the available body of research, score changes of approximately 1 
point represent minimally important (but perhaps not very important) decreases in 
pain when using the NPRS. This provides the rationale for defining what constituted a 
clinically important change in our study. It is acknowledged that this needs to be 
confirmed in future studies that directly assess patient evaluations of what is 
noticeable, important, and major improvement in the pregnancy-related pelvic girdle 
pain population. 
The NPRS is more responsive than other commonly used pain rating scales 
(such as the Visual Analogue Scale, Verbal Rating Scale and Faces Pain Scale-Revised) 
(Ferreira-Valente et al., 2011). Furthermore, in a study using temperature change to 
differentiate pain levels (1 °C - 7 °C), the NPRS, when compared to the VAS, was found 
to have a marginal increase in effect size (0.25- 0.59 NPRS compared to 0.22- 0.58 VAS) 
and higher f values (93.49 - NRS and 85.74 - VAS).  
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Jensen et al., (1999) concluded that pain scale ratings consisting of 0-10 are 
psychometrically robust in terms of reliability, validity and responsiveness in a wide 
range of disease populations. It was suggested that a 0-10 point scale provides 
maximal reliability when using smaller sample sizes or following pain intensity in an 
individual. To further support its use within this study, it has been recommended for 
group level analysis as it allows for statistical testing (Jensen et al., 1999). Additional 
qualities that influenced the choice of the NPRS related to its ease of use, simplicity 
and time effectiveness (it takes less than three minutes to complete). In line with this, 
it has been reported to have higher compliance rates and less error rates when 
compared to the VAS which was deemed to be potentially more complicated 
(Hjermstad et al., 2011). 
 
3.3.6.2 Secondary Outcomes 
 
3.3.6.2.1 Pelvic Girdle Questionnaire (PGQ) 
The Pelvic Girdle Questionnaire (PGQ) is a condition-specific, self-report 
questionnaire. It was initially developed because of the lack of distinction between low 
back pain and PGP outcome measures, and evaluates treatment outcomes relating to 
activity/participation and body functions/symptoms specifically for the pregnant PGP 
population (Stuge et al., 2011). The PGQ consists of 25 questions, using a 4-point Likert 
scale (0, not at all; 1, to a small extent; 2, to some extent and 3, to a large extent). The 
25 questions are related to activity (20 questions) and symptoms (5 questions). It is 
easy to use and takes approximately three minutes to complete. It is the first, and to 
my knowledge the only, condition-specific questionnaire designed for PGP; with 
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limited studies to date that have evaluated its psychometric qualities. The initial study 
by the developer of this outcome measure, Stuge et al. (2011) reported acceptability, 
high validity and reliability, however more research is required to further support this 
claim. 
In the development of this questionnaire, focus groups were undertaken of 
patients experiencing PGP (both antenatal and post-partum), during which time they 
were asked to detail the activities they considered most important to them. This was 
undertaken to optimise its content validity (Grotle et al., 2012; Stuge et al., 2011).  
Alongside this, literature searches were completed to identify all other outcome 
measures that had been used to evaluate PGP; and a Rasch analysis undertaken to 
enable item reduction (Stuge et al., 2011). 
Grotle et al. (2012) provides evidence to support the discriminative validity of 
the PGQ, demonstrating that the questionnaire discriminated females who were 
pregnant from females who were not, and also females who were peri-partum from 
those who were post-partum. The PGQ included pain location as it was specifically 
designed for patients suffering with PGP. 
The PGQ has also been shown to have high reliability (Cronbach’s alpha=0.86) 
and test re-test reliability (ICC=0.93) within the pregnant PGP population (Grotle et al., 
2012; Stuge et al., 2011). 
There is limited published evidence to support the responsiveness of the PGQ. 
The MDC, i.e. the smallest amount of change which is considered real change and not 
due to measurement error, and is commonly used to determine the responsiveness of 
a measure. For the PGQ it has been calculated at between 7-14% in the pregnant PGP 
population (Grotle et al., 2012). 
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In conclusion, there is a small body of evidence to suggest the PGQ has  good 
internal consistency, test re-test reliability and validity (content, face and 
discriminative). It has been recommended for the evaluation of treatments aimed at 
pregnancy related PGP participants by identifying symptoms and disability in both 
clinical and research environments; however, more research is needed to further 
explore the psychometric properties of the PGQ. 
 
3.3.6.2.2 Short Form 36 – Version 2 
The Short-Form 36 – item health survey version 2 (SF-36v2) is a self-report 
questionnaire developed from the Medical Outcomes Study (MOS), and is described as 
the gold standard self-report questionnaire for generic health related quality of life 
(HRQoL) (Ware, 1992; Ware and Gandek, 1998). The SF-36v2 asks participants to rate 
their quality of life over the past week. Given that assessments were undertaken on a 
two weekly basis in our study, this version was selected over the standard SF-36 which 
uses a four-week timeframe for the participants to consider when rating their quality 
of life, and which therefore was inappropriate. It contains 36 questions, assessing eight 
of the following dimensions: physical functioning, social functioning, function 
limitations secondary to physical problems, function limitations secondary to 
emotional problems, mental health, vitality, pain and general health. Participants are 
required to answer the questions using a three, five and six-point Likert scale (one 
answer per question). To analyse the data ‘raw scores’ are converted to a 100 point 
scale in which a higher number reflects a better health related functional status 
(Forger et al., 2005; Ware et al., 2000). 
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The SF36 has been shown to have good internal consistency (Cronbach’s alpha 
level a=0.85) and test re-test reliability (intra-class correlation coefficient [ICC] =0.75) 
(Brazier et al., 1992), for all dimensions except social functioning where internal 
consistency has shown to be lower (Cronbach’s a=0.64) (Picavet and Hoeymans, 2004); 
potentially because of the low number of items (two) in that dimension (Brazier et al., 
1992). The test re-test reliability has also been confirmed by Grotle et al. (2012), with 
an acceptable to good level of test re-test reliability (ICC = 0.78-0.89).  
Evidence from a range of studies in varied populations demonstrates that the 
SF36 has good validity (for example, Brazier et al., 1992; Grotle et al., 2012). More 
specifically in relation to PGP the study by Grotle et al., (2012) assessed the SF36’s 
construct and discriminative validity along with other commonly used outcome 
measures with females suffering with PGP. It was shown that the SF36 had good 
construct validity when used within this population, however, the measure did not 
satisfactorily discriminate for patients suffering with pregnancy related PGP, and this 
could be because it is not a disease specific questionnaire. The PGQ which is a disease 
specific questionnaire (previously discussed in section 3.3.6.2.1) was deemed to have 
the best discriminatory validity in this population. 
To evaluate the effect that an intervention has had on a participant’s HRQoL 
the MDC has been considered within previous studies (Escobar et al., 2007; Grotle et 
al., 2012; Quintana et al., 2005). The study by Grotle et al. (2012) assessed the SF-36 
responsiveness within the pregnancy PGP population. They identified an MDC 
(individual) of 7.3 and 12.8 and MDC (Group) of 1.1 to 2.0. Measurement errors were 
reported to be low at 7% to 14% for the MDC (individual), and for MDC (group) was 
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18% to 22% which was similar to previous studies reported for self-report 
measurements (10% to 35%) (Grotle et al., 2012 Wolfe et al., 2007). 
Other advantages of the SF36v2.0 are the practicality of the measure and its 
broader coverage (Picavet and Hoeymans, 2004). It requires low contact time with 
patients which reduces patient burden, and which can be cost effective when 
undertaking research and also within a clinical setting when patient time is limited, it is 
easy to use and it is self-administered. It has also been shown to have no floor or 
ceiling effects, giving confidence that the measure will detect both improvement and 
decline in a patient’s outcome or health.  
 
3.3.6.2.3 European Quality of Life - 5 dimensions – 5 Level (EQ5D – 5L) 
The European Quality of Life - 5 Dimensions Questionnaire (EQ-5D) is a short, 
generic, self-report questionnaire for subjectively describing and valuing HRQoL. It is 
one of the most common, nationally used outcome measurement tools (Johnsen et al., 
2013) and has been clinically and scientifically approved (Rabin and de Charro, 2001). It 
was developed to be a non-disease specific measure that could be used alongside 
other HRQoL measurement tools. It can be used to measure health and to  gain a 
standardised health index to complete a cost utility or cost-effectiveness analysis 
(Badia et al., 2001).  
The instrument is comprised of five questions divided into mobility, self-care, 
usual activities, pain/discomfort, anxiety and depression. The participants answer the 
questions using a five-point Likert scale. When the questionnaire is complete it is 
scored to give a health index. The values allocated range from one to five (no problem 
=1, slight problem = 2, moderate problem = 3, severe problem = 4 and unable = 5), 
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therefore an answer of ‘no problem’ for each question gives a health index of ‘11111’, 
indicating “full health”. This health index is then used to calculate an index value (using 
EQ5D software) which is compared to a value set which provides an overall health 
profile. 
Some authors have expressed concerns that pre-set values can lead to wrongly 
expected views due to population norms variation which may occur with different 
cultures, experiences and language differences (Badia et al., 2001). The European 
Quality of Life group have completed value sets for the UK, France, Denmark, 
Germany, Netherlands, Japan, Spain, Zimbabwe and the United States to allow for 
more accurate profiles to be gained (Grenier et al., 2003). There are a total of 243 
potential health states that have been validated by the Measurement and Valuation of 
Health Group, who undertook a large-scale survey within the UK to validate the EQ-5D 
time trade off health states using 2997 interviews of the general population (Rabin and 
de Charro, 2001). There is also a VAS ranging from 0 (worst health you can imagine) to 
100 (best health you can imagine) which is 20 centimetres long to score how good or 
bad your health is today.  
A significant  benefit of the EQ5D is that  Quality Adjusted Life Years (QALYs) 
can be calculated from the index score which enables a cost utility or cost-
effectiveness analysis to be completed to test the effectiveness of the intervention. 
QALYs are the number of life years that would be added following an intervention 
(Rabin and de Charro, 2001); they are calculated using a time trade off technique.  
Despite the EQ5D being a non-disease specific outcome measure there is a 
direct relevance to both the primary and secondary aims of the RCT study undertaken 
for this dissertation;  its  dimensions are relevant to the  symptoms experienced by 
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females with pregnancy related PGP showing good face, content and construct validity. 
Further, it has been found to have good test re-test reliability (Keller et al., 1998). 
To test the responsiveness of the EQ5D, Orbradovic (2013), compared the 
questionnaire to the SF-6D and a disease specific questionnaire, in this case, chronic 
pain (Obradovic et al. 2013). The standard response mean (SRM)) is one of several 
available effect size indices used to gauge the responsiveness of scales to clinical 
change along with mean (M). The SRM is computed by dividing the mean score change 
by the standard deviation of the change. It was shown the EQ-5D had a greater SRM 
than the SF-6D, with participants within the mild to moderate criteria reporting 
SRM=0.65 (M=0.142), moderate to severe SRM = 1.33 (M=0.418) and severe to 
extreme 2.02 (M=0.608). The EQ-5D has been used amongst the PGP population to 
identify changes in HRQoL. The study by Gutke et al. (2011) identified one in three 
participants reported moderate to severe disability (Gutke et al., 2011). It was also 
shown by Picavet (2001) who used both the EQ-5D and SF-36 to identify HRQoL 
changes associated with musculoskeletal disorders. The EQ5D was able to discriminate 
in detecting participants with a musculoskeletal disorder compared to the general 
population and this was represented with a worsening quality of life. The studies 
above identify the EQ-5D’s ability to detect worsening health, however, Harrison et al. 
(2009) reported that it was also responsive in detecting improvement in a participant’s 
health.  
Some disadvantages of the EQ-5D have been reported by Brazier et al. (1999), 
who highlighted potential ceiling effects when compared to the SF-6D. He identified 
that participants who reported full health in the EQ-5D were still identified as having 
some difficulties with physical functioning, mental health and vitality. These are 
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sections which are included within the EQ-5D, but it was suggested by Brazier et al. 
(1999) that the addition of more intermediate levels within each section may reduce 
any ceiling effect. 
The EQ-5D was chosen for use within this study for its robust psychometric 
properties in evaluating HRQoL. It has been previously used within a pregnancy related 
PGP population and all of the dimensions within the measure relate directly to our 
study aims.   
3.3.6.2.4 Resource Use Questionnaire  
The resource use questionnaire was developed in association with a health 
economist and a consultant obstetrician. It was a customised questionnaire, and 
covered key items of direct and indirect resource use such as medication, walking aids, 
health care use, sick leave and partner sick leave (to assist with care).  
3.3.6.2.5 Cost Effectiveness  
To allow for a cost effectiveness analysis to be undertaken the resource use 
questionnaire was developed, as previously discussed. The direct and indirect costs, 
along with the mode of delivery costs of participants were required to calculate 
associated costs. The EQ5D allowed a health index to be calculated for each participant 
and the SF36-V2, was translated (Quality Metric Outcomes TM Scoring Software 4.5) to 






3.3.7 Sample Size Calculation 
A  RCT assessing the effectiveness of two different forms of pelvic belts (rigid 
and non-rigid) plus exercise on PGP in pregnant women (Depledge et al., 2005) 
provided the data upon which the sample size was calculated for this study. Depledge 
et al. (2005) measured average pain (VAS scale) before and after a one-week 
intervention. The non-rigid pelvic belt plus exercise group experienced a decrease in 
pain from 42.5% to 38.5% with a mean SD of 11 whilst a rigid pelvic belt plus exercise 
decreased pain from 52% to 38.5% also with a mean SD of 11. The resultant effect size 
was 0.86 ((42.5-38.5)-(52-38.5)/11). For a two-tailed unpaired t-test at 85% power and 
significance level of 0.05 an estimated 25 people are required in each group. Depledge 
et al’s. (2005) attrition rate was 6.6% for two outcome measures spaced one week 
apart; attrition rates of 0-20% have been reported in other studies. With an estimated 
10% attrition rate for each measure (n=4) the intention was to recruit 36 participants 
in each group, therefore having a total of 72 participants. 
3.3.8 Randomisation 
Many methods of randomisation were considered for the random allocation of 
participants in this study, such as simple randomisation, restricted randomisation, and 
covariate-balancing randomisation (stratification and minimisation).  
Allocation by simple randomisation allocates participants to either an 
intervention or control group. It maintains an unbiased approach due to the 
unpredictability of which group a participant will be allocated (Herbert et al., 2005). 
Simple randomisation does not consider the effect of baseline prognostic factors, as in 
large studies where large sample sizes are present, a balance of prognostic factors will 
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be ensured (McPherson et al., 2012). However, it is common practice for simple 
randomisation to cause an unbalance in groups (Scott et al., 2002), and while  this is an 
acceptable risk with larger sample sizes,  in smaller studies it is important to reduce 
the risk of this occurring. Since our study sample size was relatively small, and the 
literature demonstrated essential prognostic factors that needed to be identified at 
baseline, simple randomisation was ruled out.  
Restricted randomisation allocates participants into permuted blocks. This 
allows for a balance in participants into either an intervention or control group, which 
cannot be guaranteed with simple randomisation (McPherson et al., 2012). While this 
method can also allow for certain baseline characteristics, it still fails to take into 
consideration baseline prognostic factors and therefore was also ruled out. When 
compared to minimisation through a computer simulation, minimisation has shown to 
outperform restricted random allocation and result in fewer imbalances (Scott et al., 
2002).  
Stratified random allocation maintains balance between groups and takes into 
consideration a limited number (1-2) of baseline prognostic factors. This involves 
allocating participants into permuted blocks using either simple randomisation or 
permuted blocks (McPherson et al., 2012).  A disadvantage of stratified random 
allocation is the potential for some  participant groups to fill up more quickly than 
others, leading to potential imbalances if the study prematurely ceases and also leads 
to prediction of the last participant to be known (Herbert et al., 2005). When 
compared to minimisation, stratified random allocation performs similarly when using 
a limited number of prognostic factors, however, when there are more than three 
prognostic factors, Scott et al. (2002) have shown that minimisation begins to 
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outperform stratified random allocation when sample sizes exceed 50. Thus, since the 
intended study sample size was 72, and there were seven prognostic factors; 
minimisation was determined as the most viable and effective method for random 
allocation of the participants.  
Treatment allocation by minimisation is a widely accepted alternative to 
stratification. It is  increasingly used in clinical trials (Taves, 2010) and has been 
described by CONSORT as the platinum standard for clinical trials (Schulz et al., 2011). 
This method ensures that there is a balance between treatment groups with respect to 
predefined participant factors (Scott et al., 2002) and was the chosen method of 
randomisation for this study. When using minimisation, the user has to consider 
important prognostic factors before the trial has started, increasing adherence to the 
studies protocol (Taves, 2010). 
Some authors (Scott et al., 2002) have questioned the credibility of studies 
using minimisation, due to the to the persuasive nature of allocation  ensuring precise 
balance between groups and prognostic factors. However, it is argued that there is 
sufficient evidence in the literature to support the need for the groups to be balanced 
with regard to these factors to enable an unbiased comparison of the interventions. 
One potential disadvantage of minimisation is the element of predictability, and some 
authors have therefore described it as a non-random method. To reduce this risk the 
first 10 participants were randomly allocated to this study using an external 
randomisation computer programme (described below). This procedure was 
undertaken to avoid potential criticism regarding this approach being non-random in 
nature.    
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With the added complexity required to structure the allocation of participants 
by minimisation it has been suggested that this can add time, cost and potentially 
harm recruitment (Peto et al., 1976). The use of free software, as used in this study, 
helps to limit the time and cost required to organise manually and also helps with 
record keeping as this is automatically completed.   
3.3.8.1 Sequence Generation (Minimisation) 
An external randomisation computer programme (http 
http://www.random.org/) was used to randomise the initial 10 participants into the 
study as suggested by Scott et al. (2002). The remaining participants were allocated 
using ‘Minim’ software (www.sghms.ac.uk/depts/phs/guide/randser.htm). This 
computer software allows the researcher to set up the number of groups required and 
the number of prognostic factors considered. This study required two groups (Group A 
and Group B), with prognostic factors of age, gestation, parity, BMI, pre pregnancy, 
low back pain or pelvic pain and PGP. After the initial 10 participants were allocated 
using the external randomisation computer programme, the participant’s information 
was entered into the Minim software that made a decision on group allocation, as 
determined by the characteristics of participants already in the study. 
3.3.8.2 Allocation Concealment Mechanism 
Allocation concealment is considered an essential component to maintain an 
unbiased randomisation process and limit exaggerated treatment effect size (Schulz 
and Grimes, 2002). The first step in ensuring appropriate randomisation is the 
sequence generation. As above (see section 3.3.8.1), this can be undertaken using 
random number generators or software. The second crucial process is ensuring that 
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the sequence used for randomisation cannot be deciphered and is concealed from the 
person who is undertaking the random group generation (allocation concealment); if 
this is not in place then the randomisation process fails (Schulz and Grimes, 2002).  
In this study the random allocation to intervention groups was undertaken by 
the researcher using either a random number generator (for the first 10 participants), 
or minim software (for the remaining participants). This was necessary for the study to 
maintain a balance between groups when using a relatively small sample size. Once 
the participant had been screened for their enrolment into the study and their 
baseline data taken (see section 3.3.3), they would leave the clinic room, and then the 
randomisation by minimisation would take place having first entered the prognostic 
variables into the computer software to allow for the balance between groups. This 
also identifies a clear procedure of enrolment. 
As described previously, many forms of randomisation were considered, 
however, minimisation was the only available method of randomisation that was able 
to incorporate the increased number of prognostic factors. The use of computer 
software meant that the minimisation software was able to determine the group 
allocation and removed this responsibility from the researcher, limiting the potential 
to allocate participants to favoured intervention groups. All that was required was the 
baseline data to be inputted by the researcher.  
As previously discussed, there are possible ways of deciphering minimisation, 
as the next allocation is based on the previous characteristics of participants already 
enrolled. However, when inputting the participant characteristics into the 
minimisation software, it calculates the group allocation internally, meaning the 
researcher does not have access to the database of previous participant 
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characteristics. The only potential for the researcher to decipher the minimisation 
process was therefore the access they had to participants’ baseline data during their 
enrolment. Theoretically, this could have been manually written down and deciphered 
to attempt to interpret the next group allocation, however, would be labour-some to 
complete.  
While researchers are required to always remain unbiased, there is evidence to 
show that this doesn’t always happen (Schulz et al., 1995); when asked via an 
anonymous survey it was found that many researchers were able to decipher the 
randomisation due to inadequate methods. Ultimately, it resides with the integrity of 
the researcher to be responsible for the allocation concealment and the adequacy of 
their method,  to prevent such activity.  
3.3.8.3 Implementation of Randomisation Sequence  
The researcher generated the random allocation using the external 
randomisation computer programme and the minim software. The researcher was also 
responsible for enrolling participants into the study and the minim software would 
assign each participant to either group A or B to prevent any bias towards allocation or 









Eligible participants were randomised to receive one of two pelvic orthoses 
plus standardised advice (Serola Belt, Group A; Customised DEFO, Group B) using 
allocation by minimisation (See section 3.3.8.1). The researcher, who is a Chartered 
Society of Physiotherapy registered musculoskeletal physiotherapist (Band 7), provided 
the intervention for all participants in both groups. As he is male, in line with 
professional practice, all of the assessments were completed with the assistance of a 
female chaperone, within the hospital setting. The two pelvic orthoses were:  
 
3.3.9.1  Serola Belt (Group A) 
This is an ‘off the shelf’ rigid pelvic belt (supplied by Serola Biomechanics Inc., 
https://www.serola.net/) which consists of an open cell urethane inner layer (3” in 
width), wrapping the circumference of the pelvic girdle and fastening with Velcro tape 
(Figure 3.2). It has added extra-strong, double-pull elastic straps, which can be applied, 
also with Velcro tape, for further tension and support. To prescribe the appropriate 
size of the Serola Belt, a single waist measurement is required, which takes 
approximately one minute to complete (see Appendix 11a). This was undertaken by 
the researcher.  
3.3.9.2  Customised Dynamic Elastomeric Fabric Orthoses (DEFO, Group B) 
This customised Dynamic Elastomeric Fabric Orthoses (DEFO) (supplied by DM 
Orthotics’ Ltd, https://www.dmorthotics.com/) is individually tailored to the 
participant based on 12 measurements for the 2nd trimester participants (20-27 weeks 
pregnant) and 13 measurements for 3rd trimester participants (28-36 weeks pregnant). 
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This required a combination of circumferential measurements of the torso, pelvis and 
thighs, along with linear measurements of the torso, pelvis and thighs to establish 
length. The extra measurement in the third trimester required an additional 
circumferential measurement at the level of the sternum to cater for growth during 
the third trimester (see Appendix 11b). The measurement process is undertaken by a 
trained assessor, in this case the researcher with the assistance of a female chaperone. 
It takes approximately five to seven minutes to complete. 
Designed in the form of a pair of shorts as opposed to the standard belt, the 
customised DEFO is made of a flexible compression fabric (Lycra) to aid pelvic stability, 
with the intention of providing comfort and movement (Figure 3.2). It has reinforced 
panelling for strength and stability with an option for open crotch available (a closed 




Figure 3.2 The orthotic interventions Serola belt (left) and customised Dynamic 




3.3.9.3 Standardised Advice 
During a physiotherapy appointment, it is typical for any patient experiencing 
pregnancy related PGP to be routinely given standardised advice alongside their 
intervention. For this reason the researcher provided each participant in both Group A 
and Group B a standardised advice sheet ‘Guidance for mothers to be and new 
mothers: Pregnancy-related pelvic girdle pain’ supplied by the Association of Pelvic, 
Obstetric and Gynaecological Physiotherapy (POGP) website 
(https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf). There were a number of 
advantages of providing this publicly available, approved, standardised leaflet: it 
enabled the information given to each participant to be the same; ensured the 
information provided was reflective of current best practice, and was more efficient 
than memorising a script to ensure all advice was given to all participants equally. The 
participant could also use this as an on-going resource throughout their pregnancy. 
 
3.3.9.4 Blinding 
The researcher was blinded to the participant’s treatment effects (self-report 
questionnaire results). As previously described in section 3.2.9.4, an independent 
blinded assistant had the remit of checking returned self-report questionnaire booklets 
and supplying the researcher with any missing information or incorrectly answered 
questions, to maintain the blinding of the researcher. To maintain blinding of the 
independent  assistant, they were only privy to the participants ID and questionnaire 
booklet responses and did not know which participants were allocated to which group 
(customised DEFO or Serola Belt) as no information regarding groups were placed on 
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the returned envelopes or questionnaire booklets. All questionnaire booklets were 
locked into a steel cabinet and the key was held by the independent assistant only.  
All attempts were also made to blind the participant as to which group they 
were allocated. The Participant Information Sheet (and associated verbal discussion) 
stated that “the study was evaluating the effectiveness of two different pelvic support 
orthoses aimed at reducing pelvic girdle pain during pregnancy”; neither of the 
orthoses were specifically named or described.  In addition, to minimise the effects of 
attention in relation to the time spent with each participant, and to further avoid 
potential un-blinding, every participant, whether allocated to the Serola or DEFO group 
underwent either 12 or 13 measurements (dependent on their gestation), at the initial 
assessment (see section 3.3.9).  
 
3.3.9.5 Statistical Methods 
Ongoing statistical advice and support from the University of Plymouth 
Statistics Department was undertaken over the course of the study.  
 
3.3.10  Data Analysis 
Descriptive statistics were used to describe the sample in terms of 
demographic and diagnostic issues. Due to a variable baseline length, as a result of 
participants entering the trial at different time points relative to their delivery date, 
the analyses of outcome measures were calculated using the final three time points 
pre partum (antenatal -6 /-4 /-2 weeks) and the first three time points post-partum 
(postnatal +2/+4/+6 weeks). Separate analyses were performed for each of the 
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outcome measures using SPSS Software (IBM Corp. Released 2013. IBM SPSS Statistics 
for Windows, Version 22.0. Armonk, NY) and Quality Metric Outcomes TM Scoring 
Software 4.5 to score the SF36 - V2. Separate 2x3 (Group x Time) repeated measures 
analysis of variance (RM-ANOVA), were used to analyse the NPRS and the EQ - 5D 
dimensions and EQ-5D- VAS pre and postpartum. A Mann- Whitney U test was used for 
analysis of the SF36v2 to compare group differences at each time point and Freidman’s 
test to compare differences between time intervals within each group. A Mann-
Whitney U test was used for analysis of the PGQ and the EQ- 5D subscales. For all 
tests, the alpha level was set at .05 and Bonferroni corrections were used when post 
hoc pair wise comparisons were calculated. 
The primary outcome measure, NPRS, was assessed for clinical significance 
using a Minimal Clinically Important Difference (MCID) of one point (Salaffi et al., 
2004). The mean difference from the final pre-pregnancy data point (-2 weeks) was 
compared against baseline in both the groups to identify any reduction in pain score. 
 
3.3.10.1 Cost Effectiveness Analysis (CEA) 
With regard to the cost effectiveness analysis, ongoing advice and support was 
available from a Health Economist. The data were presented descriptively. Analyses 
were undertaken over the same time frame as the clinical outcomes, and no 
discounting of future costs was required. Unit costs were obtained from the personal 
social services research unit (PSSRU), office of national statistics (ONS), NICE 
guidelines, and NHS supply chains for walking aids (source references detailed in Table 
3.7). To complete the cost effectiveness analysis resource use, direct and indirect 
costs, mode of delivery costs and quality of life years (see Table 3.7) had to be 
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calculated. Means and standard deviations were calculated for direct and indirect costs 
along with the mode of delivery costs, which were included within the cost 
effectiveness analysis (Table 3.8). 
The EQ5D and the SF6D were used to gain QALYs and both means and standard 
deviations were calculated. QALYs were obtained at baseline, final pre-pregnancy data 
point (final data point prior to delivery) and final post-partum data point (6 weeks 
post-delivery). There was no requirement to adjust for baseline as minimisation was 
used to equally balance participants in both groups. 
For the cost effectiveness analysis the total DEFO (novel intervention) costs 
were subtracted from the Serola Belt (usual care) costs to calculate incremental cost 
(Table 3.9). This included cost of intervention, direct and indirect costs. The total 
effectiveness was calculated using both the EQ5D and SF6D to calculate the 
incremental effectiveness. To complete the cost effectiveness analysis the incremental 














Figure 3.3 shows the flow of participants to the study and table 3.5 shows the 
sample characteristics. Table 3.6 shows the descriptive statistics for all outcome 











Figure 3.3 Flow of the participants recruited to the study  
 
 
Assessed for eligibility (n=89) 
Failed to attend initial screening (22) 
 
Excluded (n=17) 
Not meeting inclusion criteria (n=17) 
Declined to participate (n=0) 
Other reasons (n=0) 
Treatment allocation by 
minimisation (n=72) 
Allocated to intervention (n=36) 
Received allocated intervention (n=36) 
Did not receive allocated intervention (n=0) 
Allocated to intervention (n=36) 
Received allocated intervention (n=36) 
Did not receive allocated intervention (n=0) 
 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
 
 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
 
Analysed (n=36) 
Excluded from analysis (n=0) 
 
Analysed (n=36) 





Table 3.5 Sample Characteristics  
 
There was complete data for all participants for all time points; Serola = off-the-
shelf rigid orthosis; DEFO = customised Dynamic Elastomeric Fabric Orthosis. All 
participants were female with an average age 29 years old (±4.97) in the Serola group 
and 30 years old (±5.91) in the DEFO group. Average gestation week was 29 (±4.98) in 
the Serola group and 28 (±4.06) in the DEFO group. Average parity of participants in 
the Serola group was 1.3 (±1.17) and 1.4 (±1.29) in the DEFO group. Overall, this 
recognises the randomisation process was effective in producing the baseline group’s 








(n=72) Serola (n=36) DEFO (n=36) 
Age (mean (range)) 29 (18-39) 30 (20-40) 
Gestation (mean (range)) 29 (20-35) 28 (20-35) 
Parity (mean (range)) 1.3 (0-3) 1.4 (0-3) 
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3.4.1 Primary Outcome Measure 
3.4.1.1 Numerical Pain Rating Scale – Day (NPRS-Day): 
NPRS Day -6 to -2 
  With baseline score as a covariate there was no significant main effect of time 
F(2, 138) = .000, p = 1.000, or interaction between time and group F(2, 138) = .705, p = 
.496. However, there was a significant difference between groups F(1, 69) = 4.491 p = 
.038, with lower NPRS scores being seen in the DEFO group (see figure 3.4 and 3.5) 
  NPRS Day +2 to +6 
With baseline score as a covariate there was no significant main effect of time 
F(2, 138) = .000, p = 1.000, or interaction between time and group F(2, 138) = .705, p = 
.496 . No significant differences were found between groups F(1, 69) = .002 p = .966 
(see figure 3.4 and 3.5). 
The MCID was found in the DEFO group with a one point reduction in the NPRS 
(baseline = 5.917; final pre-pregnancy data point = 4.917 (-2)). The MCID was not 
found for the Serola group. 
3.4.1.2 Numerical Pain Rating Scale – Night (NPRS-Night) 
NPRS Night -6 to -2 
With baseline score as a covariate there was no significant main effect of time 
F(2, 138) = .391, p = .677, or interaction between time and group F(2, 138) = 1.286, p = 
.280. No significant differences were found between groups F(1, 69) = 1.531, p = .220) 




Figure 3.4 Day-time Numerical Pain Rating Scale (NPRS) Scores, shows mean day 
NPRS for Serola  and DEFO groups at pre-birth time points (-6, -4, -2 weeks) and post-





Figure 3.5 Day-time Numerical Pain Rating Scale (NPRS) Scores, shows grand average 
day NPRS for Serola and DEFO groups over the pre and post birth periods, along with 





Figure 3.6 Night-time Numerical Pain Rating Scale (NPRS) Scores, shows mean night 
NPRS data for both Serola  and DEFO, at pre-birth time points (-6, -4, -2) and post-birth 




Figure 3.7 Night-time Numerical Pain Rating Scale (NPRS) Scores, shows total mean 










NPRS Night +2 to +6 
 With the baseline score as a covariate there was no significant main effect of 
time F(2, 138) = .260, p = .772, or interaction between time and group F(2, 138) = 
1.097, p = .337. There was no significant difference groups F(1, 69) = .332 p = .566 
when baseline scores  were included as a  covariate (see Fig 3.6 and 3.7). 
There was no MCID found for either the Serola or DEFO, although both groups 
reported a reduction in pain. However, the mean difference between baseline and 
final antenatal (-2 weeks) NPRS score for the DEFO approached clinical significance 
(0.94), but not for the Serola group (0.64). 
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Table 3.6 Descriptive statistics for all outcome measures across time and allocated groups (Serola and DEFO)  
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† Pelvic Girdle Questionnaire (PGQ) Secondary outcome measure – higher scores = more pain during tasks; positive change score = 
improvement  
‡EuroQol 5 dimension (EQ5D) secondary outcome measure higher scores = worse quality life; positive change score = improvement 
§EuroQol 5 dimension Visual Analogues Scale (EQ5D – VAS) secondary outcome measure lower scores = worse quality of life; negative 
change score = improvement  
 || Short Form 36 item questionnaire – physical component (SF36 (PC)) secondary outcome measure Low scores = worse quality of life; 
positive change score = improvement  
¶ Short Form 36 item questionnaire – mental health component (SF36 (MC)) secondary outcome measure. Low scores = worse quality of 
life; † change score = improvement 
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3.4.2 Secondary Outcome Measures 
3.4.2.1 EuroQOL- 5 DimensionS, 5 Level: (EQ5D-5L) 
EQ5D-5L -6 to -2 
  Analysis of the EQ5D antenatal data with baseline score as a covariate revealed no 
significant main effect of time F(2, 138) = 2.394, p = .095, or interaction between time and 
group F(2, 138) = .559, p = .545. No significant differences were found between groups F(1, 
69) = .001 p = .972.  
EQ5D-5L +2 to +6 
  Postpartum data revealed no significant main effect of time F(2, 138) = 2.363, p = 
.098, or interaction between time and group F(2, 138) = .439, p = .646. No significant 
differences were found between groups F(1, 69) = .168 p = .683. 
 
3.3.2.2 EuroQOL - 5 Dimensions – Visual Analogue Scale (EQ- 5D-VAS) 
EQ5D VAS -6 to -2 
Analysis of the antenatal (-6 to -2) data with baseline scores as a covariate revealed 
no significant main effect of time F(2, 138) = .714, p = .492, or interactions between time 
and group F(2, 138) = .888, p = .414. No significant differences were found between groups 
F(1, 69) = .008, p = .931.  
EQ5D VAS +2 to +6 
Postnatal results revealed no significant main effect of time F(2, 138) = 2.438, p = 
.091, or interaction between time and group F(2, 138) = 1.130, p = .273. There were no 
significant differences between groups F(1, 69) = 2.873, p = .095.  
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3.4.2.3 Pelvic Girdle Questionnaire (PGQ) 
PGQ -6 to -2 
No significant effect of time was found F(2, 138) = .241, p = .786, or interactions 
between time and group F(2, 138) = .894, p = .411. There was no significant differences 
between groups F(1, 69) = .033, p = .857, indicating that both groups reported similar levels 
of activity and pain over time.    
PGQ +2 to +6 
No significant effect of time was found F(2, 138) = 1.330, p = .270, or interactions 
between time and group F(2, 138) = .734, p = .483. No significant differences were found 
between groups F(1, 69) = .985, p = .327.  
 
 
3.4.2.4 Short Form-36, Version 2 (SF-36v2) 
SF36 MCS -6 to -2  
Analysis of antenatal data with baseline scores as a covariate revealed a significant 
decrease in health related quality of life over time F(2, 138) = 5.761, p = .004, and no 
significant interaction between time and group F(2, 138) = 2.423, p = .092. No significant 
differences were found between groups F(1, 69) = .140, p = .709.  
SF36 MCS +2 to +6 
No significant main effect of time was found during analysis of the postnatal scores 
F(2, 138) = .344, p = .709, or interactions between time and group F(2, 138) = .944, p = .392. 
No significant differences were found between groups F(1, 69) = .052, p = .821. 
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SF36 PCS -6 to -2 
Analysis of antenatal data with baseline scores as a covariate revealed a significant 
decrease in health related quality of life over time F(2, 138) = 8.248, p = .001, and no 
significant interaction between time and group F(2, 138) = 2.771, p = .066. However,there 
was a group effect with significantly lower scores for the Serola group compared to the 
DEFO F(1, 69) = 4.623, p = .035.   
SF36 PCS +2 to +6 
No significant main effect of time was found during analysis of the postnatal scores 
F(2, 138) = .612, p = .544, or interactions between time and group F(2, 138) = .365, p = .631. 
Consistent with antenatal scores, significantly lower scores were found for the Serola group 
compared to the DEFO F(1, 69) = 4.265, p = .043 when baseline scores were included as a 
covariate. 
 
3.4.3 Cost Effectiveness Analysis 
The product cost of the usual care orthotic (Serola Belt) was £35.99 compared to the 
customised DEFO, which was £260.00. Direct costs for the Serola belt were £196.04 in 
comparison to £163.26 for the DEFO. Indirect costs were higher in the DEFO group with a 
mean difference of £92.76 (Serola £548.17 and DEFO £640.93). The DEFO has higher 
combined direct and indirect costs of £1064.19 in comparison to the Serola belt at £780.20. 
The DEFO also had higher mode of delivery costs at £65,572.00 compared to the Serola belt 
£63,460.00 (see Table 3.8). With the total effectiveness obtained from the SF6D of 0.176 
QALYs gained in the Serola group and 0.166 gained in the DEFO group, there was a mean 
difference of 0.01 incremental effectiveness (see Table 3.9). There was no requirement to 
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adjust for baseline as all participants were randomised into the study using minimisation 
(see chapter 3.2.8). The total cost effectiveness for the DEFO in comparison to the usual 








Basis of Estimate 
Health Services       
GP £44.46 PSSRU 
2017 
GP/Appt at surgery, based on 11.7 mins (£3.8 per minute) 
Midwife £44 p/h PSSRU 
2017 
Based on hospital cost per hour 
Physiotherapist £34 p/h PSSRU 
2017 
Based on hospital cost per hour 
Walking Aids       
Walking stick/cane £6.45 nhs 
supplies 
https://www.supplychain.nhs.uk/ 
Elbow Crutches £19.95 nhs 
supplies 
https://www.supplychain.nhs.uk/ 
Walking frame £29.95 nhs 
supplies 
https://www.supplychain.nhs.uk/ 

































Based on average weekly gross salary £506 





Based on average weekly gross salary £506 
 












NHS Costs n= mean resource 
use (SD) 





  n= £ Mean 
Cost (SD) 

























            
Walking Stick 36 0 36 0 0 
 
36 0.00 36 0.00 0.00 
Elbow crutches 36 0.33 (0.47) 36 0.19 (0.40) 0.14 
 
36 6.65 (9.54) 36 3.88 (8.01) 2.77 
Walking Frame 36 0 36 0 0 
 
36 0.00 36 0.00 0.00 
SOCIETAL Costs 
           
Patient sick 
leave 




















































Table 3.8 Mean costs for direct/indirect and mode of delivery
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Table 3.9 Mean and Standard deviation QALYs using both EQ5D and SF6D 
  A B C D E 








Serola Belt  
(Usual Care) 




£1,064.19 0.166 -£283.99 0.01 -£28,399 
Table 3.10 The cost effectiveness analysis
Measure 
(Time-point) 













36 0.127 36 0.122 0.005 
  




36 0.075 36 0.074 0.001 
0.001  





36 0.117 36 0.116 0.001 
0.001  
(-0.010 - 0.011) 
SF-6D:   
(Baseline) 
36 0.143 36 0.143 0 
  
SF-6D:    
(Final Pre-
Preg) 36 0.145 36 0.140 0.005 
0.005  
(0.00 - 0.009) 
SF-6D:   
(12/52 
Follow-up) 36 0.176 36 0.166 0.01 
0.010  
(0.001 - 0.019) 
137 
 
3.5 Adverse Effects 
There were no adverse effects related to the intervention reported during the 
undertaking of this RCT. 
3.6 Discussion 
This is the first double blinded, randomised comparative trial evaluating the 
effectiveness of a rigid belt orthosis with a DEFO during pregnancy. Further, it includes 
the evaluation of a novel intervention, the customised DEFO. It shows that, in 
comparison to the ‘off the shelf’ rigid pelvic belt (Serola Belt), antenatal day time pain 
levels for those wearing the customised DEFO were, on average,  significantly less 
during the day time. These changes in antenatal day time pain were clinically 
significant, as determined by a one point reduction in the NPRS, which equates to a 
‘slightly better’ improvement in pain. Whilst no significant difference was detected 
between the two groups with regard to the secondary outcomes of activity levels and 
quality of life, it is highlighted that the study was not powered to detect changes in 
these outcomes. Further studies could address this issue. 
Lee and Vleeming (1998) report the need for force-form closure, 
neuromuscular control and emotion/awareness for optimum joint function and a 
balance between movement and control for optimal stability (Lee and Vleeming, 1998) 
During pregnancy, multiple factors have been shown to affect these aspects and 
potentially contribute to PGP.  This reduction in stability can lead to increased shear 
forces through the SP and SIJ potentially causing pain (Mens et al., 2009). The 
European Guidelines for Management and Diagnosis of PGP, along with a systematic 
review completed by Aldabe et al. (2012), reported that there was a low association 
between relaxin levels and pregnancy related PGP, therefore no conclusion could be 
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drawn (Aldabe et al., 2012; Vleeming et al., 2008). Biomechanical changes occur in the 
lumbar spine and pelvis during pregnancy due to the need to adapt the centre of 
gravity as a result of the increasing weight of the womb (Liddle and Pennick, 2015). 
The increase in maternal weight is believed to play a role in the requirement for 
changing lumbar biomechanics, with increased lordotic adjustment in the lumbar spine 
required to maintain the centre of gravity (Branco et al., 2014; Foti et al., 2000). Other 
changes such as reduced muscular activity and compensatory muscle patterns can also 
be a potential cause of pain through reduction of joint proprioception and 
neuromuscular control (Oh et al., 2014). 
Pelvic belts are hypothesised to enhance ‘force closure’, thereby aiding stability 
of the pelvic ring and reducing shearing forces through the SP and SIJ (Arumugum et 
al., 2012; Bertuit et al., 2018a;  Mens et al., 2006; Mens et al., 2017). Applying external 
pelvic compression can: be a substitute for normal isometric abdominal activity; 
increase hip adduction strength; and reduce SIJ laxity (Arumugum et al., 2012; Mens et 
al., 2006; Mens et al., 2017). This can also lead to a decrease in compensatory 
mechanisms through the pelvis and lumbar spine and facilitate load transfer more 
appropriately (Oh et al., 2014). A pelvic belt has been observed to influence 
proprioception and neuro-motor control, which can also contribute with the reduction 
of compensatory patterns, further improving force closure (Arumugum et al., 2012; 
Bertuit et al., 2018a; Shaffer and Harrison, 2007; Sicthing et al., 2014; Soisson et al., 
2015; Takasaki et al., 2009). With changing pelvic biomechanics, it has been observed 
that a pelvic orthosis can release strain on sacroiliac ligaments which can reduce 
potential tensile stress thus reducing the pain (Liddle and Pennick, 2015; Takasaki et 
al., 2009; Sichting et al., 2014). As passive force-closure using a pelvic belt reduces 
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abdominal muscle activation and there are concerns this could lead to muscle 
weakness (Hu et al., 2010). The European Guideline advocates that pelvic belts should 
be considered alongside other treatment modalities (Vleeming et al., 2008); our study 
supplemented its use with standardised advice. 
Following the undertaking of the cost effectiveness analysis (see section 3.4.3) 
it was deemed that the customised DEFO was not deemed to be cost effective.  
3.7 Strengths and limitations of the study 
This  study is the first to compare the relative clinical and cost effectiveness of a 
rigid pelvic orthosis with a DEFO (plus standardised advice) on pain, activity levels and 
quality of life, providing clinicians,  patients and commissioners with evidence on 
which to guide treatment selection. Self-report questionnaires were used in this study, 
primarily to reduce participant burden and missing data in a sample who may find it 
difficult to attend follow-up assessments due to work and family commitments and in 
whom travelling can irritate their pain. This approach, alongside our data checking and 
management systems, are strengths of this study since there was no missing data. This 
is important since missing data can compromise inferences made from clinical trials 
(Little et al., 2012). The minimisation procedure utilised to reduce the likelihood of 
disparity between the groups, was successful in ensuring there were no significant 
difference between the two groups in their baseline level of pain and the time they 
entered the study. 
A particular challenge in this trial was that a pre-defined threshold of pain 
needed to be reached before participants were eligible for entry, resulting in 
participants entering the study at different time points during their pregnancy (relative 
to delivery date). This was successfully dealt with by the analytical approach used 
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which focused on the final three data points in the antenatal phase and the first three 
data points in the post-partum phase – a total of 12 weeks. Future studies could 
explore whether a DEFO could be used at an earlier stage in those individuals at high 
risk of developing PGP since with many musculoskeletal conditions prevention/early 
intervention is favoured. 
In this study fitting and provision of the two orthotic devices was undertaken 
by a single band 7 physiotherapist, specialised in musculoskeletal physiotherapy. 
Further, the orthoses were only evaluated for pregnant women that met specific entry 
criteria, which included a pre-defined threshold of pain. It is possible therefore that the 
results may not generalise to all pregnant women who experience PGP, or when the 
intervention is implemented by differing grades of physiotherapist. The highly 
protocolised nature of the assessment process, and the standardised format of the 
information sheet provided, means that the skill level of staff is unlikely to significantly 
influence the outcome. Nevertheless these factors should be taken into account when 
considering generalisability of the study results.  
3.8 Conclusion 
The novel, customised dynamic elastomeric fabric orthosis was more effective 
than the off-the-shelf rigid Serola pelvic belt at reducing antenatal day time pain in 
















Management of Post-Partum Pelvic Girdle Pain: A Replicated Case Series 
of Single Case Studies Evaluating the Effectiveness of a Customized 

















This chapter describes the evaluation of the customised DEFO in females 
suffering from chronic post-partum PGP in a single case study series (n=8). An 
explanation of the study research question, aims and objectives will be followed by a 
discussion of the approach used to address the research question. The chapter will 
include an evaluation of the research methods. 
4.1.1 Research Question 
 This single case study series asked the question “In women with chronic post-
partum PGP, does wearing a dynamic elastomeric orthosis affect pain, activity, health 
related quality of life, incontinence, anxiety and depression?” 
4.2 Background 
This chapter continues the journey for females suffering from PGP following 
the birth of their child. During the RCT in Chapter 3, information was gathered for 12 
weeks following the delivery of their child, as the literature suggests that symptoms 
resolve during this time span (Albert et al., 2001). During an incidental discussion 
whilst undertaking the RCT a midwife asked if she could trial one of the orthotics being 
used for the RCT as she had suffered with persistent PGP  for more  than six years 
following the delivery of her second child. This lead to discussions with the research 
team, a review of the literature and the development of a replicated case series of 
single case studies to better understand the pelvic girdle pain journey that females 
may undertake following delivery and to explore whether the customized DEFO might 
be effective in managing post-partum PGP. There is a scarcity of studies, which have 
evaluated the management of chronic PGP post-partum, which is problematic since it 
143 
 
has been reported in the literature that this condition does not appear to be self-
limiting and can continue for many years following childbirth (Sjodhal et al., 2013). 
Therefore, preliminary research to identify the effectiveness of the DEFO within this 
population was felt to be indicated and justified. 
As previously stated, PGP occurs in 70% of pregnant women, of whom an 
estimated 25% have severe pain and 8% severe disability requiring the use of crutches, 
wheelchair or confinement to bed (Wu et al., 2004). PGP is difficult to manage; 
activities such as turning in bed, prolonged walking, or carrying items may cause pain; 
impacting negatively on quality of life (Wang et al., 2004). This PGP during pregnancy is 
thought to occur due to increased pelvic joint motion as a consequence of hormonal 
and biomechanical factors (Mens et al., 2009). Whilst PGP symptoms are considered by 
some authors to be self-limiting and that they should resolve within three months of 
delivery for the majority of women (Albert et al., 2001) this is not always the case.  For 
instance, the prevalence of postpartum PGP is reported by some authors to be 
between 33% to 38% of females beyond three months following delivery (Gutke et al., 
2010; Van de Pol et al., 2006). Others estimate that up to 80% of females who suffer 
from pregnancy related PGP continue to have persistent post-partum symptoms 
following delivery; varying from recurrent to constant pain (Bergstrom et al., 2014). It 
is evident therefore that there is a large variation in the reported prevalence of chronic 
PGP (Bergstrom et al., 2014). One reason for this variation in reported prevalence 
could be related to the lack of research into this condition. Geographical variation 
could also account for this, since factors such as sick leave (which can differ markedly 
in different countries) could affect reporting of the condition (Bergstrom et al., 2014; 
Bergstrom et al., 2016).   
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It is unknown why chronic symptoms develop, but high maternal age, parity, 
pre-pregnancy-BMI and previous PGP have been identified as risk factors associated 
with chronic PGP, along with emotional and psychosocial factors (Robinson et al., 
2010).  Another factor that is believed to increase the risk of chronic PGP symptoms is 
the preferred mode of delivery. Due to increasing PGP throughout the pregnancy, an 
increasing number of women are electing for caesarean section for early symptomatic 
relief, which is supported by guidelines produced by the National Institute for 
Healthcare and Care Excellence (NICE) on caesarean sections in 2011 (NICE, 2011).  
However, this is believed to be a risk factor for the chronicity of PGP (Bjelland et al., 
2013). 
Orthoses such as rigid pelvic belts (Wang et al., 2004) are commonly prescribed 
with the aim of improving pelvic joint stability and reducing pain (Damen et al., 2002; 
Hu et al., 2010; Ostgaard et al., 1994). More recently dynamic elastomeric fabric 
orthoses (DEFO) have been developed to address this problem. In my previous study 
(Chapter 3), I evaluated the comparative effectiveness of these two orthotic 
interventions in women during pregnancy (Cameron et al., 2018) (Clinical Trials.gov ID - 
PGP-LC12; NRES Ethics Ref - 12/SW/0014). The single-case study series described here 
complements this by broadening the investigation to women postpartum with chronic 
PGP. The intention was to undertake a preliminary evaluation of the potential benefits 
of the customised DEFO on chronic post-partum PGP symptoms in terms of how it 
might impact on pain, health related quality of life, activity levels, urinary 





4.3 Research Aims 
 
 
4.3.1 Primary Aim: 
To investigate the effectiveness of a customised DEFO (plus standardised 
advice) in reducing pain in women with post-partum chronic PGP. 
4.3.2 Secondary Aims: 
To investigate the effectiveness of a customised DEFO (plus standardised 
advice) for women with post-partum chronic PGP in:-  
 optimising activity levels 
 optimising health-related quality of life 
 reducing anxiety and depression 





4.4.1 Trial design 
A series of replicated single case studies was undertaken. Single case research 
design has been acknowledged as a scientifically robust and clinically useful method of 
exploring the effectiveness of an intervention when there is little existing evidence 
(Graham et al., 2012). An AB design was chosen for its applicability to this specific 
clinical setting (Zhan and Ottenbacher, 2001). The A-B design is the basic single-subject 
design. It includes a set baseline phase with repeated measurements (phase A) 
followed by a set intervention phase continuing the same measures (phase B).  The 
initial baseline serves as a control to enable comparison against the intervention 
phase.   
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Each single case study incorporated an AB multiple baseline randomisation test 
that allows the results of single case studies to be combined to assess for group effects 
(Todman and Dugard, 2001). In total, there were 18 data points that were taken at 
weekly intervals. The baseline measurement phase (A) consisted of at least eight 
consecutive weekly data points where no intervention was in place. The intervention 
phase (B) consisted of at least eight consecutive weekly data points where the orthotic 
intervention (customised DEFO) was in place (Nourbakhsh and Ottenbacher, 1994).  
The onset of intervention phase was randomised and could occur at weeks 9, 10 or 11. 
Therefore, the baseline phase or intervention phase could consist of between 9-11 
data points. The point of randomisation was determined for each participant using a 





4.4.2.1 Inclusion Criteria 
Women were included in the study if they fulfilled the following criteria:  
 Experiencing PGP, commenced or aggravated during pregnancy,  where 
symptoms have continued for > 3 months post-partum,  
 PGP which causes walking and/or stair climbing to be bothersome  







4.4.2.2 Exclusion Criteria 
Women were excluded from the study if they had:  
  A recent history/signs or symptoms indicative of serious causes of pain 
that might be inflammatory, infective, traumatic, neoplastic, 
degenerative or metabolic, i.e. 
o  trauma 
o unexplained weight loss 
o history of cancer 
o steroid use 
o drug abuse 
o HIV infection 
o immunosuppressed state 
o neurological symptoms/signs (such as bowel, bladder, sensory, 
motor, reflex involvement) 
o  cauda equina, lumbar disk lesion or spinal stenosis  
o history of chronic back or pelvic pain requiring surgery, focal 
inflammatory signs/tenderness of spine (spondylolisthesis), 
o fever, systemically unwell 
o obstetric complications 
o pain that does not improve with rest/severe disabling pain,  





4.4.2.3 Setting and Location 
Recruitment was conducted through local children’s centres within the 
Plymouth area using a poster advertisement. This had ethical approval from the 
National Research Ethics Service Committee South West (Cornwall and Plymouth) 
(IRAS Project ID 177493, REC Reference 15/SW/0160); University of Plymouth ethics 
committee; and Plymouth City Council. We aimed to recruit a convenience sample of a 
maximum of eight participants from three different centres (Plymstock Children’s 
Centre, Plum Tree Children’s Centre and Plym Bridge Nursery School and Children’s 
Centre). The poster (Appendix 8) included details of the trial, contact telephone 
numbers for the research physiotherapist and an email address for a generic email 
account (pelvicgirdlepain@plymouth.ac.uk).  
4.4.3 Intervention 
As the researcher was male, in line with professional practice the assessments 
were completed with the assistance of a female chaperone. TIDieR Guidelines were 
adhered to for the reporting of the intervention (Hoffman et al., 2014) utilised during 
the intervention period (phase B). 
4.4.3.1 Customised Dynamic Elastomeric Fabric Orthoses (DEFO) 
In this single case study, 12 measurements were undertaken for each 
participant to inform the production of the customised DEFO (see Appendix 11b). 
These were the same measures taken at the second trimester for participants 




4.4.4 Data Collection Procedure 
 
 
4.4.4.1 Screening Procedure 
All the screening and testing was completed by a single tester (LC, Chartered 
Physiotherapist) in order to optimise the reliability of the measures taken. Screening 
(visit 1) was carried out at The Peninsula Allied Health Centre (PAHC), School of Health 
Professions, Derriford Road, Derriford, PL6 8BH. 
When a potential participant had responded to the poster advertisement,  via 
the phone or e-mail contact numbers provided, they were contacted within 24 hours 
and an appointment arranged with them (visit 1) wherein the project was discussed 
and their written informed consent obtained (Appendix 8). After written consent had 
been gained, the participant was screened to determine their suitability for inclusion 
to the study. Demographic and diagnostic descriptive data and a pain referral map 
(Appendix 4) were completed at baseline. The participant also completed a self-report 
questionnaire booklet at baseline (Appendix 10). Pain provocation tests (described in 
section 3.3.5) were completed where a female chaperone was present during 
assessments. Participants found to be eligible were measured for the fitting of a 
customized DEFO (Chapter 3, Section 3.3.9.2), which was the intervention used during 
phase B. 
The self-report questionnaire booklets were then completed by the 
participants at weekly intervals, and returned in stamped and self-addressed 
envelopes provided, for the 8 (to 11) week control period (Phase A).  Following the 
completion of the initial 8 (to 11) week control period (Phase A) the participant was  
then supplied and fitted with a customised DEFO and commenced an 8 (to 11) week 
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intervention period (Phase B), during which time the same self-report data was be 
gathered in the same way.  
In the unlikely event that the participant demonstrated a full recovery on all 
outcome measures by the end of the baseline, it was protocolised that this would be 
noted, and the participant would be withdrawn from the study. 
 
4.4.4.2 Pain Provocation tests 
The same provocation tests were chosen for the single case study case series as 
were used within the RCT for both SIJ and SP Symptoms (see Chapter 3, Section 3.3.5 
for details). The same criteria was also used with positive outcomes on three out of the 
seven provocation tests required for inclusion in the study. 
4.4.4.3 Outcome Measures 
The same outcome measures were chosen for the single case study case series 
as were used within the main study (see Chapter 3, section 3.3.6 for further details). 
The tests were: 
 Numeric Pain Rating Scale (NPRS)  - day and night 
 Pelvic Girdle Questionnaire (PGQ ) 
 European Quality of Life – 5 Dimension – 5 Level (EQ5D – 5L) 
 European Quality of Life – 5 Dimension – Visual Analogue Scale (EQ5D – VAS) 
 Short form 36 item Questionnaire  - Version 2 – Physical Component Score 
(SF36 – V2 PCS) 
 Short form 36 item Questionnaire  - Version 2 – Mental Component Score  
(SF36 – V2 MCS)  
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Two new outcome measures were undertaken in addition to those used in the 
RCT during this single case study series, to identify other issues within PGP, which have 
been identified in the literature (Gutke et al., 2017). As previously discussed there is an 
emotional impact of PGP and hence the Hospital Anxiety and depression Scale (HADS) 
was incorporated within the battery of outcome measures to identify if there were any 
changes in anxiety and depression. Further, the International Consultation on 
Incontinence Questionnaire – Short Form (ICIQ) was used to identify if incontinence 
was experienced alongside the chronic PGP, and whether this was impacted upon by 
the DEFO. 
4.4.4.4.1 Hospital Anxiety and Depression Scale (HADS) 
The Hospital Anxiety and Depression Scale is a 14-item self-report 
questionnaire designed to detect anxiety and depression in people with physical health 
problems. Seven items relate to anxiety (HADS-A) and seven items to depression 
(HADS-D). Each item on the questionnaire is scored from 0-3, with a possible total 
score range of 0 - 21 for either anxiety or depression. A cut-off point of 8/21 for 
anxiety or depression has been identified (Bjelland et al., 2002). For anxiety, this gave a 
specificity of 0.78, and a sensitivity of 0.9. For depression, this gave a specificity of 0.79 
and a sensitivity of 0.83 (Bjelland et al., 2002). The HADS has also shown good internal 
consistency, test-retest reliability and construct validity when used in the pregnancy 
PGP population (Gutke et al., 2011; Elden et al., 2017). 
4.4.4.4.2 International Consultation on Incontinence Questionnaire (ICIQ) 
The International Consultation on Incontinence Questionnaire Short Form 
(ICIQ-UI- SF), comprised three scored questions regarding how often the participant 
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leaked urine, what amount, and how much it interfered with their everyday life, in 
addition to an unscored question about type of urinary incontinence (UI). UI was 
defined as either absent (0) or present (≥1). In a study of pregnant Taiwanese women, 
the ICIQ-UI SF was reported as being a suitable instrument for evaluating UI (Chang et 
al., 2001).  It has also been reported that the ICIQ has good internal consistency and 
test re-test reliability, with no floor or ceiling effects, suggesting that it can be 
effectively and efficiently used for patients suffering from varying severities of UI 
(Hajebrahimi et al., 2012).  Finally, it has shown to have good discriminate validity 
within the pregnancy related PGP population (Fitzgerald et al., 2012). This combined 
evidence supporting its psychometric properties provided the justification for its use in 
this single study case series.   
4.5 Data Analysis 
Data from each outcome measure at each time-point was plotted on a separate 
graph for each single case study participant, with the baseline and intervention phases 
differentiated. Visual inspection initially looked for changes in trend, level, slope and 
variability (Parker et al., 2011). The celeration line method, also known as the split-
middle technique (Kazdin, 1982) was used as a straightforward method of identifying if 
any of the plotted intervention data differed from the plotted baseline data. The 
celeration line was obtained by dividing the plotted baseline data in half. Then the 
median is taken from each half of the baseline data. The two calculated median points 
are then joined together. The celeration line is then extended into the intervention line 
using the equation from the trend line to predict the continuation of this data. This 
provided some evidence to help identify any treatment effect. If, for example, the 
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celeration line divided the baseline data into four data points above and below the 
celeration line, if this trend is not continued into the intervention phase (e.g. there are 
now more values above the celebration line) then it is deemed that there has been a 
change (Nourbakhsh and Ottenbacher, 1994).  
The two standard deviation band method (+/- 2SD) was also applied to 
strengthen these initial visual findings (Nourkbakhsh and Ottenbacher, 1994).  The 
mean and standard deviation (SD) was calculated from the baseline scores. The SD was 
multiplied by two, then added to the mean to give the +2 SD band and subtracted from 
the mean to give the -2 SD band. A significant change in performance occurs when at 
least two consecutive data points fall outside the 2SD range within the intervention 
phase (Nourkbakhsh and Ottenbacher 1994).  
The Point of Non-overlapping Data (PND) statistic was also applied to the data 
to further strengthen visual findings (Scruggs and Mastropieri, 2001). Here, the most 
extreme data point within the baseline is identified (this can be either the highest or 
lowest data point depending on the expected direction of improvement on the scale 
used). The intervention data points are then counted to determine how many data 
points fall above or below (again depending on the direction of improvement on the 
scale) the extreme data point identified during the baseline phase. A percentage is 
then calculated (e.g. if six out of eight intervention data points fall outside the extreme 
data point then the  PND percentage is 75%). For a very effective treatment a PND 
score of ≥ 90% is required, 70% - 90% = effective treatment, 50% - 70% = questionable 
effectiveness and <50% = ineffective treatment (Scruggs et al., 1986).  The use of these 
statistical tests in addition to the visual analysis enables consistent interpretation of 
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results and reduces the requirement for stable baselines (Nourbakhsh and  
Ottenbacher, 1994). 
 
4.6 Randomisation Testing 
AB multiple baseline randomisation tests (Todman and Dugard, 2001) were 
undertaken using MatLab (MathWorks, UK) for each of the outcome measures (with 
and without the DEFO). This enabled the data from all the single case studies to be 
combined and examined to see whether any improvement was due to the intervention 
or chance. This method works on the principle of comparing the change in an outcome 
measure between the baseline and intervention period across all participants. As the 
onset of the intervention phase was randomised between the eight participants, it is 
possible to compare the actual change in the score with the change in the score if the 
onset had occurred at one of the other possible intervention points. In this case, 
intervention could occur at three possible points (week 9, 10 or 11). Six single case 
studies were able to be analysed in this way. The first single case study (participant 1) 
did not undergo the randomisation procedure. Participant 6 had missing data in week 
18 that precluded the inclusion in the analysis. With six participants, this resulted in a 
potential 729 potential intervention-start combinations or 36. The MatLab program 
randomly generated 500 combinations that could start on day 9-11 for subjects 2-5 
and 7-8. In each case the difference between the mean of the baseline and 
intervention, periods were calculated. The percentage of randomly generated change 
scores that were lower than that actually recorded provides a probability that the 
actual change did not occur by chance. If their actual change was higher than all the 
randomly generated change scores this resulted in a probability of 0.002 (i.e. 1 in 500 
155 
 
comparisons). Significance level was set at 0.05. Therefore, if more than 50 randomly 
generated change scores were higher than that actually achieved then the probability 
that this occurred by chance is >0.05 and considered to be non-significant. 
4.7 Results 
 Adherence was extremely high with 70% applying their orthotic for the 
recommended 12 hours. A further 10% were wearing the orthotic for longer than the 
recommended 12 hours and 20% wearing below the recommended 12 hours. Table 4.1 
details participant characteristics and Table 4.2 shows results of the celeration line, 
2+/- standard deviation band method and PND statistic for all outcome measures for 









Table 4.1 Participant characteristics
Participant Age Parity Mode of Delivery 




1 40 2 Caesarean 74 23.2 
2 39 1 Normal delivery 6 25.1 
3 31 1 Ventouse 18 21.8 
4 28 2 Normal delivery 12 24.3 
5 26 2 Normal  delivery 30 25.6 
6 31 3 Normal  delivery 48 26.1 
7 28 1 Forceps 24 26.8 
8 33 2 Ventouse 36 25.9 
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Table 4.2 Shows participant outcome measure results for each analysis used; celeration line, 2SD+/- band method  







Table 4.2 provides an overview of the outcome measure results for each of the eight 
subjects across the three separate analysis methods used; celeration line, 2SD+/- band 
method and PND statistic.  Each of these analyses provides their own measure of change 
(see section 4.5). However, for ease of reference a colour-coded overview has been 
provided indicating where either a positive, questionable or a negative change had occurred 
based on the individual measure of change. 
NPRS Day 
Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for 6/8 participants. The PND statistic 
demonstrated an effective change for one of the participants (75%) and a questionable 
change for two participants. The 2SD band method revealed a significant treatment effect 
for 3/8 participants with the observation of two or more consecutive data points occurring 
out with 2SDs within the intervention phase.  
NPRS Night 
Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for 6/8 participants. The PND statistic 
demonstrated a significant change for four of the participants (70%-90%). The 2SD band 
method revealed a significant treatment effect for 5/8 participants with the observation of 
two or more consecutive data points occurring outwith 2SDs within the intervention phase. 
PGQ 
Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for 6/8 participants. The PND statistic 
demonstrated a questionable change for three participants (50%-70%), an effective change 




2SD band method revealed a significant treatment effect for 5/8 participants with the 
observation of two or more consecutive data points occurring outwith 2SDs within the 
intervention phase. 
EQ5D – 5L 
Visual analysis of the celeration line indicated that there was no change in the 
intervention phase for all participants. The PND statistic demonstrated a significant change 
(70%-90%) for 2/8 participants. The 2SD band method revealed a non-significant treatment 
effect for all participants as no observations of two or more consecutive data points outwith 
2SDs were seen within the intervention phase. 
EQ5D – VAS 
Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for 3/8 participants. The PND statistic 
demonstrated an effective change for 3/8 participants. The 2SD band method revealed a 
significant treatment effect for 6/8 participants with the observation of two or more 
consecutive data points occurring outwith 2SDs within the intervention phase. 
SF36 - V2 PCS 
Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for 2/8 participants. The PND statistic 
demonstrated a questionable change for one participant (50%-70%), an effective change for 
one participant (70%-90%), and a very effective change for one participant (>90%). The 2SD 
band method revealed a significant treatment effect for 3/8 participants with the 






SF36 - V2 MCS 
Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for one participant. The PND statistic 
demonstrated a very effective change for one participant (>90%), but a non-significant 
change for the remaining 7/8 participants. The 2SD band method revealed a significant 
treatment effect for one participant with the observation of two or more consecutive data 
points occurring outwith 2SDs within the intervention phase. 
HADS 
Participant one was the only participant not to undertake the HADS outcome 
measure. Visual analysis of the celeration line indicated that there was a positive and 
significant change in the intervention phase for 3/7 participant (see Table 4.2). The PND 
statistic and 2SD band method identified no change in the intervention phase for all 
participants. 
ICIQ 
Participant one was the only participant not to undertake the ICIQ outcome 
measure. Visual analysis of the celeration line indicated that there was no change in the 
intervention phase for all participants. The PND statistic and 2SD band method identified no 
significant change in the intervention phase for all participants. 
4.7.1 Participant 1 
Participant one was a 40 year old female who worked as a midwife. She had suffered 
from her PGP symptoms for approximately seven years. Her symptoms commenced during 
her first pregnancy, which involved both a ventouse and caesarean section. Following the 




and reduced function. The participant believed that her “traumatic pregnancy” was the 
reason why her symptoms were continuing. Her symptoms continued into her second 
pregnancy, where she opted for a caesarean section to prevent the trauma that had 
occurred in the first pregnancy. Following the delivery of her second child her symptoms 
persisted. She had seen a wide variety of NHS and private health care professionals to assist 









Figure 4.1 Participant 1 Numerical pain rating scale (Day) results, A = Celeration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
 
Figure 4.2 Participant 1 Numerical pain rating scale (Night) results, A = Celeration line and 









4.7.2 Participant 2 
Participant Two was a 39 year old female who was a lecturer at a university. She had 
reported symptoms for approximately six months following the delivery of her child. She 
reported generalised pain into her posterior pelvis during pregnancy that did not resolve in 
the post-partum period. This led to general pain and discomfort, causing reduced activity 
and function (see Figure 4.3 and 4.4 for results). 
 
 
Figure 4.3 Participant 2 Numerical pain rating scale (Day) results, A = celeration line and 
position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
Figure 4.4 Participant 2 Numerical pain rating scale (NIGHT) results, A = celeration line and 








4.7.3 Participant 3 
  Participant Three was a 31 year old female who was a nurse. She had suffered with 
persistent PGP symptoms following her pregnancy with symptoms continuing at 18 months 
following the natural delivery of her child. She had previously attempted to seek help but 
reported being dismissed by her General Practitioner (GP) and subsequently continued to 
attempt to manage her symptoms independently with modification of her activities (see 
Figure 4.5 and 4.6 for results). 
 
Figure 4.5 Participant 3 Numerical pain rating scale (Day) results. A = celebration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
Figure 4.6 Participant 3 Numerical pain rating scale (Night) results, A = celebration line and 








4.7.4 Participant 4 
Participant Four was a 28 year old female who worked as a bank administrator. She 
had two children and her last delivery was a natural birth. She had experienced pregnancy 
related PGP symptoms during her second pregnancy and had not experienced symptoms in 
her first pregnancy. Her PGP had persisted for approximately 12 months. She had reported 
not seeking any help to manage her current symptoms (see Figure 4.7 and 4.8 for results). 
 
 
Figure 4.7 Participant 4 Numerical pain rating scale (Day) results, A = celeration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
Figure 4.8 Participant 4 Numerical pain rating scale (Night) results, A = celeration line and 








4.7.5 Participant 5 
Participant Five was a 26 year old female who worked as an administrator for an 
insurance company. She had two children and reported that her pregnancy related PGP 
commenced during the end of her first pregnancy and persisted into her second pregnancy, 
which commenced less than 12 months following the delivery of her first child. In total, her 




Figure 4.9 Participant 5 Numerical pain rating scale (Day) results, A = celeration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
 
Figure 4.10 Participant 5 Numerical pain rating scale (Night) results, A = celebration line and 








4.7.6 Participant 6 
 
Participant six was a 31 year old full time mother. She had experienced PGP 
symptoms for approximately 48 months following the delivery of her third child. She 
reported requiring instrumented delivery during the delivery of her first child, however, the 
delivery for her third child was a natural delivery (see Figure 4.11 and 4.12 for results). 
 
 
Figure 4.11 Participant 6 Numerical pain rating scale (Day) results, A = celeration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
 
Figure 4.12 Participant 6 Numerical pain rating scale (Night) results, A = celebration line and 










4.7.7 Participant 7 
Participant seven was a 28 year old female, healthcare assistant. She reported 
suffering with PGP that commenced during her pregnancy and had persisted for 
approximately 24 months. She required a forceps delivery during her delivery (see Figure 




Figure 4.13 Participant 7 Numerical pain rating scale (Day) results, A = celeration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
 
Figure 4.14 Participant 7 Numerical pain rating scale (Night) results, A = celeration line and 










4.7.8 Participant 8 
Participant eight was a 33 year old full time mother. She reported having two 
children, requiring instrumented deliveries for both deliveries. Her most recent delivery 
required ventouse instrumented assistance. She reported a 36 month history of PGP 
symptoms. She reported initial symptoms commenced during her first pregnancy however 
these were mild and resolved following her delivery. During her second pregnancy her 
symptoms of PGP returned and she reported symptoms of 36 months from this onset (see 
Figure 4.15 and 4.16 for results). 
 
Figure 4.15 Participant 8 Numerical pain rating scale (Day) results, A = celeration line and 
Position of Non-overlapping Data statistic (PND), B = +/- 2 standard deviation Band Method  
 
Figure 4.16 Participant 8 Numerical pain rating scale (Night) results, A = celeration line and 









4.7.9 Group Randomisation Testing Results 
 
 
Table 4.3 Randomisation test p values for all outcome measures (* significant values) 
These values indicate if there is a statistically significant difference between the 
actual changes at baseline to intervention scores compared with the randomly generated 
change when all participant scores are grouped together.  The values compare the baseline 
The results of group analysis, combining six participants using a randomisation test 
are shown in Table 4.3 below. Participant 1 was excluded as they were the original case 
study and only 16 data points were used; eight pre and eight post, with baseline and 
intervention period not randomised. Participant 6 was excluded due to a missing data point. 
Outcome Measures Customised DEFO 
NPRS (DAY) 0.002* 




SF36-V2 - PCS 0.661 






scores to the scores obtained during the intervention period whilst wearing the customised 
DEFO. This highlights that there was a significant effect with the use of the DEFO for both 
day and night pain (NPRS day and night). 
4.8 Discussion 
The results of this replicated single case study case series  provides evidence to 
suggest that a customized DEFO can potentially help to reduce day and night time pain and 
reduce anxiety and depression in persons experiencing  chronic, post-partum PGP.  These 
findings are supported on a case-by-case basis as well as the group analysis. When visually 
analysing the data, many participants presented with variable baselines throughout all 
outcome measures, with data points at both high and low extremes (e.g. for Participant 1 
there was a five point difference between the highest and lowest data point on the NPRS – 
lowest being 1 and highest being 6) . This reflects the natural variability of symptoms that 
can occur with this chronic condition, a situation that clinicians are regularly faced with in 
practice. Nevertheless the visual analysis of data for most participants did indicate an 
improvement during the intervention phase compared to baseline; alongside this it was 
apparent that the scores were more consistent (aka “stable”) during the intervention phase.  
Although not assessed, it could be that the increased stability of symptoms during the  
intervention phase could be important in allowing participants to plan activities more 
confidently with the knowledge that pain levels would not vary before, during or 
afterwards. 
It was observed that Participant 4 had a significant reduction in pain over two data 
points during the baseline phase of the primary outcome measure; which coincided with her 
holiday/annual leave. This impacted upon the overall results of participant 4, with tests such 
as PND and 2+/- SD band method having less positive results. Participant 6, on visual 




demonstrated  a significant change in the standard deviation band method for the NPRS and 
EQ5D-VAS indicating improvement in pain and health. Participant 3 appeared to show 
improvement in her baseline phase which continued into the intervention phase. It would 
be difficult to postulate the cause for this as her work patterns were consistent (working as 
a nurse and continuing with 12 hour working shifts) but it is possible that this could have 
been related to the standardised physiotherapy intervention (see section 3.3.9.3) which was 
provided to all participants. In summary, most participants appeared to present with 
improvement in the intervention phase.  
When considering the disease specific questionnaire, the PGQ showed a significant 
improvement for five out of eight females who reported improvement in pain and activity 
levels. Participant 4 was again affected by the two weeks of improvement, which coincided 
with her annual leave during the baseline data collection phase. An improvement in the 
PGQ was observed for participant 6 who did not visually, or on analysis, appear to have a 
marked improvement during the intervention phase on pain with no effect of night pain and 
an effect on day pain only suggested by one method. From observations and analyses 
participant 1 also had a significant response for most outcome measures (except HAD and 
ICIQ as they didn’t undertake them) but did not gain as positive a result on the NPRS night 
unlike the others. This suggests that improvements in quality of life and activity may not 
always be strongly associated with a reduction in pain.  
  The unstable baseline in some of the case studies complicated the interpretation of 
the NPRS pain data. In addition to this there were limitations to some of the analyses 
methods. For example, when using the 2+/- SD band method, the extreme scores resulted in 
large SD’s which prevented the possibility for findings to be significant, since the minus 2+/- 
SD band fell below a score of zero. Of interest the NPRS ‘night’ had a lower pain score at 




less; this is opposite to PGP during pregnancy. Whether there are differences in sleep 
patterns and sleep quality between the two groups and with the intervention is a potential 
area of future study. In a similar fashion, the relatively wide-ranging scores during baseline 
also impacted on the interpretation of the PND statistic (PND = <50% ineffective). 
Pelvic orthotics have been reported to influence pelvic joint stability and this could 
have been one potential mechanism for the improvement of the participants’ symptoms 
(Damen et al., 2001; Mens et al., 2017). By improving their force/form closure throughout 
the pelvis and enabling optimisation of muscle function as a result of compression and joint 
stability, this could have led to reduced pain and improved function (Mens et al., 2017). It 
has been previously stated that enhanced joint shear forces could be a mechanism for pain 
to commence in PGP and subsequently any improvement in pelvic stability could have 
reduced this symptoms. The effects of pelvic orthotics have been previously reported to 
improve SIJ stability when undertaking an ASLR (Damen et al., 2001; Beales et al., 2010).  
Alongside the potential for enhanced pelvic stability to improve symptoms, pelvic 
orthotics are also speculated to improve proprioceptive deficit (Bertuit et al., 2018a). The 
compression gained to both joint and soft tissue is believed to influence subcutaneous 
receptors further improving joint positional awareness and potentially improving impaired 
muscle function (Shaffer and Harrison et al, 2007). All of these components could lead to 
reduced joint and soft tissue irritation. Direct evidence for this mechanism of action 
however is limited. Future work could assess joint movement thresholds and joint position 
sense at the hip with and without the DEFO. This could look at the minimal velocity of hip 
movement that could be subjectively detected using motorised devices such as a 
dynamometer to slowly move a joint at different speeds (for the same amplitude of 
movement) whilst other sensory cues (e.g. the sound of the motor) are nulled. Joint position 




by moving one joint to a position passively by an examiner/motor and then asking the 
participant to match the position with the contralateral limb. For this test, the contralateral 
limb should not be affected whilst in PGP the pain is often felt bilaterally. Finally it may be 
possible to assess sensori-motor control by assessing whether the response to short, fast 
motor-driven stretches to the hip adductors result in larger stretch reflex responses in the 
hip adductors when wearing the DEFO. This would imply that for the same stimulus (stretch 
amplitude and speed) the motor output is larger when wearing the DEFO implying that the 
stretch caused a larger afferent volley into the spinal cord (reflecting the hypothesised 
increased in afferent stimulation with the DEFO).   
All the females within this study reported symptoms of PGP for longer than three 
months.  With this chronicity in mind, it is important to be aware that many factors may 
contribute to post-partum PGP.  Although the true nature is still not well understood, it 
could be hypothesised that a combination of factors leads to the continuing symptoms. 
Factors such as reduced pelvic stability, suboptimal muscle functioning, poor motor control, 
and reduced proprioception could be important alongside factors such as low mood, 
reduced confidence along with biopsychosocial issues (Vleeming et al., 2008; Shaffer and 
Harrison, 2007; Mens et al., 2017; Bergstrom et al., 2014).  Not all of these factors could be 
immediately modifiable with a DEFO. However, although the DEFO may act through 
mechanical stabilisation and sensory stimulation its impact on activity may have longer 
consequences. The immediate improvements in pain could allow people to increase activity 
levels, which in turn could impact positively on other causative factors such as muscle 
strength and motor control. Greater ability to move pain free could also impact on factors 
such as occupation, participation and mood. These in turn could further help to reduce the 




Females suffering from chronic PGP have been shown to present with higher rates of 
depression than healthy individuals (Elden et al., 2016). It is for this reason that the HADS 
was included in the battery of outcome measures. On group analysis, a significant 
improvement in the HADS was observed. Future work could explore in more detail the 
association between pain reduction and improvement in mood with DEFOs and to ascertain 
whether changes occur in parallel or whether changes in one variable precedes the other to 
get an indication of cause-and-effect relationships.  
Interestingly, studies identify maternal age as a risk factor for suffering from chronic 
PGP and the average age for females in this single case study series was 32 years old 
(Bergstrom et al., 2014). It was identified by Bergstrom 2014, that females aged 30 and 
above are at higher risk (Bergstrom et al., 2014). Although this factor is not modifiable it 
could be used clinically to identify at risk individuals as part of a future PGP care pathway. 
Although enhanced  activity levels could positively affect muscle strength, it is 
important  to be mindful that research undertaken by Hu et al. (2010) identified that pelvic 
belts cause a decrease in both the transverse and oblique abdominal musculature (Hu et al, 
2010). This is supported by Beales et al. (2010) who showed a continued abnormal muscular 
response despite improvement in joint stability (Beales et al., 2010).  This could result from 
disuse muscle atrophy as the belt / orthotic assumes responsibility for the stabilisation role 
of the muscles. As undertaken in this study, the provision of standardised physiotherapy 
advice and a holistic approach to rehabilitation would hopefully prevent this. Future work 
could therefore look at whether the observed improvements with the DEFO can be further 
enhanced with more intensive, personalised rehabilitation package. It is also important to 
look at the longer term (>2 months) effect of a DEFO to see whether people still require the 
orthosis long term or whether they develop (e.g. through improvements in stability, 




long term use, although potentially affecting local muscle strength (e.g. causing abdominal 
weakness), may allow other factors underlying force closure (e.g. ligament support) to 
improve. For example, repeated positioning of a joint in shortened position (as facilitated 
with the DEFO) might lead to increased stiffness. The short and long term stability of the SIJ, 
for example, could be assessed using the ultrasound transmission of vibratory stimuli across 
the joint as has been performed previously (Vlaanderen et al., 2005). 
4.9 Strengths and Limitations  
The ability to undertake group testing was a strength to this study. Single case 
studies can give valuable insight into conditions and research issues, such as the suitability 
of outcome measures.  However, single case studies can be limited in their generalizability. 
The ability to undertake randomisation tests in this case study series, provides preliminary 
evidence that improvements in pain, quality of life, activity levels and mood could be 
occurring at a group level. 
Unfortunately, there was missing data for participant 6. This precluded them from 
group testing which may have affected the overall randomisation results. Participant 1 was 
also precluded from group testing as they were the original case study, which prompted the 
development of a case study series. Participant 1 was therefore not randomly allocated to 
their baseline or intervention period and only undertook 16 data points opposed to the 
suggested 18.  The results of these single case studies suggest that future work, such as a 









This replicated single case study series was undertaken in eight females who all 
suffered from chronic post-partum PGP where the pain was not self-limiting, as previous 
evidence suggests. This preliminary work identified some promising results for the benefit of 
using the customised DEFO in the management of this condition.  
It has been shown that evidence for treatment modalities for females suffering from 
chronic PGP is lacking. This single case study series suggests that a customized DEFO could 
potentially reduce pain, increase health related quality of life, improve mood and increase 
activity levels for persons suffering from chronic, post-partum, pelvic girdle pain thereby 
hopefully identifying a possible new treatment option for managing this condition. This 
single case study series has also given a more in-depth awareness into the magnitude of 
improvement that may be associated with the customized DEFO. The results of this single 
case study series provides the basis for a larger clinical trial. 
In summary, information gleaned from this case study series has highlighted that 
chronic post-partum PGP is not necessarily self-limiting and proposes a novel intervention, 


























































In this discussion chapter the intention is to provide a brief critical reflection of key 
methodological challenges, followed by a summary of the findings from the three studies 
which contribute to this dissertation: (1) the fabric testing; (2) randomised controlled trial; 
(3) case series studies. This is followed by a deeper contextualisation of key future research 
directions and understandings from the knowledge gained from undertaking this novel work 
within pregnancy related PGP. The chapter will finish with the conclusions drawn from the 
research presented.  
5.2 Summary of findings 
 The impetus for the development of research studies for this thesis originated from 
the recommendations from the European Guidelines for the management and treatment of 
PGP (Vleeming et al., 2008). It stated that there was a lack of high quality research evidence 
to support the use of a pelvic orthotic to treat PGP, no evidence to recommend the use of a 
pelvic orthotic as a single treatment, only recommended to be used to test for symptomatic 
relief, and only applied for short periods of time. My clinical experience, however, suggested 
that orthoses often appeared effective in managing PGP, and the lack of specific guidance in 
this area was frustrating. The need for further research was clearly evident.  At around this 
time, the use of DEFOs was being investigated as an innovative orthotic approach in the 
management of PGP in athletes; and it was apparent that there were many parallels 
between the orthotic management of these two conditions.  The amalgamation of these 
issues was the starting point for developing the research questions which are addressed in 
this dissertation.       
Each chapter, summarised below, provides a brief account and discussion of the 




5.2.1 Chapter 1: Literature Review  
This chapter, provides an updated critical review of the studies undertaken that have 
investigated the orthotic management of pregnancy related PGP. It clearly identifies the 
considerable growth in research since the advent of the 2008 Guidelines (Vleeming et al, 
2008). Since the publication of these Guidelines, the landscape of orthotic management in 
this area has significantly changed in line with the considerable growth of research in this 
area. Eleven studies (nine of which are RCTs) have been published since the 2008 
international Guidelines. Although the research undertaken suffers from a range of 
methodological flaws, the general trend in the findings from these studies contradict those 
of the Guidelines,  suggesting that pelvic orthotics are potentially beneficial for reducing 
pain and function in pregnancy related PGP. Two of the studies undertaken as part of this 
dissertation, the RCT (Chapter 3) and series of replicated single case studies (chapter 4) both 
support this conclusion with regard to improved day time pain and contribute to this body 
of evidence 
One could argue therefore that the recommendations from Vleeming’s et al. (2008) 
guidelines may be outdated.  Conventionally, the median lifespan of a clinical guideline is 60 
months (Alderson et al., 2014), with updating of guidelines in the US being typically every 
3.5 years, and in the UK (NICE guidelines) every 5 years; thereby ensuring guidance and 
practice is relevant (Alderson et al., 2014). Eleven studies (nine of which are RCTs), together 
with the two studies undertaken as part of this dissertation, have been published since the 
2008 international Guidelines.  
The literature review highlighted a number of methodological flaws that persist in 
the design and implementation of many of these published studies. These include, for 
example, the lack of stratification within the randomisation process, which has resulted in 




of certainty as to whether baseline characteristics are well matched because these data are 
not reported (e.g. parity). The latter, for instance, are potential risk factors for suffering 
from PGP (Kanakaris et al., 2013; Gutke et al., 2008; Vleeming et al., 2008; Vermani et al., 
2010), and hence it is argued that there are benefits to implementing more refined methods 
of randomisation such as minimisation. A lack of blinding, both from the perspective of the 
assessor and the participant, was also  noted in the literature review as an ongoing problem 
which has not, as yet, been resolved in many of the studies. Whilst recognising that 
reporting guidelines for research studies have escalated in recent years, a key finding, even 
with regard to the newer studies, was that they did not report adhering to CONSORT 
guidelines. None of the RCTs reviewed reported their trial in line with CONSORT guidelines, 
despite the original CONSORT guidelines being published in 1996. Furthermore, six of the 
RCTs were published after the publication of the revised 2010 CONSORT guidelines (Maher 
et al., 2010; Pandis et al., 2017).   
5.2.2 Chapter 2: Fabric Testing  
This repeated measures design study was undertaken to determine the fabric 
stiffness and elastic hysteresis of different fabric colours. This was a crucial question to 
address because the DEFO that was tested in the planned RCT, could be made from a range 
of colours.  It was therefore critical to know whether it would be possible for the 
participants to be offered a choice of colours for their customised DEFO (which we 
anticipated might impact on adherence to wearing the orthoses). The findings of the study 
demonstrated that there were significant differences in the stiffness and elastic hysteresis 
between the fabrics of different colours. The decision was therefore made to standardise 
the colour of fabric for all participants within the customised DEFO group. The findings of 
this study, enabled standardisation of fundamental characteristics of the customised 




was chosen based on user preference. However, one potential issue to consider with the 
black Lycra is its relatively low stiffness and high viscosity. This means that a greater stretch 
would be required to achieve a given tension compared to other colours and hence with 
repeated stretch-release cycles there would be greater energy dissipation as heat. Thus, 
future work could assess whether different fabric properties (stiffness and viscosity) are 
associated with differences in subjective reports of comfort and coolness. Differences in 
DEFO design (e.g. lines of pull and position of tensioned fabric) on applied pelvic pressure 
could also be assessed in future studies. This may require the production of an instrumented 
manikin capable of measuring applied forces in three dimensions. 
5.2.3 Chapter 3: Management of Antenatal Pelvic Girdle Pain Study (MAPS): A single 
centre, double blinded, randomised comparative trial evaluating the effectiveness of two 
pelvic orthotics  
 This chapter describes the RCT undertaken to investigate the comparative 
effectiveness of the off the shelf rigid Serola pelvic belt and the customised DEFO.  The 
initial scoping review of the literature had highlighted the rigid belt as being commonly 
provided within NHS practice, hence being defined in this RCT as ‘standard care’. To 
complement this, as is often the case in usual care (based on the authors anecdotal 
experience, since there is a lack of published data describing “usual care”), standardised 
advice and education was provided and the participants were able to access other 
treatments as they saw fit. This comparative trial enabled an important clinical question to 
be addressed as to whether one type of orthotic was more effective than another.  The RCT 
was designed to address some of the methodological flaws that had been identified in the 
literature review (Chapter 1). For instance, the RCT was double blinded to reduce risk of 
bias. Further, the minimisation procedure ensured an equal balance of key characteristics 




that the novel, customised DEFO was more effective (both with respect to statistical and 
clinical significance) than the off-the-shelf rigid Serola pelvic belt at reducing day time pain 
(the primary outcome measure) in pregnant women with PGP. It is notable, however, that 
the changes in day time pain are defined as minimally important (but perhaps not very 
important) in terms of clinical significance and hence some caution is advised when 
translating these results to clinical practice.  
5.2.4 Chapter 4: Management of post-partum pelvic girdle pain Study: A replicated case 
series of single case studies evaluating the effectiveness of a customized Dynamic 
Elastomeric Fabric Orthoses (DEFO)  
 As the work for this dissertation evolved over time, the significance of chronic PGP 
became increasingly self-evident. Whilst undertaking the RCT, the midwife that was working 
in the department where the RCT was being conducted, posed the question, would the 
customised DEFO be effective in managing chronic PGP symptoms. In response, an informal 
review of the literature was undertaken which identified a clear knowledge gap, which 
prompted me to further investigate this aspect. A subsequent comprehensive literature 
research highlighted that no previous studies had explored this question in relation to the 
use of customised DEFOs in the management of chronic PGP; the use of a replicated single 
case study design was therefore chosen as an appropriate method for investigating this.  A 
key benefit of undertaking a case study series (n=8) was that it enabled investigation of the 
impact of the DEFO on a wide range of outcomes, to more fully understand the potential 
effectiveness of the DEFO. By using group randomisation and analysis, clearer conclusions 
could also be drawn about the potential value of this intervention at both the level of the 
individual and the group. An incidental, and somewhat alarming finding, from this study was 
the apparent lack of awareness of the prevalence or impact of this problem, both within the 




5.3 Future work within the context of these studies  
This section aims to consider the future direction of research and clinical 
management of antenatal and post-partum pelvic girdle pain. An important clinical question 
is, “Does better management in the acute phase of pregnancy related PGP, ultimately 
impact on the likelihood of reduction of chronicity in the post-partum stage?” Although this 
question was not addressed in this thesis, it was highlighted as an important issue by one of 
the participants who complained of persistent PGP symptoms (6-7 years) following the 
delivery of her second child. This participant’s experience echoes the findings of a recent 
qualitative systematic review investigating the psychological and emotional effect of 
pregnancy (and post-partum) related PGP (MacKenzie et al., 2018). This identified that 
sufferers of PGP commonly report negative emotions such as anger and frustration due to 
typical effects of PGP, pain and reduced function. The authors showed that this, in turn, was 
associated with women abusing analgesics to manage symptoms, especially if they lacked 
the social support to manage activities of daily living. There was also a safety issue raised 
related to the expectations placed on them to care for a baby/toddler/ young child 
(especially when the child becomes more mobile), despite their chronic pain and restricted 
function (MacKenzie et al., 2018). It is apparent that there is a general expectation that PGP 
is a normal process of pregnancy and post-partum stages which women need to deal with 
(Albert et al, 2001); however, this is not the case (Fishburn and Cooper, 2015). 
A more accurate understanding of the prevalence of PGP is important to know 
whether “this is a normal process of pregnancy”. The UK currently lacks updated prevalence 
information, with a heavy reliance on data from other regions, such as Scandinavia, in 
relation to this. The context for countries such as Sweden, however, is significantly different 
for the diagnosis and management of pregnancy related PGP. For example, the Swedish 




different than that of the UK. Furthermore, the financial support given to women and 
partners in Sweden during parental leave is substantially higher, receiving full pay for up to 
16 months, in conjunction with parental leave being compulsory, with an allocation of 480 
days to be taken between parents 
(https://ec.europa.eu/social/main.jsp?catId=1130&langId=en&intPageId=4808 ).  When 
considering parents returning to work, there is further support given to parents, as figures 
suggest the average cost of nursery fees are significantly lower in comparison to the UK with 
an average of £196 fees per month in Sweden compared to £700 in the UK 
(www.forsakringskassan.se). These, and other factors, provide some indication as to why 
there is a higher interest in pregnancy related issues; as reflected by Sweden appearing to 
be leading the way with pregnancy related research.  With this in mind, discussions have 
been held with an obstetrics and gynaecology consultant at Treliske hospital, Cornwall as to 
the potential for undertaking research to better understand the prevalence of women 
suffering from chronic PGP within the UK, and to gain further insight into the current 
problem at hand.  
Determining whether early effective management of antenatal pain may reduce the 
likelihood of symptoms persisting in the longer-term post-partum, is important. It is 
acknowledged, however, that this is a complex research question, and one which would 
require the design of a RCT with long-term follow-up for an estimated two years. This would 
require considerable resource, both in terms of finance, time and participant engagement. 
This study design would allow the participant’s symptoms to be mapped from early onset of 
the condition, through the post-partum stages. Had resources (finance and time) been 
available,  it would have been ideal if the participants from the RCT undertaken for this 
dissertation had been followed up for longer than the 12 weeks, however, this was not 




into whether early intervention would be beneficial both in the short and longer term 
(Fishburn and Cooper, 2015). The questionnaire-based outcome measures used in the 
current study could facilitate long-term follow up by reducing the burden on the 
participants compared to having to attend outcome measurement sessions away from the 
home. 
Undertaking research in the area of chronic PGP is important, both in identifying 
potential effective treatment options, and in raising awareness of this condition. Clinical 
experience suggests that women with chronic PGP are frequently slow in  being identified 
and are often not referred for intervention (Bishop et al., 2016); this has been recognised as 
an area that needs further exploration (Close et al., 2016). One participant in the chronic 
case studies reported attending her GP, only to be told “I don’t deal with women’s 
problems”; future qualitative research could provide a method for determining whether this 
is a common experience for women with pregnancy related PGP.  Research which explores 
the perspectives of people with a condition, has the potential to increase insight into the 
way this condition is experienced (Osborn et al., 2010), as well as enhance understanding 
about how the condition is identified and managed by healthcare services (Al Busaidi et al., 
2008; Barry et al., 2000; Crawford et al., 2002) . 
It is recognised that, just as listening to people with a condition will help to increase 
knowledge about the conditions and its management, so too can their involvement enhance 
the effectiveness of the research process itself. An essential aspect of future research would 
be the utilisation of patient and public involvement (PPI). In the design of the RCT for this 
dissertation this was incorporated to some extent by the use of an initial single case study to 
consider issues such as patient burden, patient preference, and to guide the selection of 
outcome measures. On reflection, however, greater use of PPI would have been beneficial. 




would have been a mechanism for considering different strategies to improve this such as 
the best methods of raising study awareness, appropriate wording in adverts, and 
alternative  recruitment strategies.  Future research in this area should ensure that PPI is 
incorporated more comprehensively to help with issues such as these.  
A systematic review could be considered as a starting point (key to strong evidence is 
the methodological rigour of this method). The review of literature undertaken for this 
thesis found that many of the published RCTs had methodological flaws.  In response, the 
aim was to design a methodologically robust comparative study which had been highlighted 
as lacking in the current literature, and as recommended by the European guidelines.  
5.4 Guidelines 
It was considered a high priority to utilise current reporting guidelines to enhance 
the transparency and robustness of the reporting of the RCT study undertaken for this 
dissertation. Since 2014, TIDier guidelines have been produced to ensure interventional 
studies provide a clear description of the intervention in order to facilitate replication of 
studies, and CONSORT guidelines which provide a framework for optimising the 
transparency and robustness of the reporting of randomised controlled trials (Hoffman et 
al., 2014; Maher et al., 2010). In 2017, further guidelines such as GRIPP2 were developed 
with the aim to further improve the quality, transparency and consistency of PPI in studies. 
Future RCTs investigating the effects of DEFOs on chronic post-partum PGP should 






5.5 NHS Implementation 
Following the dissemination of the research to the wider research team, a consultant 
Obstetrician and Gynaecologist highlighted the need to raise awareness about the potential 
use of the customised DEFO with patients in the NHS, given that it had demonstrated to be 
effective within the RCT, although we have to take into account the lack of control group 
within the study. In line with this, there are currently ongoing discussions within one NHS 
hospital as to whether information about this product might be offered to patients during 
their consultation. This has the advantage of providing patient choice and engaging the 
individual in the shared decision making process. 
 Other implementation considerations are the need to raise awareness of the 
potential benefit of using orthotics in the management of both antenatal and post-natal 
PGP. As a result of the studies undertaken for this dissertation, patient care clinical 
pathways have been implemented within my NHS Trust, to facilitate earlier interventions to 
aid the management of PGP. Alongside this, the results have also informed the development 
of tailored training in an intermediate skills programme for senior musculoskeletal staff. 
Future work will involve the development of services for the chronic PGP population. 
5.6 Priorities for Future Research  
Areas for future research have been highlighted in the discussion sections of each 
chapter. Of particular importance is the under-researched area of chronic PGP, which 
appears to be a particularly neglected issue. Prevalence data in the UK is outdated and 
future research is urgently needed to fill this knowledge gap. Following discussion with an 
NHS consultant within obstetrics and gynaecology, who feels that this could be a multi-
centre study, there is potential for my work in this field to continue to develop and provide 





The thesis was developed on the basis of undertaking research to fill a knowledge 
gap and the call for future research in orthotic management of pregnancy related PGP. 
During the undertaking of this thesis, a literature review has provided information to 
suggest that current guidelines (Vleeming et al., 2008) may be outdated in their 
recommendations, and that orthotic management in pregnancy related PGP appears 
effective in reducing antenatal daytime pain. Prior to undertaking the RCT, laboratory 
testing of orthotic fabric was undertaken to inform decisions about the selection of fabric 
and to ensure standardisation of intervention. The RCT results concluded that the 
customised DEFO was effective in reducing day antenatal day time pain in comparison to 
the rigid Serola belt; the difference between the two groups was statistically significant. 
When considering the DEFO’s clinical application, it bordered clinical significance when 
using the lower threshold of the MCID (1 point) indicating some caution when considering 
clinical application.  This research has been published in a peer review journal (Cameron et 
al., 2018). The thesis also explored pregnancy related PGP that persisted into the post-
partum period. Although not planned for at the start of the PhD, the single case study series 
provided a natural progression to cover orthotic management in both the antenatal and 
post-partum period. Future work should consider identifying the true prevalence of chronic 










Appendix 1: Fabric Testing Chapter Spreadsheet of each fabric colour and 














Purple_                
Powernet 
White_                         
Powernet 
Black_                          
Powernet 
Beige_                        
Powernet 
Blue_                           
Powernet 
Red_                     
Powernet 
1.96 14.07 13.65 11.61 29.68 13.55 10.79 
3.92 23.61 28.99 27.95 42.51 32.71 23.33 
5.88 38.8 44.5 45.61 63.53 53.41 41.65 
7.84 51.22 54.61 59.12 81.42 69.74 57.16 
9.8 66.98 64.94 74.15 102.59 91.34 79.68 
11.76 80.89 73.61 85.39 118.77 107.95 100.76 















1.96 13.42 5.35 7.47 8.49 10.18 7.85 
3.92 24.45 16.62 16.2 17.85 19.75 16.37 
5.88 40.26 31.22 26.47 29.21 32.23 27.43 
7.84 49.39 41 35.34 38.01 40.93 35.23 
9.8 60.68 52.81 45.54 48.47 52.06 45.46 
11.76 69.15 61.88 53.28 55.82 59.66 52.82 




Appendix 2. RCT Written Informed Consent Form 
                                      
    
Royal Cornwall Hospitals NHS Trust 
Princess Alexandra Wing  
Royal Cornwall Hospital  




PELVIC GIRDLE PAIN IN PREGNANCY: A BLINDED RANDOMIZED TRIAL 
EVALUATING THE EFFECTIVENESS OF TWO PELVIC SUPPORT BELTS. 
 
Researcher taking Consent:  Lee Cameron  
 
 
If you have any unanswered questions about this study then do NOT complete this form. 
 
 
PLEASE INITIAL ALL BOXES                    
 
1 
I confirm that I have read and understood the information sheet (Version 1, 
December 13th 2011) for the above study and have had the opportunity to ask 
questions. 
 
2 I confirm that I have had the opportunity to discuss the study with the researcher. I 




I understand that the information collected during this study will remain strictly 







Name of Patient      _________________________________________________________ 
   
Date            ____________________   Signature ___________________________ 
   
 
Name of Person taking consent   _______________________________________________  
 
Date           ____________________    Signature ___________________________ 
 
 






4 I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason and without affecting my medical or 
physiotherapy care or legal rights.  
 
5 I agree that auditors, monitors, regulatory authorities and ethics committees may 
have restricted access to my research records. 
 
6 I agree to my GP being notified of my participation 
 
 











BASELINE DESCRIPTIVE DATA 
 
 
Project Title: PELVIC GIRDLE PAIN IN PREGNANCY: A BLINDED RANDOMIZED TRIAL 








3) Mode of Delivery……………………………… 
 
 
4) Occupational status (tick the correct answer) 
 
Full-time paid or self-employment                  Part-time paid or self-employment 
 
Voluntary employment                      Sheltered employment 
 




     Retired                      Other (specify)   
 
 
5) Occupation (if employed) 
 
     Professional (e.g. health, teaching, legal)                   
            
     Associate professional (e.g. technical, nursing) 
 
     Clerical worker/secretary                  
 
     Services/sales (e.g. retail) 
 





    Skilled labourer/craftsman (e.g. building, electrical etc.)     
 
    Elementary occupation (e.g. domestic, caretaker, labourer)                    
 
    Armed Forces                   
 
    Other (Please specify) 
 
 
6) Body-mass Index (BMI)  
……….......................................................... 
 
7) History of low-back pain? 
 
Before current pregnancy   YES                   NO 
 
During current pregnancy   YES                   NO 
 
8) History of pelvic pain?  
 
Before current pregnancy   YES                   NO 
 
















Appendix 4. Pain Referral Map 
 
1) Pelvic Girdle Pain Referral Map: 
 
Please look carefuly at the pictures and indicate the site of your pain: 
 
 
                                             










Appendix 5. RCT Self-Report Questionnaire Booklet 
   
 
                                                                                                                    
                
        Pelvic girdle pain during pregnancy: a blinded randomized trial 
evaluating the effectiveness of two pelvic support garments. 
 
          
                   
                    
Participant Number:  
 
 
Questionnaire Number:  
 
 
Date sent:                                                                                  
 
 
Date completed:   







Royal Cornwall Hospitals  
NHS Trust 
                                                                                     
Princess Alexandra Wing 
Royal Cornwall Hospital 
Truro, TR1 3LJ  
 
 
The University of Plymouth 
Faculty of Health, Education and Society 











 The aim of this project is to compare the effectiveness of two different types of pelvic support 
garments with regard to management of pregnancy-related pelvic girdle pain (PGP), daily function 
and quality of life.   
 
 We hope that you will complete this questionnaire booklet since the information you provide is 
very important for the success of the project. If you have trouble reading or writing you can ask 
someone to help you. 
 
 You may find some of the questions a bit repetitive, or possibly not very relevant to you, however 
please answer all the questions in this booklet. 
 
 If you have any questions about completing the questionnaire booklet please call the researching 
physiotherapist Mr. Lee Cameron at: 01752-587541, or the research supervisor Dr. Jenny Freeman 
at: 01752-588835, or email us @ pelvicpainstudy@plymouth.ac.uk and they will be glad to 
help you. 
 
 Please note that your full name does not appear anywhere in this booklet and all the information 
that you provide will be treated with complete confidentiality. 
 
 It is important that you complete this questionnaire on the last day of the two-week interval, or as 
close to it as possible. 
 
 Please return the completed questionnaire booklet to Plymouth University in the stamped 





















 NUMERIC RATING SCALE FOR PAIN INTENSITY 
 
Instructions: 
On a scale from 0 to 10 please circle the number that best describes 
the level of your pelvic pain: 
 
1) Over the last 2 weeks, how would you rate your average level of pelvic 
pain during the day? 
 
 
      0     1       2       3       4      5      6       7      8       9      10 
 NO PAIN                                                                                             UNBEARABLE                                               
                MILD PAIN    MODERATE PAIN   SEVERE PAIN            PAIN       
 
                                    
 
2) Over the last 2 weeks, how would you rate your average level of pelvic 
pain during the night (after going to bed)? 
 
 
      0     1       2       3       4      5      6       7      8       9      10 
 NO PAIN                                                                                             UNBEARABLE                                               
               MILD PAIN     MODERATE PAIN    SEVERE PAIN            PAIN       
 











          
          
          






PELVIC GIRDLE QUESTIONNAIRE  
To what extent do you find it problematic to carry out the activities listed below because of 
pelvic girdle pain? For each activity tick the box that best describes how you are today. 
 
 
How problematic is it for you 
because of your 




















To a large  
extent (3) 
1) Dress yourself     
2) Stand for less than 10 minutes     
3) Stand for more than 60 minutes     
4) Bend down     
5) Sit for less than 10 minutes     
6) Sit for more than 60 minutes     
7)  Walk for less than 10 minutes     
8) Walk for more than 60 minutes     
9) Climb stairs     
10) Do housework     
11) Carry light objects     
12) Carry heavy objects      
13) Get up/sit down     
14) Push a shopping cart     
15) Run     
16) Carry out sporting activities*      
17) Lie down      
18) Roll over in bed       
19) Have a normal sex life*     
20) Push something with one foot     
*If not applicable, mark box to the right 
How much pain do you experience None (0) Some (1) Moderate (2) Considerable (3) 
21) In the morning     
22) In the evening     
 
 
To what extent because of  
pelvic girdle pain: 
 
Not at  
all (0) 
 







To a large  
extent (3) 
23) Has your leg/have your legs 
given away? 
    
24) Do you do things more slowly?     







































This survey asks for your views about your health. This information will help keep track of 
how you feel and how well you are able to do your usual activities. 
Answer every question by marking the answer as indicated. 
If you are unsure about how to answer a question, please give the best answer you can. 







                                                                                     Circle one number 
Much better now than one year ago…………………………………. 1 
Somewhat better now than one year ago…………………………….2 
About the same as one year ago……………………………………...3 
Somewhat worse now than one year ago…………………………….4 









SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
3) The following questions are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much? 
 











a) Vigorous activities, such as running, lifting 
heavy objects, participating in strenuous sports 
1 2 3 
b) Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or playing 
golf 
1 2 3 
c) Lifting or carrying groceries 1 2 3 
d) Climbing several flights of stairs 1 2 3 
e) Climbing one flight of stairs 1 2 3 
f) Bending, kneeling, or stooping 1 2 3 
g) Walking more than a mile 1 2 3 
h) Walking half a mile 1 2 3 
i) Walking one hundred yards 1 2 3 
j) Bathing or dressing yourself 1 2 3 
 
4) During the past week, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of your 
physical health? 
 
















a) Cut down the amount of time you 
spent on work or other activities 
1 2 3 4 5 
b) Accomplished less than you would 
like 
1 2 3 4 5 
c) Were limited in the kind of work or 
other activities  
1 2 3 4 5 
d) Had difficulty performing the work or 
other activities (e.g. it took extra effort) 











SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
5) During the past week, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any 
emotional problems (such as feeling depressed or anxious)? 
 
 
















a) Cut down the amount of time you 
spent on work or other activities 
1 2 3 4 5 
b) Accomplished less than you would 
like 
1 2 3 4 5 
c) Didn’t do work or other activities as 
carefully as usual 
1 2 3 4 5 
 
6) During the past week, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
















SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
                                                Circle one number 
Not at all…………………………………...1 
Slightly……………………………….........2 
Moderately………………………………...3 
Quite a bit………………………………….4 
Extremely………………………………….5 
 











8)  During the past week, how much did pain interfere with your normal work 









9) These questions are about how you feel and how things have been with you 
during the past week. For each question, please give the one answer that 
comes closest to the way you have been feeling. How much of the time during 
the past week… 
 

















a) Did you feel full of life? 1 2 3 4 5 
b) Have you been a very nervous person? 1 2 3 4 5 
c) Have you felt so down in the dumps 
than nothing could cheer you up? 
1 2 3 4 5 
d) Have you felt calm and peaceful? 1 2 3 4 5 
e) Did you have a lot of energy? 1 2 3 4 5 
f) Have you felt downhearted and low? 1 2 3 4 5 
g) Did you feel worn out? 1 2 3 4 5 
h) Have you been a happy person? 1 2 3 4 5 










                                                Circle one number 
Not at all……………………………………1 
A little bit…................................................2 
Moderately................................................3 






SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
10) During the past week, how much of the time has your physical health or 










11) How TRUE or FALSE is each of the following statements for you? 
 











a) I seem to get ill a little easier than other 
people 
1 2 3 4 5 
b) I am as healthy as anybody I know 1 2 3 4 5 
c) I expect my health to get worse 1 2 3 4 5 






            








                                   Circle one number 
All of the time……………………………1 
Most of the time………………................2 
Some of the time……….…………….....3 
A little of the time…................................4 





EQ-5D HEALTH QUESTIONNAIRE 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
MOBILITY 
 I have no problems in walking about                                                                     
 I have slight problems in walking about                                              
 I have moderate problems in walking about                                        
 I have severe problems in walking about                                          
 I am unable to walk about  
                                                                
SELF-CARE 
 I have no problems washing or dressing myself 
 I have slight problems washing or dressing myself 
 I have moderate problems washing or dressing myself 
 I have severe problems washing or dressing myself 
 I am unable to wash or dress myself 
 
USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities) 
 
 I have no problems doing my usual activities 
 I have slight problems doing my usual activities 
 I have moderate problems doing my usual activities 
 I have severe problems doing my usual activities 
 I am unable to do my usual activities                                                     
 
PAIN/DISCOMFORT 
 I have no pain or discomfort 
 I have slight pain or discomfort 
 I have moderate pain or discomfort 
 I have severe pain or discomfort 
 I have extreme pain or discomfort 
 
ANXIETY/DEPRESSION 
 I am not anxious or depressed 
 I am slightly anxious or depressed 
 I am moderately anxious or depressed 
 I am severely anxious or depressed 








EQ-5D HEALTH QUESTIONNAIRE continued 
 
 We would like to know how good or bad your health  
is TODAY. 
 This scale is numbered from 0 to 100. 
 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
 Mark an X on the scale to indicate how your health is 
TODAY. 












RESOURCE USE FOR PELVIC GIRDLE PAIN (PGP) 
 
1) MEDICATION USE 
 
1a) During the last 2 weeks, did you use any kind of pain-relieving or other type of medication to treat your PGP?  
 
YES                    NO 
  
1b) If YES, please specify: 
 
Name of medicine How many tablets did you take 
and how often? 
How did you obtain this medicine? If the medicine was bought by yourself, how 








Bought by yourself over the counter 
£2.50 
  Prescribed  
Free prescription 
Bought by yourself over the counter 
 
  Prescribed  
Free prescription 
Bought by yourself over the counter 
 
  Prescribed  
Free prescription 
Bought by yourself over the counter 
 
  Prescribed  
Free prescription 










2) USE OF WALKING AIDS 
 
2a) During the last 2 weeks, did you use any walking-aids (crutches, walking-frame, wheelchairs etc.) because you had difficulty walking as a 
result of your pelvic girdle pain? 
 
YES                     NO                    
 
 
2b) If YES, please specify: 
 
What type of walking aid did you 
use? 
How did you obtain this walking aid? If bought/rented by yourself, how much 
did you pay? 





























3) USE OF HEALTH SERVICES 
 
3a) During the last 2 weeks, did you use the services of a health-practitioner to treat your pelvic girdle pain? 
 
YES                  NO 
  






Service  If treatment was obtained privately, how 
much did you pay per visit? 
How many times did you see the 
health-practitioner during the last 2 
weeks? (put number in box) 
Family Doctor (GP) NHS (leave blank) NHS 
Midwife NHS (leave blank) NHS 
Obstetrician NHS (leave blank) NHS 
Physiotherapist (PT) NHS 
 
Private Practice 
Less than £30 
£30- £50 





Occupational Therapist (OT) NHS 
 
Private Practice 
Less than £30 
£30- £50 





Chiropractor Private Practice Less than £30 
£30- £50 






Less than £30 
£30- £50 








4) TRAVEL COSTS 
 
4a) How much did you spend on travel costs (e.g. bus/taxi/train fares) to attend 
these appointments over the last 2 weeks? 
   
            £                          . 
4b)  If you used your own car to attend health-care appointments, please tell us 
the approximate number of miles travelled. 





5a) How many hours do you work (on average) per week? (If employed) 
 
        Hours: 
 
5b) During the last 2 weeks, did you have to take any days off from work because 
of your pelvic girdle pain? 
 
YES                 NO                  
 
 
5c) If YES, how many days have you been absent from work because of your 
pelvic girdle pain over the last 2 weeks?  
  Days: 
5d) Have you lost any earnings over the last 2 weeks, as a result of your pelvic 
girdle pain? 
 
YES                    NO                  
 
 
 5e) Have you given up any leisure time in the last 2 weeks, as a result of your 
pelvic girdle pain?     
YES                 NO                  
 
 







6) SUPPORT FROM OTHERS 
 
6a) During the last 2 weeks, have friends and/or relatives stayed off work to help 
you? 
 
YES                     NO                  
 
 
6b) If YES, how many days did they take off from work during the last 2 weeks?  
  Days: 
 
 
7) COMPLIANCE WITH TREATMENT 
 
7a) During the last 2 weeks, for how many days did you wear your pelvic 
garment? 
 Every day 
             
 If not every day, please specify for how many days you didn’t wear it:  
 
           Days: 
 
7b) During the last 2 weeks, approximately how many hours per day did you wear 
your  
pelvic garment?  
    
 12 hours (recommended) 
 
 More than 12 hours 
 
 Less than 12 hours 
 
7c) If you didn’t wear your pelvic garment every day, or wore it for less than 12 
hours per day, 















 Aesthetic reasons 
 





















Appendix 6. Washing advice 
WEARING AND CARING FOR YOUR GARMENT 
 
Wearing your garment 
For best results, you should wear the shorts during the day (recommended: 12 
hours) including (if desired) for activities such as swimming. Do not wear the 
shorts at night as they may cause circulation problems. If irritation or rash is 
encountered, discontinue use and see a doctor. 
 
Care of your garment: 
The shorts are extremely easy to care for. They can be washed either by hand, or 
in a washing machine at 30°C. Their lightweight composition enables them to dry 
overnight, ready for next day use. Do not tumble dry or place over heat source 
(e.g. radiators). 
 
If you have any questions please contact: 
 
Mr Lee Cameron   TEL: (01752) 587541 
















































MANAGEMENT OF POST-PARTUM PELVIC GIRDLE PAIN: EVALUATING THE EFFECTIVENESS OF A 
CUSTOMISED PELVIC SUPPORT GARMENT 
 
Researcher taking Consent:  Lee Cameron  
 
PLEASE INITIAL ALL BOXES                    
              
 Name of Participant      _______________________________________________________ 
 
1 
I confirm that I have read and understood the information sheet (Version 1, 
September 3rd 2013) for the above study and have had the opportunity to ask 
questions. 
 
2 I confirm that I have had the opportunity to discuss the study with the researcher. 




I understand that the information collected during this study will remain strictly 
confidential and accessible only to appropriate members of the research team. 
 
4 I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason and without affecting my medical or 
physiotherapy care or legal rights.  
 
5 I agree that auditors, monitors, regulatory authorities and ethics committees may 
have restricted access to my research records. 
 
6 I agree to my GP being notified of my participation 
 
 
7 I agree to take part in the above study  





 Date            ____________________   Signature __________________________________ 
 
 Name of Person taking consent   _______________________________________________ 
Date           ____________________    Signature __________________________________ 
 























Management of postpartum pelvic girdle pain: replicated 
single case series study evaluating the effectiveness of a 
customised elastomeric fabric orthoses (DEFO) 
 
          
                   
                    
Participant Number:  
 
 
Questionnaire Week No:  
 
 
Date Sent:                                                                                  
 
 
Date Completed:   
(please fill this in) 
 
 





 We hope that you will complete this questionnaire booklet since the information you provide is 
very important for the success of the project. If you have trouble reading or writing you can ask 
someone to help you. 
 
 You may find some of the questions a bit repetitive, or possibly not very relevant to you, however 
please answer all the questions in this booklet. 
 
 If you have any questions about completing the questionnaire booklet please call the researching 
physiotherapist Mr. Lee Cameron at: 01752-587541, or the research supervisor Dr. Jenny Freeman 
at: 01752-588835, or email us @ pelvicpainstudy@plymouth.ac.uk and they will be glad to 
help you. 
 
 Please note that your full name does not appear anywhere in this booklet and all the information 
that you provide will be treated with complete confidentiality. 
 
 It is important that you complete this questionnaire on the last day of the one-week interval, or as 
close to it as possible. 
 
 Please return the completed questionnaire booklet to Plymouth University in the stamped 



















NUMERIC RATING SCALE FOR PAIN INTENSITY 
 
Instructions: 
On a scale from 0 to 10 please circle the number that best describes 
the level of your pelvic pain: 
 
4) Over the last week, how would you rate your average level of pelvic pain 
during the day? 
 
 
      0     1       2       3       4      5      6       7      8       9      10 
 NO PAIN                                                                                             UNBEARABLE                                               
                MILD PAIN    MODERATE PAIN   SEVERE PAIN            PAIN       
 
                                    
 
5) Over the last week, how would you rate your average level of pelvic pain 
during the night (after going to bed)? 
 
 
      0     1       2       3       4      5      6       7      8       9      10 
 NO PAIN                                                                                             UNBEARABLE                                               
               MILD PAIN     MODERATE PAIN    SEVERE PAIN            PAIN       
 









          
          
          




PELVIC GIRDLE QUESTIONNAIRE  
To what extent do you find it problematic to carry out the activities listed below because of 
pelvic girdle pain? For each activity tick the box that best describes how you are today. 
 
 
How problematic is it for you 
because of your 




















To a large  
extent (3) 
26) Dress yourself     
27) Stand for less than 10 minutes     
28) Stand for more than 60 minutes    
29) Bend down     
30) Sit for less than 10 minutes     
31) Sit for more than 60 minutes     
32)  Walk for less than 10 minutes     
33) Walk for more than 60 minutes     
34) Climb stairs     
35) Do housework     
36) Carry light objects     
37) Carry heavy objects      
38) Get up/sit down     
39) Push a shopping cart     
40) Run     
41) Carry out sporting activities*      
42) Lie down      
43) Roll over in bed       
44) Have a normal sex life*     
45) Push something with one foot     
*If not applicable, mark box to the right 
How much pain do you experience None (0) Some (1) Moderate (2) Considerable (3) 
46) In the morning     
47) In the evening     
 
 
To what extent because of  
pelvic girdle pain: 
 
Not at  
all (0) 
 







To a large  
extent (3) 
48) Has your leg/have your legs 
given away? 
    
49) Do you do things more slowly?     




































This survey asks for your views about your health. This information will help keep track of 
how you feel and how well you are able to do your usual activities. 
Answer every question by marking the answer as indicated. 
If you are unsure about how to answer a question, please give the best answer you can. 







                                                                                     Circle one number 
Much better now than one year ago…………………………………. 1 
Somewhat better now than one year ago…………………………….2 
About the same as one year ago……………………………………...3 
Somewhat worse now than one year ago…………………………….4 





SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
14) The following questions are about activities you might do during 
a typical day. 
Does your health now limit you in these activities? If so, how much? 
 











k) Vigorous activities, such as running, lifting 
heavy objects, participating in strenuous sports 
1 2 3 
l) Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or playing 
golf 
1 2 3 
m) Lifting or carrying groceries 1 2 3 
n) Climbing several flights of stairs 1 2 3 
o) Climbing one flight of stairs 1 2 3 
p) Bending, kneeling, or stooping 1 2 3 
q) Walking more than a mile 1 2 3 
r) Walking half a mile 1 2 3 
s) Walking one hundred yards 1 2 3 
t) Bathing or dressing yourself 1 2 3 
 
15) During the past week, how much of the time have you had any 
of the following problems with your work or other regular daily activities as a 
result of your physical health? 
 
















b) Cut down the amount of time you 
spent on work or other activities 
1 2 3 4 5 
b) Accomplished less than you would 
like 
1 2 3 4 5 
e) Were limited in the kind of work or 
other activities  
1 2 3 4 5 
f) Had difficulty performing the work or 
other activities (e.g. it took extra effort) 







SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
16) During the past week, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any 
emotional problems (such as feeling depressed or anxious)? 
 
 
















d) Cut down the amount of time you 
spent on work or other activities 
1 2 3 4 5 
e) Accomplished less than you would 
like 
1 2 3 4 5 
f) Didn’t do work or other activities as 
carefully as usual 
1 2 3 4 5 
 
17) During the past week, to what extent has your physical health or 
emotional problems interfered with your normal social activities with family, 



















                                                Circle one number 
Not at all…………………………………...1 
Slightly……………………………….........2 
Moderately………………………………...3 
Quite a bit………………………………….4 
Extremely………………………………….5 
 











SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
19)  During the past week, how much did pain interfere with your normal work 









20) These questions are about how you feel and how things have been with you 
during the past week. For each question, please give the one answer that 
comes closest to the way you have been feeling. How much of the time during 
the past week… 
 

















j) Did you feel full of life? 1 2 3 4 5 
k) Have you been a very nervous person? 1 2 3 4 5 
l) Have you felt so down in the dumps 
than nothing could cheer you up? 
1 2 3 4 5 
m) Have you felt calm and peaceful? 1 2 3 4 5 
n) Did you have a lot of energy? 1 2 3 4 5 
o) Have you felt downhearted and low? 1 2 3 4 5 
p) Did you feel worn out? 1 2 3 4 5 
q) Have you been a happy person? 1 2 3 4 5 







                                                Circle one number 
Not at all……………………………………1 
A little bit…................................................2 
Moderately................................................3 






SHORT FORM 36-ITEM HEALTH SURVEY (SF-36v2) continued 
21) During the past week, how much of the time has your physical health or 










22) How TRUE or FALSE is each of the following statements for you? 
 











e) I seem to get ill a little easier than other 
people 
1 2 3 4 5 
f) I am as healthy as anybody I know 1 2 3 4 5 
g) I expect my health to get worse 1 2 3 4 5 











                                   Circle one number 
All of the time……………………………1 
Most of the time………………................2 
Some of the time……….…………….....3 
A little of the time…................................4 





EQ-5D HEALTH QUESTIONNAIRE 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
MOBILITY 
 I have no problems in walking about                                                                     
 I have slight problems in walking about                                              
 I have moderate problems in walking about                                        
 I have severe problems in walking about                                          
 I am unable to walk about  
                                                                
SELF-CARE 
 I have no problems washing or dressing myself 
 I have slight problems washing or dressing myself 
 I have moderate problems washing or dressing myself 
 I have severe problems washing or dressing myself 
 I am unable to wash or dress myself 
 
USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities) 
 
 I have no problems doing my usual activities 
 I have slight problems doing my usual activities 
 I have moderate problems doing my usual activities 
 I have severe problems doing my usual activities 
 I am unable to do my usual activities                                                     
 
PAIN/DISCOMFORT 
 I have no pain or discomfort 
 I have slight pain or discomfort 
 I have moderate pain or discomfort 
 I have severe pain or discomfort 
 I have extreme pain or discomfort 
 
ANXIETY/DEPRESSION 
 I am not anxious or depressed 
 I am slightly anxious or depressed 
 I am moderately anxious or depressed 

























 We would like to know how good or bad your health  
is TODAY. 
 This scale is numbered from 0 to 100. 
 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
 Mark an X on the scale to indicate how your health is 
TODAY. 












RESOURCE USE FOR PELVIC GIRDLE PAIN (PGP) 
 
1) MEDICATION USE 
 
1a) During the last week, did you use any kind of pain-relieving or other type of medication to treat your PGP?  
 
YES                    NO 
  
1b) If YES, please specify: 
 
Name of medicine How many tablets did you take 
and how often? 
How did you obtain this medicine? If the medicine was bought by yourself, how 








Bought by yourself over the counter 
£2.50 
  Prescribed  
Free prescription 
Bought by yourself over the counter 
 
  Prescribed  
Free prescription 
Bought by yourself over the counter 
 
  Prescribed  
Free prescription 
Bought by yourself over the counter 
 
  Prescribed  
Free prescription 







USE OF WALKING AIDS 
 
2a) During the last week, did you use any walking-aids (crutches, walking-frame, wheelchairs etc.) because you had difficulty 
walking as a result of your pelvic girdle pain? 
 
YES                     NO                    
 
 
2b) If YES, please specify: 
 
What type of walking aid did you 
use? 
How did you obtain this walking aid? If bought/rented by yourself, how much 
did you pay? 



























6) USE OF HEALTH SERVICES 
 
3a) During the last week, did you use the services of a health-practitioner to treat your pelvic girdle pain? 
 
YES                  NO 
  





Service  If treatment was obtained privately, 
how much did you pay per visit? 
How many times did you see the 
health-practitioner during the last 2 
weeks? (put number in box) 
Family Doctor (GP) NHS (leave blank) NHS 
Midwife NHS (leave blank) NHS 
Obstetrician NHS (leave blank) NHS 
Physiotherapist (PT) NHS 
 
Private Practice 
Less than £30 
£30- £50 





Occupational Therapist (OT) NHS 
 
Private Practice 
Less than £30 
£30- £50 





Chiropractor Private Practice Less than £30 
£30- £50 






Less than £30 
£30- £50 








3) TRAVEL COSTS 
 
4a) How much did you spend on travel costs (e.g. bus/taxi/train fares) to 
attend these appointments over the last 2 weeks? 
   
            £                          . 
4b)  If you used your own car to attend health-care appointments, please tell 
us the approximate number of miles travelled. 





5a) How many hours do you work (on average) per week? (If employed) 
 
        Hours: 
 
5b) During the last 2 weeks, did you have to take any days off from work 
because of your pelvic girdle pain? 
 
YES                 NO                  
 
 
5c) If YES, how many days have you been absent from work because of your 
pelvic girdle pain over the last 2 weeks?  
  Days: 
5d) Have you lost any earnings over the last 2 weeks, as a result of your 
pelvic girdle pain? 
 
YES                    NO                  
 
 
 5e) Have you given up any leisure time in the last 2 weeks, as a result of 
your pelvic girdle pain?     
YES                 NO                  
 
 
     
5) SUPPORT FROM OTHERS 
 
6a) During the last week, have friends and/or relatives stayed off work to help 
you? 
 






6b) If YES, how many days did they take off from work during the last 2 
weeks?  




6) COMPLIANCE WITH TREATMENT 
 
7a) During the last week, for how many days did you wear your pelvic 
garment? 
 Every day 
             
 If not every day, please specify for how many days you didn’t wear it:  
 
           Days: 
 
7b) During the last week, approximately how many hours per day did you 
wear your  
pelvic garment?  
    
 12 hours (recommended) 
 
 More than 12 hours 
 
 Less than 12 hours 
 
7c) If you didn’t wear your pelvic garment every day, or wore it for less than 
12 hours per day, 










 Restriction of movement 
 
 Aesthetic reasons 
 





Appendix 11a – Serola Belt 
 





1 Brief name Serola belt, (Serola biomechanics, Inc, https://www.serola.net/)  
 
2 Why The pelvic orthotic is an external compression device aimed at increasing stiffness 
and stability through the pelvis. It is designed to improve pain by providing targeted 
stability, support and re-alignment of the pelvis, whilst optimising movement and 
function. It is postulated that a reduction in shear forces through the symphysis pubis 
and sacroiliac joints leads to a reduction in pain irritation.  
3 What materials The Serola Belt consists of an open cell urethane inner layer (3” in width), wrapping 
the circumference of the pelvic girdle and fastening with Velcro tape. It has added 
extra-strong, double-pull elastic straps, which can be applied, also with Velcro tape, 
for further tension and support  
4 What: Procedures When the participant was fitted with the Serola belt they were also provided with a 
standard advice sheet regarding the washing of their orthotic and a standard advice 
booklet from the association of Pelvic, Obstetric and Gynaecological Physiotherapy 
(POGP), https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf.  
 
5 Provider A senior musculoskeletal physiotherapist (Band 7) who was experienced in assessing 
and treating females with pregnancy related pelvic girdle pain (PGP) by following 




6 How If randomised to the Serola belt group, each participant received their own Serola 
belt. 
7 Where The participant would wear these during their normal daily activities. 
8 When and how much  
a) Intensity Participants were advised not to wear their Serola belt for longer than 12 hours each 
day and not to be wear them at night. 
b) Frequency Participants would wear their Serola belt daily. There was potential for some 
participants to wear their Serola belt for longer periods depending on which 
trimester they entered the trial on. However, minimisation was used to balance 
groups for gestation.  
c) Session time One face-to-face physiotherapy session to fit the orthotic and provide advice.  
Orthotic wear time: Advised not to wear for longer than 12 hours per day. 
d) Overall duration Orthotic worn for the duration of the participant’s engagement in the study, with 
advice to continue to wear the orthotic following cessation of the trial if they wished.  
Advised not to wear orthotic for longer than 12 hours per day. 
9 Tailoring Individual measurements were undertaken for each participant who was allocated to 
the Serola group. The Serola belt group only required one measurement around their 
waist; however, to maintain consistency and ensure equal time spent on the 
measurement process, every participant underwent customised DEFO measurements 
(see Appendix 11b). 
10 Modification There were no modifications to the intervention during the course of the study. 
11 How well: Planned  
a) Fidelity strategies No other strategies were used to maintain or improve fidelity 
b) Fidelity assessment Not assessed 







Appendix 11b – Customised Dynamic Elastomeric Fabric Orthosis (DEFO) 
 





1 Brief name Customised Dynamic Elastomeric Fabric Orthoses (DEFO), (DM Orthotics’ Ltd, 
https://www.dmorthotics.com)  
2 Why The pelvic orthotic is an external compression device aimed at increasing stiffness 
and stability through the pelvis. It is designed to improve pain by providing targeted 
stability, support and re-alignment of the pelvis, whilst optimising movement and 
function. It is postulated that a reduction in shear forces through the symphysis pubis 
and sacroiliac joints leads to a reduction in pain irritation.  
3 What materials The customised DEFO is a Lycra based orthotic, designed in the form of customised 
pelvic support shorts, with biomechanically positioned lycra and powernet 
reinforcement panels.  
4 What: Procedures When the participant was fitted with the DEFO they were also provided with a 
standard advice sheet regarding the washing of their orthotic and a standard advice 
booklet from the association of Pelvic, Obstetric and Gynaecological Physiotherapy 
(POGP), https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf.  
5 Provider A senior musculoskeletal physiotherapist (Band 7) who was experienced in assessing 
and treating females with pregnancy related pelvic girdle pain (PGP) was trained by 
DM Orthotics to undertake the measurements required for the DEFO. 






7 Where The participant would wear these during their normal daily activities. 
 
8 When and how much  
a) Intensity Participants were advised not to wear their DEFO for longer than 12 hours each day 
and not to be wear them at night. 
b) Frequency Participants would wear their DEFO daily. There was potential for some participants 
to wear their DEFO for longer periods depending on which trimester they entered the 
trial on. However, minimisation was used to balance groups for gestation. 
c) Session time One face-to-face physiotherapy session to fit the orthotic and provide advice.  
Orthotic wear time: Advised not to wear for longer than 12 hours per day. 
d) Overall duration Orthotic worn for the duration of the participant’s engagement in the study, with 
advice to continue to wear the orthotic following cessation of the trial if they wished.  
Advised not to wear orthotic for longer than 12 hours per day. 
9 Tailoring Individual measurements were undertaken for each participant who was allocated to 
the DEFO group. Depending on which trimester they entered the trial, they would 
undergo wither 12 measurements (2nd Trimester) or 13 measurements (3rd 
trimester). This required a combination of circumferential measurements of the 
torso, pelvis and thighs, along with linear measurements of the torso, pelvis and 
thighs to establish length. The extra measurement in the third trimester required an 
additional circumferential measurement at the level of the sternum to cater for 
growth during the third trimester.  
10 Modification There were no modifications to the intervention during the course of the study. 
11 How well: Planned  
a) Fidelity strategies No other strategies were used to maintain or improve fidelity 
 
b) Fidelity assessment Not assessed  
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